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Abstract

TRANSLATIONAL INSIGHTS INTO THE GENETIC BASIS OF MENTAL HEALTH
DISORDERS: EXAMINING RISK FACTOR MODELS, NEUROIMAGING, AND CURRENT
DISSEMINATION PRACTICES
By Jessica Lynn Bourdon, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy of Clinical and Translational Sciences – Psychiatric, Behavioral, and Statistical
Genetics concentration at Virginia Commonwealth University.
Virginia Commonwealth University, 2019.
Director: John M. Hettema, Associate Professor, Department of Psychiatry, Virginia Institute for
Psychiatric and Behavioral Genetics

Psychiatric genetics is a basic science field that has potential for practical application and
effective translation. To date, translational frameworks utilized by this field have been linear
(e.g., sequential) in nature, focusing on molecular genetic information. It is proposed that nonlinear (e.g., socio-ecological) frameworks are a better way to immediately translate nonmolecular genetic information. This dissertation explored the translation of psychiatric genetic
information in two ways. First, a survey was sent to academic stakeholders to assess the state of
the science regarding the translation of genetic information to the clinical care of mental health
disorders. Findings from this indicate a translation-genetic competence gap whereby genetic
knowledge reinforces linear frameworks and genetic competence is needed to achieve effective
translation in this content area. Second, a new risk factor model for social anxiety was created
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that incorporated genetic, environmental, and neurophysiological risk factors (behavioral
inhibition, parental bonding, emotion reactivity). Findings indicate that genetic etiology is more
informative knowledge that can influence risk factor models and possibly prevention and
intervention efforts for social anxiety. Overall this dissertation paves the way for examining the
translational capacity of psychiatric genetics in a clinical setting. It constitutes the first
examination of barriers to and a potential solution for the most effective translation of psychiatric
genetic information.

xiii

Chapter 1: The Intersection of Translational Science and Psychiatric Genetics
Introduction
Effective development and translation of genetically-informed models is key to
leveraging our knowledge of the etiology of psychiatric diseases and improving treatment
(International Society of Psychiatric Genetics, 2017). As we enter a post-genome-wide
association study (GWAS) era, it is time to reflect upon the breadth and application of genetic
information to maximize its impact (Dick et al., 2018). While genetically-informed research
utilizes data from epidemiological (twin, family) and molecular (linkage, GWAS, genome-wide
complex trait analysis, next-generation sequencing, polygenic risk scores, epigenetics) sources
(Kendler & Eaves, 2005), the latter has been the primary focus of any genetics-related
translational efforts (Fernandez et al., 2013; Kimball, Nowakowski, Maschke, & McCormick,
2014; Klitzman et al., 2013; Sullivan et al., 2018). Translation of this type of information has
been effective for chronic, physical disorders such as cardiovascular disease (Arnett et al., 2007;
Ebomoyi, 2013; Vornanen et al., 2016; Khera & Kathiresan, 2017), breast cancer (Cornel & El,
2017; Gil et al., 2003; Macdonald, Sarna, Weitzel, & Ferrell, 2009; Norman & Brain, 2005;
Phillips et al., 2006), macular degeneration (Black & Clark, 2016), and other similarly complex
disorders. However, it has had little effect on the care of psychiatric conditions (International
Society of Psychiatric Genetics, 2017; Sullivan, Daly, & O’Donovan, 2012; Sullivan et al., 2018;
Visscher et al., 2016). There are several key barriers that have prevented forward momentum in
translating genetic information to the care of mental health disorders.
Barriers to translating genetic information broadly, regardless of disorder type, include
education and training, stigma, overall engagement of stakeholders (Sperber et al., 2017; Zhou et
al., 2014), and disagreement over whose responsibility it is to discuss genetic information with
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patients (Sullivan et al., 2012; Visscher et al., 2016; Finn & Smoller, 2006). These barriers are
amplified in the context of mental health care. This is likely due to the assumption that the
translational frameworks that have been effective for chronic, physical conditions will be equally
effective for psychiatric disease. Such an assumption has been bolstered by recent success in
identifying and replicating genetic variants associated with Schizophrenia (Schizophrenia
Working Group of the Psychiatric Genomics Consortium, 2014; International Schizophrenia
Consortium, 2009), bipolar disorder (International Schizophrenia Consortium, 2009), and autism
spectrum disorder (ASD) (Schizophrenia Working Group of the Psychiatric Genomics
Consortium, 2014). (For broader discussions also see: Cross-Disorder Group of the Psychiatric
Genomics Consortium, 2013; Dick et al., 2018; Sullivan et al., 2012; Visscher et al., 2016).
However, these disorders are the exception rather than the norm for what is currently understood
about psychiatric disorders at the molecular genetic level. The mental health conditions for
which we know the most at a molecular level tend to display higher heritability. This means that
at the population level, most of the variance that is associated with development of the disorders
can be currently attributable to genetic risks. However, most psychiatric disorders have at least
equal influences of genetic and environmental factors, if not more influences of the environment
(Polderman et al., 2015). The vast majority of psychiatric disorders have little-to-no known
replicated molecular genetic variants. There have been some replicated variants associated with
alcohol use disorder (AUD) (Bierut et al., 2012; Gelernter et al., 2014), cannabis use disorder
(Agrawal et al., 2018), and depression (CONVERGE Consortium, 2015), but these variants
account for such little genetic variance and are likely not actionable anytime in the near future.
What is known about all psychiatric disorders, though, derives from twin and family sources
(i.e., non-molecular genetic epidemiological data).
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By shifting focus from molecular to epidemiological sources of genetic information, there
should be an accompanying shift in translational frameworks used when approaching researchto-practice in this area. There should also be a shift toward determining the translational
applicability of not just psychiatric genetic information broadly, but information specific to
common mental health conditions where more epidemiological than molecular information is
known (i.e., shift from focusing on molecular to non-molecular information). It is in these shifts
that appropriate examination of how best to incorporate genetic information into the care of
mental health disorders can occur.
This dissertation examines these shifts both broadly and specifically. The first aim
assesses the state of the science regarding the translation of genetic information to the clinical
care of mental health disorders. The second develops a genetically-informed risk factor model
for pre-adolescent social anxiety by examining its relationship with behavioral inhibition and
parental bonding. The final aim is an extension of the second, assessing the inclusion of
neurophysiological data into the risk factor model for pre-adolescent social anxiety. Together,
these aims will constitute the first examination of barriers to and a potential solution for the most
effective translation of psychiatric genetic information.
Translational Science Frameworks
There are many approaches of translational science, each with specific purposes and foci.
When considering how best to translate genetic studies for use in mental health care, five
approaches are commonly considered: (a) bench-to-bedside, (b) precision medicine, (c)
dissemination and implementation science, (d) prevention science, and (e) research-to-policy.
The first two frameworks are traditional and linear in nature (van der Laan & Boenink, 2012)
having been commonly used when translating genetic information as already mentioned and with
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little effect for psychiatric conditions (Visscher et al., 2016). The latter three take a socioecological approach to translation and as such, may be better suited for translation of nonmolecular genetic information in treating mental health conditions.
Bench-to-bedside is an approach that begins with basic bench science aimed at
identifying mechanisms for disease and moves through a structured series of studies to examine
the applicability of basic findings to treatment of disease (Waldman & Terzic, 2010; Khoury et
al., 2007). Personalized medicine is broadly the use of any biological information about an
individual patient to improve their health that may be acquired from the bench or beyond (i.e.,
family history of disease, known drug allergies, etc.) (Collins & Varmus, 2015; Jameson &
Longo, 2015). More often than not, it is the application of bench-to-bedside findings (i.e.,
techniques or drugs deemed effective and efficacious in clinical trials). Both bench-to-bedside
and precision medicine utilize biological information and thus, in the context of psychiatric
disorders, rely heavily on gene-finding efforts that have thus far been unsuccessful (Visscher et
al., 2016; Sullivan et al., 2016) except for the aforementioned highly heritable diseases
(Schizophrenia, bipolar disorder, ASD) (Schizophrenia Working Group of the Psychiatric
Genomics Consortium, 2014; International Schizophrenia Consortium, 2009; Cross-Disorder
Group of the Psychiatric Genomics Consortium, 2013). They also focus on treatment and
intervention with a patient-level perspective.
Dissemination and implementation science (D&I) is another approach to translation.
Similar to the former two approaches, D&I embraces an individualized view of translation by
focusing on treatment and intervention more than prevention, although this is beginning to
change (Collins & Varmus, 2015). Unlike the bench-to-bedside and precision medicine, D&I
uses multiple lenses to understand and model how scientific findings can influence services
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downstream. Most D&I frameworks emphasize building interventions with the ecology of the
service system in mind including the perspectives of multiple stakeholders. For example,
interventions specific to mental health must consider patient, family, provider, agency, and
broader systemic perspectives to achieve the most beneficial public health effects (Atkins,
Rusch, Mehta, & Lakind, 2016; Schoenwald & Hoagwood, 2001; see also Cox, Martinez, &
Southam-Gerow, 2019). The ecological approach of D&I science relies more heavily on
collaborations among stakeholders and assumes a non-linear path to translation (van der Laan &
Boenink, 2012; Chambers & Azrin, 2013; Glasgow et al., 2012). This deep communication and
collaboration improves the flow of information between stakeholders and brings a focus to both
persons and settings in the socio-ecology (Atkins et al., 2016), ultimately leading to more
informed treatment and improved patient outcomes.
Prevention science is a translational approach similar to D&I science in that also focuses
on collaboration and involvement of multiple stakeholders. However, prevention science focuses
on general public health with a strong emphasis on prevention efforts more so than treatment or
intervention (Bradshaw & Haynes, 2012). Examples can be found in community-based
participatory research (Minkler & Wallerstein, 2008), public health genomics (Arnett et al.,
2007; McBride et al., 2010), and school-based programs (Conrod et al., 2013; Schuckit et al.,
2012). Here, emphasis is placed on screenings, health education, and similar public health
approaches to identify individuals who are at risk of a disorder. Finally, research-to-policy is the
translation of knowledge into policy changes at the local, state, or federal level. While the
remainder of the dissertation will not focus on this framework, it still deserves mention. There
are no specific policies about genetic information specific to mental health. Even 23andMe does
not offer testing for mental health conditions (the most closely related variant that they test for is
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the one responsible for the alcohol flush reason) and strongly advise against using their tests for
health reasons (23andMe Inc., 2019). However, organizations such as the American Society for
Human Genetics have made official statements warning patients about the results of direct-toconsumer marketing of genetic tests (Hudson, Javitt, Burke, & Byers, 2007). There is also a
lively research base investigating the ethics of biobanking (Kimball et al., 2014) and the return of
incidental findings to patients (Fernandez et al., 2013; Klitzman et al., 2013; Ramoni et al., 2013;
Wilson et al., 2016), issues which will likely lead to official policy in the near future.
A Brief Overview of Psychiatric Genetic Information
Psychiatric genetics is a basic science field but has potential for practical application and
translation. There are three key questions that comprise the foundation of the field: (a) do genes
affect a trait, (b) how much do genes affect a trait, and (c) where/what are the genes. The first
two questions fall under the non-molecular, genetic epidemiology umbrella while the latter
utilizes molecular genomic techniques (Kendler & Eaves, 2005). It is widely accepted that for
complex traits such as psychiatric disorders, each trait is the product of the effects of hundreds (if
not thousands) of genes that themselves are inherited by Mendel’s traditional laws of inheritance
(infinitesimal model) (Fisher, 1918). The effect of each gene will contribute little to the overall
variation of the trait, but all of the genes create a cumulative effect (i.e., the trait) with a normal
distribution (central limit theorem) (Neale, Ferreira, Medland, & Posthuma, 2008). This normal
distribution likely represents an additive model whereby the effect of each individual gene
aggregates to form the likelihood of disease when also combined with environmental factors. In
biometrical modeling (Neale & Cardon, 1992), the averaged cumulative effects at each
quantitative trait locus (i.e., the alleles of a gene) are estimated based on the expected
correlations between varying types of related individuals, in particular twins. Using this basic
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knowledge, heritability estimates, family history and aggregation of a trait, gene-environmental
interplay, endophenotypes (intermediate phenotypes), sibling contrast effects, cultural
transmission, genetic attenuation and innovation, and more (Neale & Cardon, 1992) can be
estimated without needing to rely on molecular techniques. The specific epidemiological
techniques for these types of analyses will be discussed in subsequent chapters.
Shifting Focus to a Specific Disorder: Social Anxiety
Due to the fact that most psychiatric disorders are common and the product of the
environment plus hundreds or thousands of genes (i.e., polygenic effects), additional questions
that focus on the translation of information need to be posited in the field of psychiatric genetics
which complement the core three. These are: (a) is this information actionable, (b) if so, for
whom is this information actionable, (c) how can this information be used, and (d) what are the
barriers to using this information. Such questions make the field of psychiatric genetics, and
genetic information in general, more approachable for all stakeholders involved in translating
such information to clinical care. Instead of focusing on rare psychiatric disorders, this
dissertation examines these questions in the context of pre-adolescent social anxiety, a common
mental health concern.
Social anxiety is a major public health concern affecting 9.1% (Merikangas et al., 2010)
of adolescents with a mean age of onset of 10-13 years. (Rapee & Spence, 2004). It is associated
with several negative outcomes (Chansky & Kendall, 1997; Erath, Flanagan, & Bierman, 2007;
Spence, Donovan, & Brechman-Toussaint, 1999) and treatment and/or early intervention are
usually needed to help with symptoms (Hirshfeld-Becker & Biederman, 2002). Despite the fact
that social anxiety has a pre-adolescent mean age of onset, only the genetic epidemiology of
social anxiety in adults has been well-researched using twin methodology (Hettema, Neale, &
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Kendler, 2001; Hettema et al., 2005; Kendler, Gardner, & Lichtenstein, 2008). In addition,
neurophysiology is broadly of interest due to its biological nature and implicit ties to genetic
information (Moore, Sawyers, Adkins, & Docherty, 2017). Specific to social anxiety, while its
neurophysiology is widely studied, there is little research on the neurophysiology of the disorder
in pre-adolescents and in relation to other phenotypic risk factors. To our knowledge, no
comprehensive risk factor model exists for pre-adolescent SOC that incorporates genetic
epidemiology or neurophysiological data. This lack of inclusion of all available biological
information inhibits the flow of information to other researchers, clinicians, patients, and other
key stakeholders. Thus, there is currently no way to assess whether such information is
actionable, for whom, and how it can be used.
The standard treatment for pediatric social anxiety is cognitive behavioral therapy or
parent-based therapy (Aune & Stiles, 2009; Gould et al., 1997; Hirshfeld-Becker et al., 2010;
Spence, Donovan, & Brehcman-Toussaint, 2000), neither of which take genetically- or
neurologically-informed findings into account. The risk factor model in this dissertation may
serve as the first step toward creating a preventative intervention for social anxiety that takes
these new factors into account. To date, prevention efforts for pediatric social anxiety also utilize
cognitive behavioral therapy (Aune & Stiles, 2009) or focus on parental intervention (Gould et
al., 1997; Bayer et al., 2010). It is not unreasonable to think that non-molecular genetic or
neurological information in the form of a risk factor model could inform treatment or prevention
efforts and thus patient outcomes (Dick et al., 2018). This can be accomplished by focusing on a
few key risk factors (e.g., Degnan, Almas, & Fox, 2010) where the mechanisms of the
relationship between the risk factors and disorder of interest can be examined in more depth.
This is in contrast to broad models that may not provide much detail (e.g., Acarturk et al., 2009;
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Ollendick & Benoit, 2012; Rapee & Hemberg, 1997; Rapee & Spence, 2004). Thus, this
dissertation will focus on the relationship between one key risk factor for social anxiety disorder,
behavioral inhibition, and two other factors related to both phenotypes, parental bonding and
emotion reactivity (the latter constitutes a neurophysiological risk factor). Both are highly
associated with pediatric SOC (Rapee & Spence, 2004; Bayer et al., 2011; Bayer, Sanson, &
Hemphill, 2006; Fox et al., 2005) but the specific genetic and neuroimaging mechanisms
surrounding these relationships are not well understood.
Dissertation Roadmap
This dissertation is made up of two key sections. The first focuses on translational
insights into psychiatric genetic research. It is comprised of two chapters that provide a literature
review on translational science in the context of psychiatric genetics and a description of a
survey designed to assess the translation of genetic information into mental health care (aim 1),
respectively. The next section dives into translating from the ground up; in other words,
beginning with basic science research questions with potential implications for practice. This
section ends by discussing potential ecological perspectives on translating non-molecular
information into mental health care. In total, this section has five chapters that create a risk factor
model of pre-adolescent social anxiety by examining its relationship with BI from biometrical
(aim 2) and neuroimaging (aim 3) perspectives.
Overall, this dissertation will examine global and specific aspects of translating
psychiatric genetic information to the clinical care of mental health disorders. Results will
identify global barriers to this translational practice as well as create a risk factor model with
potential implementation capability specific to one common disorder. All efforts will be made to
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maintain a collaborative, socio-ecological perspective of translation throughout this dissertation,
although admittedly aims 2 and 3 have more of a linear flavor than desired.
Dissertation Aims
The aims and corresponding hypotheses, steps, and research questions for this
dissertation can be found below in Table 1.1.
Table. 1.1. Outline of dissertation aims.
Aim
Aim 1: Assess the state
of the science regarding
the translation of genetic
information to the
clinical care of mental
health disorders from an
academic perspective.

Hypothesis, Step, and/or Research question
Step 1: Descriptive statistics for each variable to get overview of
the state of the science
Step 2: Examine hypotheses / research questions from step 1 (see
below)
Step 3: Analysis of key open-ended questions
Step 4: Limited psychometrics

Chapter(s)
3

Hypothesis 1.1: There will be positive relationships between
genetic competence and questions about (a) current translational
practices, (b) the importance of translation, (c) willingness to
improve own translational skills, and (d) impact on care. In other
words, the stronger participants’ genetic competence then the more
thoroughly they can think about translating genetic information.
Hypothesis 1.2: There will be positive relationships between
genetic knowledge and questions about (a) current translational
practices, (b) the importance of translation, (c) willingness to
improve own translational skills, and (d) impact on care, but these
relationships will not be as strong as those for genetic competence.
In other words, the stronger participants’ genetic competence then
the more thoroughly they can think about translating genetic
information. Stronger genetic knowledge is a likely barrier that
prevents stakeholders from thinking in non-linear ways about
translating genetic information.
Research question 1.1: Are there differences in genetic knowledge
and competence among participants based on job type (researcher,
clinician, both, neither)?
Aim 2: Develop a
genetically-informed
risk factor model for preadolescent social anxiety
disorder.

Hypothesis 2.1: The relationship between childhood behavioral
inhibition and pre-adolescent social anxiety is causal.
Hypothesis 2.2: Parental bonding moderates the relationship
between behavioral inhibition and social anxiety.
Hypothesis 2.3: Parental bonding is a measured/specified common
environment variable in the biometrical model of behavioral
inhibition and social anxiety.
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6, 7

Aim 3: Assess the
inclusion of
neurophysiological data
into the risk factor model
for pre-adolescent social
anxiety disorder.

Hypothesis 3.1: Heightened emotion reactivity to threatening faces
will be associated with increased symptoms of pre-adolescent
social anxiety.
Hypothesis 3.2: Heightened emotion reactivity to faces will be
associated with increased symptoms of childhood behavioral
inhibition.
Hypothesis 3.3: Increased emotion reactivity moderates the
relationships between behavioral inhibition and social anxiety.
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Chapter 2: The State of Translating Psychiatric Genetics Research: A Review1
Introduction
Psychiatric disorders are a major burden in the U.S. resulting in over $300 billion
annually in cost from healthcare expenses, loss of wages, and disability benefits (Centers for
Disease Control and Prevention, 2011). Among adults, over a quarter of the population has been
diagnosed with one or more psychiatric disorders (Kessler, Chiu, Demler, & Walters, 2005).
Costs will only continue to increase without effective prevention, detection, treatment, and
support for these conditions. The translation of molecular genetic information to the clinical
realm has helped in the prevention and treatment of several chronic, physical disorders such as
cardiovascular disease, cancer, and more recently diabetes (Vornanen et al., 2016). Thus,
assessing the translation of genetic information to the care of psychiatric disorders is a necessary
step toward possibly reducing mental health morbidity and mortality (Visscher et al., 2016;
Sullivan, Daly, & O’Donovan, 2012).
Unfortunately, the application of genetic information – whether it be non-molecular
genetic epidemiological (family history, population level information) or molecular genomic
data – is absent in prevention and treatment strategies for psychiatric disorders when compared
to other chronic medical conditions. For example, the incorporation of genomics testing for
BRCA variants in the clinical setting has led to applications for the diagnosis of breast cancer and
more effective treatment (Phillips et al., 2006). Progress in the area of breast cancer has also
been made in understanding how patients, researchers, and clinicians feel about complex topics
such as the return of incidental genomic findings and biobanking of DNA samples (Kimball,
Nowakowski, Maschke, & McCormick, 2014; Fernandez et al., 2013). This level of research
knowledge (e.g., genomic findings, insights into stakeholders’ attitudes) continues to expand for
1

Modified version of the manuscript Bourdon, J. L., Davies, R., Overstreet, C. M., Langi, G., & Long, E. C. (In
Review). The state of translating psychiatric genetics research: An brief review. Translational Issues in
Psychological Science.
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many physical disorders but is not yet available for psychiatric disorders. This has lead many to
conclude that the application of genetic information to mental health is years away (Sullivan et
al., 2016; Sullivan et al., 2018; Visscher et al., 2016). It is likely that there is no “one size fits all”
approach to translation.
The type of translational framework utilized is to inform and expedite the ways in which
genetic information is integrated into the clinical care of psychiatric disorders. A proper
understanding of such frameworks and their applications, both broadly and in the context of
psychiatric genetics genetics, are a necessary first step to explore this possibility. Translational
frameworks can be divided into two broad categories, linear and non-linear / socio-ecological
(van der Laan & Boenink, 2012) (see Figure 2.1). The first are those that follow a linear
structure, such as bench-to-bedside (research that begins at the biological level and can
eventually lead to clinical trials or other patient-focused initiatives) (Khoury et al., 2007;
Waldman & Terzic, 2010) and precision medicine (the use of biological information to improve
patient health that may be acquired from the bench or beyond) (Collins & Varmus, 2015;
Jameson & Longo, 2015). These frameworks are highly prevalent across all health-related
research fields but are particularly relevant within fields possessing a medical or biological
focus. They have been largely effective for the translation of molecular genetic information
about chronic, non-psychiatric diseases such as breast cancer (Andreassen, 2017; Cornetta &
Brown, 2013), type 2 diabetes (Chan & Ginsberg, 2011), and coronary heart disease (Ginsberg &
Willard, 2009).
The second category of translational frameworks are those that require simultaneous
integration of information from many stakeholders, such as (a) dissemination and
implementation (D&I), which focuses on the ecology of service delivery (Chambers & Azrin,
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2012; Glasgow et al., 2012; van der Laan & Boenink, 2012), and (b) prevention science, which
incorporates risk factors in a trans-disciplinary manner into the prevention of behavioral
disorders (Fishbein, 2016). These frameworks have been shown to be effective for assessing
community needs (Kimball et al., 2014), evaluating mental health service delivery (Rodriguez,
Southam-Gerow, O’Connor, & Allin Jr., 2014), and targeting interventions towards individuals
at risk for alcohol use disorders (Schuckit et al., 2016). They are socio-ecological and non-linear
in nature, meaning that they integrate the simultaneous perspective of stakeholders to further
research and clinical needs.
Translational Science

Linear Frameworks
•
Stair-step
•
Uni- or Bi-directional

Non-Linear / Ecological Frameworks
•
Complex
•
Iterative

Bench-to-Bedside
•
Clinical trials
•
Animal models
•
Drug development

Dissemination &
Implementation
•
Evidence-based practice
•
Evaluation
•
Collaborative models

Precision Medicine
•
Biological-based
treatment
•
Drug prescriptions

Prevention Science
•
School-based programs
•
Targeted screenings
Research-to-Policy
•
Lobby politicians
•
Partnerships
•
Testimony

Figure 2.1. Flowchart of translational frameworks.
It has been suggested that frameworks following traditional linear views of translation
may not be as effective for psychiatric conditions as they are for other illnesses (van der Laan &
Boenink, 2012), a viewpoint that aligns with calls to shift focus from the application of genetics
to the study and care of psychiatric disorders (Sullivan et al., 2012; Wittchen et al., 2014). With
such a shift, genetic findings from all sources would be carefully and mindfully applied to
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psychiatric disorders and can even be included in prevention efforts instead of current efforts that
solely focus on finding genomic variants.
Specific Aims
It is necessary to understand the state of the science regarding the translation of
psychiatric genetic information. The current study will provide a comprehensive overview of the
literature in this area. The primary goal is to examine which frameworks/models are most
commonly utilized when translating genetic information (family history, heritability estimates,
molecular genomic data) about psychiatric disorders. Secondary analyses will examine trends in
the type of genetic information used (broad, molecular, epidemiological, epigenetics) and
disorder of interest (anxiety, alcohol use, Schizophrenia, mood, etc.) in each study. Finally,
overall benefits/challenges to such translation will be discussed.
Methods
Review
A thorough literature review was conducted in multiple steps. First, all combinations of
terms from three groups were searched in EBSCOhost, Google Scholar, and PubMed. The first
group of terms named translational frameworks (“translation;” “personalized medicine” OR
“precision medicine;” “bench to bedside;” “implementation science”), the second group
specified the illness type (“mental health;” “psychiatr*”), and the final group indicated types of
genetic information (“genetic OR genomic;” “twin OR family OR heritability”). Search results
were limited through December 2017 when the review began. The abstracts from all potentially
relevant articles were downloaded.
Next, each abstract was assigned to two reviewers who independently completed an
inclusion/exclusion checklist for each assigned abstract. Inclusion criteria were that the abstract
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must name or imply a translational framework, explicitly mention genetic information, and focus
on mental health (i.e., name a psychiatric disorder or be a broad discussion of mental health).
Exclusion criteria were not meeting one or more of these criteria, not being a peer-reviewed
article, and not being in English. Conference abstracts, short commentaries, dissertations, book
chapters, and editorials were automatically excluded. If abstracts were too brief due to journal
restrictions, reviewers were allowed to download full articles to complete the checklist.
The final step involved the lead author closely reviewing the included abstracts to settle
disagreements among reviewers, confirm that included abstracts met all inclusion criteria, and
organize abstracts into clear categories with appropriate coding. The categories of the articles
were: translational framework (precision medicine, bench-to-bedside, D&I, prevention science,
broad discussion of translation, other, multiple frameworks), type of genetic information
(epidemiology - i.e., family, twin, heritability studies; molecular genetic information - i.e.,
candidate genes, sequencing, genome wide analysis studies [GWAS], copy number variation,
knockout genes, polygenic risk scores; epigenetics; broad discussion), psychiatric disorder
(anxiety, mood, schizophrenia, neurodevelopmental [e.g., Autism Spectrum Disorder; ASD],
attention deficit hyperactivity disorder [ADHD], alcohol and substance use disorders
[AUD/SUD] and addiction, other, broad discussion of mental health, multiple disorders), and
whether the study utilized animal models (yes, no).
Analyses
Basic frequencies and cross tabulations were utilized to summarize the type(s) of genetic
information, psychiatric disorders, and translational frameworks utilized by the included papers.
Weighted Cohen’s Kappa (Fleiss & Cohen, 1973; Koo & Li, 2016; Mandrekar, 2011) was
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calculated to confirm agreement among reviewers for the abstracts as a whole. All analyses were
done in R (R Development Core Team, 2015).
Results
Search Results
The first step of the review process ended with 325 abstracts that were loosely related to
the aims of this paper. After reviewers completed the checklist and the lead author confirmed the
articles, 100 abstracts met criteria for inclusion. Overall, reviewers agreed 82% of the time with
whether an article should be included, which resulted in a weighted Cohen’s Kappa value of 0.67
(confidence interval [CI] = 0.59-0.74). Kappa values between specific pairs of reviewers ranged
from 0.47 (CI = 0.31-0.64) to 0.83 (CI = 0.71-0.96). See Table 2.1 for a list of articles included
in the review.
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Translational Frameworks
Most (53%) of the articles were from a precision medicine perspective, followed by
bench-to-bedside (25%), D&I (8%), and a broad discussion of translational science (7%). While
prevention-focused translational frameworks were not the focus of this review, a few of the
articles included this perspective (5%). Finally, 2% of articles discussed either another
framework not already mentioned or multiple frameworks.
Genetic Information
Molecular genetic information was mentioned in a majority of the articles (51%). Many
articles also discussed genetics more broadly (39%); in other words, the article simultaneously
discussed many types of genetic information or used the term “genetics” to mean all genetic
information. Neither genetic epidemiology (heritability, family history; 7%) or epigenetics (3%)
made up a substantial percentage of the genetic information discussed.
Psychiatric Disorders
Many articles discussed psychiatric conditions in a broad manner (36%) or examined
multiple psychiatric conditions (16%). Among specific disorders mentioned, AUD/SUD and
addiction were the most commonly mentioned (14%), followed by schizophrenia (13%), and
neurodevelopmental disorders (8%). Internalizing disorders (anxiety, 2%; mood, 7%) were
largely underrepresented and ADHD (1%) made up the smallest percentage. Three percent of
papers discussed other mental health conditions (e.g., stress, risky behaviors).
Other Trends
Most articles discussing precision medicine (49%), bench-to-bedside (64%), and D&I
(75%) focused on molecular genomics. A notable proportion of papers discussing each of these
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frameworks also discussed genetics broadly (40%, 28%, and 13%, respectively). Finally, a
majority (71%) of articles that discussed translation broadly also discussed genetics broadly.
Fewer obvious trends appeared when examining which psychiatric disorders were most
commonly translated among specific frameworks. A broad discussion of mental health was the
most common psychiatric context for all frameworks (24%-100%) with the exception of D&I
(13%) where discussion of multiple disorders was more common (25%). A broad discussion of
mental health was also the most common context for molecular (31%) and broad genetic (46%)
studies. A combination of multiple psychiatric disorders the most prevalent context when
translating genetic epidemiology (43%) information. Conditions for which epigenetic
information was translated were evenly split (33% each) among schizophrenia, AUD/SUD and
addictive disorders, and broad mental health.
Discussion
To date, multiple frameworks and models have been proposed for how to translate
scientific findings broadly (Collins & Varmus, 2010; Gray & Bonventre, 2002; Waldman &
Terzic, 2010) and genetic information specifically (Collins, 2011; Collins & Varmus, 2015).
Little attention has been placed on how to translate genetic information within the context of
psychiatric disorders, although there have been several proposed frameworks to help with this
(e.g., a division of translation into two phases focused on clinical trials and community
engagement (Brekke, Ell, & Palinkas, 2007) or the Translational Science Benefits Model that
evaluates resources, scientific activities, outcomes, and health/societal benefits (Luke et al.,
2017)). By studying trends among the intersection of translational frameworks, genetic
information, and psychiatric disorders, this review provides insight into the ways in which
communication regarding the genetics of psychiatric disorders is occurring. Overall, trends
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identified within the present review further highlight the need for change in how psychiatric
genetic information is translated to non-research stakeholders (McBride et al., 2010; Visscher et
al., 2016). This may be accomplished by shifting away from linear views of translation so that all
genetic information (especially non-molecular information) is better incorporated into the care of
these complex psychiatric disorders.
Historically, linear translational frameworks such as bench-to-bedside and precision
medicine have spearheaded advancements in medicine, specifically the translation of molecular
genetic information about chronic, non-psychiatric conditions (Cornetta & Brown, 2013; Legare
et al., 2016). Such frameworks have also been applied to the genetics of psychiatric disorders to
little effect (Sullivan et al., 2012; Visscher et al., 2016; Wittchen et al., 2014). The current
findings support this pattern, as most articles included in this review focused on linear
frameworks. These frameworks are limiting, as they present barriers to translating genetic
information to all stakeholders. Namely, there is an emphasis on molecular genomics and
familiarity with this type of genetic information may be limited, many facilities lack technology
to test genomic information of patients, and these forms of translation are notoriously slow
(Cornel & El, 2017; Sperber et al., 2017).
Recent public health efforts have somewhat shifted this narrative in regard to the
translation of genetic information broadly (Belsky, Moffitt, & Caspi, 2012; Cornel & El, 2017;
Doerr & Teng, 2012) but rarely for the genetics of mental health conditions (Dick, 2017;
McBride, 2018). This shift has occurred in two key ways. First, translational frameworks such as
D&I and prevention science are being recognized as having more reach and immediate impact
(Bradshaw & Haynes, 2012; Sperber et al., 2017). This may better motivate behavior change by
clinicians, patients, and other stakeholders by engaging at more levels of the translational
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process. Second, these shifts also turn attention away from molecular genomic and epigenetic
information and open up the possibility of utilizing family history, heritability, and other nonmolecular genetic epidemiological sources of information either singularly or in tandem with
genomic information (Dick, 2017; Doerr & Tend, 2012). This information is relevant and may
present genetic information in a more readily accessible form, improving the likelihood of
understanding (Bradshaw & Haynes, 2012; Dick, 2017) and thereby reducing a significant
barrier to the translation of genetic information.
A notable trend in the current findings was the large number of articles that discussed
translation, genetics, and/or mental health in broad terms. Such articles were largely not crosssectional or experimental designs but in-depth inquiries into the topic at hand. Without
diminishing the importance of such studies, it should be noted that the field of psychiatric
genetics will not advance without clear and purposeful investigations of the best translational
frameworks for specific disorders. Some examples of this exist (Arar, Delgado, Lee, & Abboud,
2012; Bradshaw & Haynes, 2012; Dick, 2017), but they are the exception rather than the
standard approach. This was especially true when focusing explicitly on psychiatric disorders.
Most of disorders specifically studied in the articles included in this review (e.g., AUD/SUD,
schizophrenia, neurodevelopmental) are those that have the most molecular genetic information
known about them, perpetuating a linear view of translation that is inextricably tied to a belief
that molecular genomic and epigenetic findings are the best sources of genetic information to
translate due to their historic role in linear translational frameworks. Little genetic translation has
even been attempted for disorders such as anxiety or ADHD where little molecular genomic
information is known despite the fact that heritability, family history, and other genetic
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epidemiological information could be communicated to stakeholders and potentially
incorporated into care.
It is hoped that these findings will help all stakeholders who are affected by, study, or
treat psychiatric conditions (researchers, clinicians, administrators, patients, families, community
members) to think more deeply about this issue. Namely, there is a need to push forward and
study potential impacts of non-molecular genetic epidemiological information in practice,
prevention, and policy. It needs to be acknowledged that linear forms of translation are not the
most effective for psychiatric disorders, and a deep investigation into how frameworks such as
D&I or prevention science can utilize genetic information is crucial. Relatedly, knowledge and
competence surrounding these three interrelated topics is needed. Lack of genetic knowledge has
already been cited as a key barrier to translation (Cornel & El, 2017; McBride, 2018), but most
individuals are also not well-versed in different translational frameworks, appropriate
stakeholder groups, or specific mental health conditions.
Limitations
There are a few limitations to note from the current study. First, the search terms used
were not exhaustive, and some key translational frameworks and key words were omitted. As
already stated, research-to-policy was intentionally left out of the terms given that policy is a
more advanced translational framework, and psychiatric genetics is arguably not ready for that.
However, mention of policy appeared in several articles included in the final list. This implies
that a search specific to policy is warranted, perhaps to explicate the intricacies of insurance,
biobanking, family history communication, and other related topics. Also, "research-to-practice”
was not used because it is often used as a catchall term and is not specific. Second, by design this
study did not require reading each article in depth but rather summarized across articles. This

29

does not detract from the current conclusions but does prevent further analysis and additional
nuances to be gleaned. Third, the Kappa values between pairs of reviewers fluctuated (although
all were within an acceptable range). This may be due to the fact that reviewers purposefully
came from different training backgrounds to facilitate interdisciplinary study and translation.
Finally, reviewers had to often use their knowledge of translational science to determine which
framework(s) articles were working under. This admittedly allowed some bias into the review as
interpretations of translational frameworks and terms are somewhat fluid.
Implications
The purpose of this review was to understand which translational frameworks guide the
application of genetic information to the clinical care of psychiatric disorders. It has direct
implications for service delivery and findings may help to relieve some burden from clinicians
by improving communication with researchers. Such work is only a small part of what is needed
to ensure proper translation among all stakeholder groups, namely researchers and clinicians.
This review complements the work currently underway to open genetic counseling centers for
psychiatric disorders, as such counseling has been shown to be efficacious for patients
(Moldovan, Pintea, & Ausin, 2017). It also highlights that there is no one-size-fits-all approach
to translation and the application of a given framework in any context needs to be carefully
evaluated. These conclusions imply that linear frameworks should not necessarily be applied to
translating psychiatric genetic information, nor should socio-ecological frameworks be used in
all contexts. Future research is still needed to determine which frameworks are best for which
psychiatric disorders and for which types of genetic information.
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Chapter 3: Assessing Stakeholder Perceptions of the Utility of Genetic Information for the
Clinical Care of Mental Health Disorders1
Overview
The purpose of this chapter is to assess the state of the science regarding the translation of
genetic information to the clinical care of mental health disorders from an academic perspective
and constitutes aim 1 of this dissertation. This was accomplished by designing and implementing
a survey on this topic. Given the overall lack of knowledge on this topic, a qualitative / inductive
approach was taken (Strauss & Corbin, 1998). This means that the purpose of the survey, and
hence the aim as a whole, was to be hypothesis-generating and gauge the state of the science of
the topic at hand. The purpose was not to create a psychometrically sound measure for assessing
attitudes and practices related to translation, although this chapter lays the groundwork for such a
future endeavor. The purpose was also not to go into the survey with clear hypotheses in a
traditionally deductive manner.
This chapter is presented in five parts because this dissertation aim took on a different
form than the others. There were no a priori hypotheses or research questions (see chapter 1).
The purpose of this aim was to assess the state of the science regarding the translation of genetic
information to the clinical care of mental health disorders from an academic perspective. Part 1
presents the rationale for this dissertation aim, survey methodology, and basic descriptive and
frequency statistics with a brief discussion. Part 2 tests hypotheses generated in part 1, provides a
few additional analyses, and concludes with a brief discussion. Part 3 includes the analyses of
key open-ended questions. Part 4 discusses the limited psychometrics of the survey, which were
not viewed as crucial to the study but are included for completeness. Part 5 provides a global
discussion and ending to this chapter.
1

Modified version of the manuscript Bourdon, J. L., Hettema, J. M., Prom-Wormley, E. C., & Southam-Gerow, M.
A. (In Review). Assessing stakeholder perceptions of the utility of genetic information fo the clinical care of mental
health disorders: We have a will but need to see the way. Translational Behavioral Medicine.
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Part 1: Aim rationale, survey methodology, basic descriptive statistics, discussion1
Introduction
There is widespread agreement that the translation of basic scientific findings to the
benefit of public health represents a critical goal in scientific research (Collins & Varmus, 2015;
Sullivan, Daly, & O’Donovan, 2012; Centers for Disease Control, 2007; Belsky, Moffitt, &
Caspi, 2012). Incorporation of genetic information specifically (e.g., family history, sequencing
results) is important for the the creation of evidence-based treatment across a range of disorders
(Collins & Varmus, 2012; Sullivan et al., 2012; Visscher et al., 2016). Impressive progress has
been made to document the role that molecular genetic information plays in the risk reduction,
identification, prevention, and treatment of physical, chronic conditions such as cardiovascular
disease (Arnett et al., 2007; Ebomoyi, 2013; Vornanen et al., 2016; International Consortium for
Blood Pressure Genome-Wide Association Studies, 2011; Khera & Kathiresan, 2017), breast
cancer (Cornel & El, 2017; Gil et al., 2003; Macdonald, Sarna, Weitzel, & Ferrell, 2009; Norman
& Brain, 2005; Phillips et al., 2006), and other similarly complex disorders. Unfortunately, genefinding for mental health conditions has proven more difficult than initially expected (Sullivan et
al., 2012; Sullivan et al., 2018; Visscher et al., 2016) and these conditions have consequently
been largely overlooked in genetic-focused translational efforts. Translation can incorporate
more than molecular information. However, it rarely does despite the fact that non-molecular
genetic epidemiological information (e.g., family history, twin information, gene-environment
interplay) has been shown to impact perceived risk across a range of complex disorders
(Vornanen et al., 2016; Prom-Wormley et al., 2019). Considering that over a quarter of the U.S.
adult population has lived with a psychiatric disorder in the past year (Kessler et al., 2005) and
that not enough is known yet about the molecular risks and mechanisms, incorporating non-
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molecular genetic information into mental health care could improve the outcomes of millions of
individuals.
Part of the challenge of effectively translating any genetically-informed research into
clinical practice for mental health conditions rests in the use of linear translational frameworks
(van der Laan & Boenink, 2012) over socio-ecological models (Belsky et al., 2012). Whereas
such linear views have had demonstrable effects for the aforementioned chronic conditions
(Arnett et al., 2007; E, 2013; Vornanen et al., 2016; International Consortium for Blood Pressure
Genome-Wide Association Studies, 2011, 2011; Khera & Kathiresan, 2017; Cornel & El, 2017;
Gil et al., 2003; Macdonald et al., 2009; Norman & Brain, 2005; Phillips et al., 2006) and will
continue to do so for the foreseeable future (Kahn, Cooper, & Del Prato, 2014), they have not
provided much benefit to their mental health counterparts (Sullivan et al., 2018; Visscher et al.,
2016; Wittchen et al., 2014). These linear views include bench-to-bedside with its structured
translational steps (i.e., basic science aimed at identifying mechanisms for disease that moves
through a structured series of studies to examine the applicability of basic findings to treatment
of disease [Waldman & Terzic, 2010; Khoury et al., 2007]) and precision medicine (i.e., the use
of biological information to inform treatment, typically information from bench-to-bedside
findings [Collins & Varmus, 2015; Jameson & Longo, 2015]). In a genetics context, these
frameworks rarely incorporate the viewpoints of multiple stakeholders simultaneously and focus
almost exclusively on molecular genetic information. This presents several key barriers that are
amplified in a mental health context. For example, these frameworks almost solely rely on genefinding efforts to complete their translational pipeline - efforts that are not currently possible for
mental health conditions except possibly schizophrenia (Sullivan et al., 2012; Sullivan et al.,
2018; Visscher et al., 2016). These linear frameworks also tend to discuss but rarely address the
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common barrier of whose responsibility it is to discuss genetic information with patients seeking
treatment (Sullivan et al., 2012; Visscher et al., 2016; Finn & Smoller, 2006), with separate
arguments made that clinicians (psychiatrists, genetic counselors, nurses, etc.) (Sperber et al.,
2017; Zhou et al., 2014; International Society of Psychiatric Genetics, 2017) and researchers
(Klitzman et al., 2013; Ramoni et al., 2013) should bear this burden. These barriers are further
subsumed by larger issues of education/training, stigma, and overall engagement of stakeholders
both across disorders (Sperber et al., 2017; Zhou et al., 2014).
Psychological disorders are thus largely seen through the strict genes-researcherclinician-patient linear vantage point instead of a cooperative or collaborative lens. This is even
true of the National Center for Advancing Translational Sciences’ (NCATS) translational
spectrum which appears visually collaborative but is described in very familiar, linear terms
(NCATS, 2016). It is important for all translational efforts, especially genetically-informed ones,
to simultaneously integrate multiple perspectives across disciplines and stakeholders (e.g.,
researchers, clinicians, patients, administrators, policy makers) in collaborative ways (Collins &
Varmus, 2015; Waldman & Terzic, 2010; Kon, 2008; Sperber et al., 2017) in order to improve
patient outcomes related to mental health care. This will likely open the door for stakeholders
considering the use of non-molecular genetic information in translational efforts. It is likely that
the solution lies in utilization of frameworks such as dissemination and implementation science
(a socio-ecological-focused framework that uses multiple lenses to understand and model how
scientific findings can influence downstream services, considering all stakeholders in the process
[Chambers & Azrin, 2013; Glasgow et al., 2012; Schoenwald & Hoagwood, 2001; SouthamGerow, Ringeisen, & Sherrill, 2006; Southam-Gerow, Rodriguez, Chorpita, & Daleiden, 2012])
and prevention science (similar to D&I with a strong focus on general public health with a strong
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emphasis on prevention efforts vs. treatment [Bradshaw & Haynes, 2012; Fishbein, 2016]).
Neither of these approaches would be burdened by needing molecular genetic information to
assist patients. Population level data such as heritability estimates or gene-environment interplay
as well as family history information may suffice (Doerr & Teng, 2012). For example, such
information could inform how often clinicians decide that a patient should come in for treatment,
patients learning about the roles genes and environment may help them cope with their disorder
(Inglis et al., 2015), and such information can be used to proactively and preventatively refer
individuals for services (Dick, 2017; Schuckit et al., 2012). It needs to be examined how these
different lines of non-molecular genetic information can be made accessible and disseminated to
appropriate stakeholders in the most effective ways possible. The end goal is that mental health
care (treatment, recovery, or prevention) will be positively impacted, although more research is
needed to determine the impact of this information.
Through an appreciation of such diverse perspectives, multi-faceted, targeted translation
plans can be developed to reflect the expertise and needs of the stakeholders involved in the
prevention and treatment of mental health conditions. To date there has only been one study that
compared the attitudes of psychiatrists and genetic counselors on their training, education, and
competency related to discussing genetic information with patients who have mental health
disorders (Zhou et al., 2014). This study found similar barriers to those that are common in linear
frameworks (i.e., discrepancies in training, education, and competency). However, this study
argued for enhanced training opportunities that includes all health professionals, focuses on
family history, and includes a patient-oriented approach to risk communication. This is in line
with a collaborative, socio-ecological perspective to the incorporation of genetic information into
mental health care more than a linear translational framework.
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Current Study
In short, the slow progress of translation in the area of genetics and mental health care
may be a result of adopting frameworks that skew perceptions of how communication around
genetic information should occur. The current study seeks to provide preliminary data to help
guide a path forward. This was done by exploring the perspectives of academic stakeholders in
mental health fields, mainly researchers and clinicians, concerning the utility of genetic
information broadly. These groups were queried on their professional translational practices,
self-rated genetic knowledge and competence, and attitudes regarding specifically the
translational of genetic information related to mental health. The purpose of this study was to
describe trends in stakeholders’ responses across these domains.
Method
Participants
Participants were actively recruited via direct email to 432 individuals across 11 mental
health related departments at Virginia Commonwealth University (VCU) (including some
individuals with dual appointment in affiliated local organizations and private practice) and 68
individuals in the Psychology Department at Michigan State University. Recruitment was limited
to faculty and staff only. Passive advertisement of the study was also used and included two
announcements in VCU’s daily email blast to all faculty/staff and four announcements in the
lead investigator’s weekly department email. Sixty-four individuals completed the survey (see
Table 3.1 for full demographic information; 12.80% response rate based on active recruitment
only). Most participants were over the age of 35 (47.62%), white (92.19%), and identified as
women (54.69%). All but one participant held a graduate degree, either a Ph.D. (57.14%),
master’s degree (23.81%), M.D. (14.29%), or Psy.D. (3.17%). About the same number of
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participants identified primarily as researchers (41.67%) or clinicians (31.67%) with the
remaining nearly split between being both (11.67%) or neither (15.00%). Those who identified
as neither identified as administrators, general research support, policy specialists, public health
professionals, or preventionists. Most (67.65%) individuals with a Ph.D. identified as researchers
while most participants with an M.D. (66.67%) or master’s (64.29%) primarily identified as
clinicians. Demographic categories that were under-powered (i.e., made up less than 10% of the
variable) (de Vaus, 2002) were excluded from those analyses (Psy.D., another degree, gender
non-conforming, Asian, Black were changed to missing).
Table 3.1. Demographic information on the full sample.
Category
Age
18-35
36-55
56+
Race
American Indian / Alaskan Native /
Native Hawaiian
Asian
Black
White
Another
Choose not to respond
Ethnicity
Hispanic
Gender
Woman
Man
Transgender
Non-conforming
Another
Chose not to respond
Highest degree obtained
Master’s
Ph.D.
Psy.D.
M.D.
Another
Job type
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n

Percentage

30
13
20

47.62%
20.63%
31.75%

0

0.00%

3
1
59
0
1

4.69%
1.56%
92.19%
0.00%
1.56%

0

0.00%

35
29
0
1
0
0

54.69%
43.75%
0.00%
1.56%
0.00%
0.00%

15
36
2
9
1

23.81%
57.14%
3.17%
14.29%
1.59%

Researcher
Clinician
Both
Neither

25
19
7
9

41.67%
31.67%
11.67%
15.00%

Survey Instrument
A survey consisting of four sections was sent to participants. These sections assessed
professional translational practices, self-rated genetic knowledge and competence, translation of
genetic information related to mental health, and demographic information. See the Appendix for
a PDF of the full survey.
Professional Translational Practices. This section of the survey was designed to assess
broad translational practices in the context of one’s profession. Participants answered five
questions related to familiarity with translational science terms and five questions about their
network of collaborators (translational science does not occur in a vacuum, and collaborators are
a key component to each framework to varying degrees).
Genetic Knowledge and Competence. Education/training are an oft-cited barrier to the
translation of genetic information (Zhou et al., 2014). Accordingly, the second section of the
survey inquired about participants’ genetic knowledge and competence separately. Participants
were asked familiarity with terms related to genetic content areas (six questions - family
history/aggregation, heritability, gene-environment relationship, twin studies, molecular
genomics, epigenetics) as a way to gauge genetic knowledge. Competence was assessed via nine
pointed questions asking how competent participants felt about discussing, reading articles,
authoring papers, and mentoring students on projects that utilized genetic information. Finally,
they were also queried on their genetics training (one question).
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Translation of Genetic Information Related to Mental Health. The third section of the
survey queried participants’ agreement on four statements that asked how important the
translation of genetic information about mental health disorders is, how much it would improve
their field, whether it is important for professionals in their field to understand this information,
and whether it would benefit students’ training. They then had to rank their likeliness of
attending five hypothetical training opportunities where they would learn about how to improve
their involvement in the translation of genetic information about mental health disorders.
Participants were also directly asked how much they believe that increased knowledge of genetic
information would improve nine different aspect of mental health research, prevention,
treatment, and recovery. They had to answer the same question in relation to each of the 13
Diagnostic and Statistical Manual - 5th edition’s (DSM-5) categories of disorders.
Demographic Information. Participants were asked about their age, race, ethnicity,
gender, highest degree obtained, and job type.
Procedure
The current instrument was administered online via REDCap (Harris et al., 2009) using
both active and passive methods that were approved by VCU’s Institutional Review Board.
Individuals recruited by active methods were emailed the survey link with a brief explanation of
the study. A reminder email was sent out approximately two weeks later. Those recruited via
passive methods were provided with the survey link in the advertisement.
Data Plan
The purpose of the survey was to be hypothesis-generating for future projects in this
research area, and qualitative, inductive analytical approaches were taken (Strauss & Corbin,
1998). This allowed for the emergence of themes and identification of key points to be explored
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in further studies. Thus, only frequency counts for each question were examined. All analyses
were done in R (R Development Core Team, 2015).
Results
Professional Translational Practices
In regard to broad translational concepts in a professional context, participants were the
most familiar with personalized medicine (see Table 3.2). Over ninety percent of participants had
at least heard of the term, followed by research-to-policy (89.75%), D&I (87.30), research-topractice (79.89%) and bench-to-bedside (76.51%). Between a third and half of participants could
define and give an example of each translational science term. Finally, more participants
reported actively participating in research-to-practice (36.15%) than any other form of
translation.
Measures of breadth and depth of collaborators revealed that most participants (54.58%)
had a network of collaborators that included at least 10 people. Participants reported meeting
regularly with their collaborators (61.29%) and that their collaborators span many job types (i.e.,
researcher, nurse, teacher) and fields (i.e., psychology, statistics, social work, etc.).
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Table 3.2. Frequencies for individual questions from the “Professional Translational Practices”
section.
Select the answer that best describes your experience with these terms related to translational
science
I have not
I have heard I can define this
I actively
heard of this
of this
and give an
participate in
example
this form of
translation
Research-to-practice
11.11%
19 .05%
33.33%
36.51%
Research-to-policy
11.11%
30.02%
37.51%
22.22%
Bench-to-bedside
23.44%
23.44%
48.38%
4.69%
Dissemination and Implementation
12.70%
20.63%
38.10%
28.57%
Personalized medicine
9.38%
20.31%
53.03%
17.19%
The size of my network of collaborators is…
I do not have a network
Less than 10
10 or more
20 or more
of collaborators
15.63%
28.13%
54.58%
1.56%
I have collaborators that are… [check all that apply]
Researchers
Clinicians
Nurses
Teachers
Other
82.81%
81.25%
39.06%
53.13%
20.31%
My collaborators span the following disciplines… [check all that apply]
Social/
Psychiatric Human /
Social
Public
Behav.
Other Psychology Psychiatry Statistics
/ Behav.
Molecular
Work
Health
Health
Genetics
Genetics
56.25% 50.00% 48.44% 29.69%
79.69%
56.25%
48.44%
48.44%
37.50%
How often do you meet/consult with individuals from your network of collaborators?
I meet/consult with individuals on
Several of us meet/consult regularly
Other
an as-needed basis
61.29%
38.71%
0.00%

Genetic Knowledge and Competence
Over half (64.06%) of participants were not active in any field of genetics with about a
quarter (23.44%) not reporting any formal genetics training (see Table 3.3). Nevertheless,
participants were quite familiar with genetic terms; many were able to at least define and give an
example of each term. Specifically, participants were the most familiar with twin studies
(90.63%) followed by heritability (89.07%), gene-environment relationship (85.94%), family
history (81.25%), epigenetics (72.88%), and molecular genomics (43.75%). More participants
reported utilizing content related to family history (31.25%) in their everyday work than other
forms of genetic information.
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Participants’ self-rated competence fluctuated depending on the content area. They were
the most comfortable reading articles that either mention genetic information (98.39%) or where
genetics is the focus of the paper (79.36%) followed by discussing genetic information with
collaborators (76.19%), trainees/students (69.84%), and patients (47.62% - note this question
was not applicable to many participants). They were the least comfortable co-authoring (29.10%)
or leading (37.09%) a paper where the genetics of a mental health disorder was the focus. Most
were also not comfortable mentoring a trainee/student who wants to study the genetics of a
mental health disorder (37.09%).
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Table 3.3. Frequencies for individual questions from the “Genetic Knowledge and Competence”
section.
Experience in the field of genetics
Currently
Not active but Not active but
Not active and
Not active but
No genetics
active in a
had training
had training
had training
had training 6training of any
field of
within last 2
within last 3-5
more than 10
10 years ago
kind
genetics
years
years
years ago
35.94%
9.38%
7.81%
9.38%
14.06%
23.44%
Select the answer that best describes your experience with each of the following content areas of
genetics
I have heard of
I can define
I utilize content
I have never
this but cannot
this and give an related to this in my
heard of this
define it
example
everyday work
Family history / aggregation
3.13%
15.63%
50.00%
31.25%
Heritability
1.56%
9.38%
60.94%
28.13%
Gene-environment relationship
0.00%
14.06%
60.94%
25.00%
(i.e., interaction or correlation)
Twin studies
0.00%
9.38%
78.13%
12.50%
Molecular genomics
7.81%
48.38%
17.19%
26.56%
Epigenetics
4.69%
23.44%
60.94%
10.94%
Rank how much you agree/disagree with the following statements
Strongly
Strongly
Not
Disagree
Agree
Disagree
Agree
Applicable
I feel competent discussing genetic information
regarding mental health disorders with my
4.76%
12.70% 47.62% 28.57%
6.35%
network of collaborators
I feel competent discussing genetic information
regarding mental health disorders with
7.94%
17.46% 44.44% 25.40%
4.76%
trainees/students
I feel competent discussing genetic information
4.76%
11.11% 38.10%
9.52%
36.51%
regarding mental health disorders with patients
I feel competent reading a scholarly article that
mentions genetic information (i.e., in the intro
0.00%
1.61%
38.71% 59.68%
0.00%
or discussion as potential implications)
I feel competent reading a scholarly article that
utilizes genetic information as a the focus of the
1.59%
19.05% 39.68% 39.68%
0.00%
overall purpose of the study (i.e., heritability
study, genome-wide association study)
I feel competent being a CO-author on a
scholarly article where the genetics of a mental
20.63%
36.51% 19.05% 10.05%
4.76%
health disorder is the focus of the study
I feel competent being a LEAD author on a
scholarly article where the genetics of a mental
55.56%
10.98% 24.19% 12.90%
1.61%
health disorder is the focus of the study
I feel competent mentoring/advising a
trainee/student who wants to study the genetics
40.32%
20.98% 24.19% 12.90%
1.61%
of a specific mental health disorder (i.e.,
cumulative project, thesis, dissertation)
Note: The genetic experience questions were not part of the knowledge or experience variables directly but needed to
be assessed and were logically put into that section.
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Translation of Genetic Information Related to Mental Health
A large majority of participants agreed or strongly agreed with all statements regarding
the importance and benefit of translating genetic information about mental health disorders in
various professional contexts (84.12-96.82%) (see Table 3.4). They agreed the most with the
broad statement that the translation between research and practice related to mental health is
important (96.82%). However, they were less enthusiastic about hypothetical activities related to
improving their own translation of genetic information about mental health disorders. Most were
not likely or very not likely to attend any of the suggested events (65.08-92.06%). The exception
was a 2-hour seminar at a conference they already planned to attend; 60.32% were likely or very
likely to do this.
Participants were in the most agreement that increased knowledge of genetic information
about mental health disorders would moderately influence care in regard to creating biological or
pharmacological therapies (56.45%), discovering new and better treatments (49.21%), and
improving diagnostic clarification of affected patients (46.78%). Otherwise, they reported that
increased knowledge of genetic information would have weak or no influence on clinical care in
the rest of the posited areas (60.65-78.93%). Accordingly, specific disorders that participants felt
would moderately benefit from increased genetic information are those that we currently know
the most about biologically – schizophrenia spectrum and other psychotic disorders (63.49%),
neurodevelopmental disorders (including ASD; 68.25%), and bipolar disorder (58.73%).
Otherwise, they reported that the translation of genetic information into clinical care would have
some or no benefit for the remaining DSM-5 disorder categories (53.95-90.47%).
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Table 3.4. Frequencies for individual questions from the “Translation of Genetic Information
Related to Mental Health” section.
Rank how much you agree/disagree with the following statements
Strongly
Disagree
Agree
Strongly
Disagree
Agree
Translation between research and practice
0.00%
3.17%
50.79%
46.03%
related to mental health disorders is important
My field would benefit from improved
translation of genetic information related to
3.17%
6.35%
50.79%
39.68%
mental health disorders
It is important for all professionals in my
field (researchers, teachers, practitioners) to
1.59%
14.29%
50.79%
33.33%
understand the genetic risk associated with
specific mental health disorders
It is important for students to be taught how
to utilize information regarding the genetic
0.00%
11.11%
50.79%
38.10%
risk associated with specific mental health
disorders, regardless of field
Below are potential ways to improve the translation of genetic information about mental health
disorders in an academic setting. Please rank the following activities in terms of how likely you
would be to utilize them if they were available to you right now. Assume the event would be geared
toward your primary role at your university (i.e., researcher, practitioner, teacher, combination
thereof).
Not Very
Not
Very
I Already Do / Have Done
Likely
Likely
Likely
Likely
Something Like This
Attend a one-day in33.33%
31.75%
33.33%
1.59%
0.00%
person workshop at VCU
Attend a in-person course
at VCU that meets once a
58.73%
33.33%
7.94%
0.00%
0.00%
week for four weeks
Take an online training
module that can be spread
27.42%
40.32
29.03%
3.23%
0.00%
out over multiple sittings
Attend a special 2-hour
seminar presentation at a
15.87%
23.81%
49.21%
11.11%
0.00%
conference you already
plan to attend
Attend regular meetings
with your network of
31.75%
33.33%
23.81%
11.11%
0.00%
collaborators
To what extent do you believe that increased knowledge of genetic information regarding the basis
of mental health disorders will influence the following?
No
Weak
Moderate
Strong
Influence Influence Influence Influence
Discovering new and better treatments for mental health
1.59%
49.21%
49.21%
0.00%
disorders
Improving diagnostic clarification of affected patients
1.61%
51.61%
46.78%
0.00%
with mental health disorders
Identifying asymptomatic patients at risk of developing
11.47%
49.18%
39.34%
0.00%
mental health disorders
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Targeting of resources to at-risk populations
11.29%
51.61%
37.10%
0.00%
Prenatal testing to guide reproductive choices
27.42%
46.77%
25.81%
0.00%
Stigma of mental health disorders
16.13%
46.77%
37.10%
0.00%
Insurance to patients with a high-risk genetic profile for
19.67%
47.54%
32.79%
0.00%
mental health disorders
Interest in psychosocial therapies for mental health
20.87%
58.06%
20.975
0.00%
disorders
Interest in biological or pharmacological therapies for
3.23%
40.32%
56.45%
0.00%
mental health disorders
Which of the following do you think will benefit the most from increased translation of genetic
information?
No
Some
Moderate Significant
Benefit
Benefit
Benefit
Benefit
Schizophrenia spectrum and other psychotic disorders
0.00%
36.51%
63.49%
0.00%
Anxiety disorders (generalized, social, panic,
4.76%
63.49%
3.17%
0.00%
separation, phobias)
Bipolar disorder
0.00%
41.27%
58.73%
0.00%
Depression disorders (major depression, melancholia)
3.17%
50.79%
46.03%
0.00%
Obsessive-compulsive disorder
0.00%
63.92%
36.51%
0.00%
Post-traumatic stress disorder
11.11%
73.02%
15.87%
0.00%
Eating disorders (anorexia, bulimia, binge eating
9.52%
65.08%
25.40%
0.00%
disorder)
Personality disorders
12.70%
68.25%
19.05%
0.00%
Neurodevelopmental disorders (autism spectrum
disorder, communication disorders, intellectual
1.59%
30.16%
68.25%
0.00%
developmental disorder)
Sleep-Wake disorders (insomnia disorder, narcolepsy)
6.35%
53.97%
39.68%
0.00%
Sexual dysfunction
22.22%
68.25%
9.52%
0.00%
Disruptive, impulse-control, and conduct disorders
11.11%
61.90%
26.98%
0.00%
Substance use disorders (alcohol, gambling, cocaine,
1.61%
56.45%
41.94%
0.00%
other substances)

Discussion
The use of genetic information in mental health care is lacking. The current study took a
broad, inductive approach to examining the potential role that genetic information may have in
the care of mental health disorders. Academic stakeholders in mental health fields were queried
about their professional translational practices, genetic knowledge and competence, and attitudes
specific to the translation of genetic information to mental health care. Findings indicate overall
enthusiasm for the translation of genetic information into the care of mental health disorders that
dissipated as more hypothetical effort was required from participants (e.g., more genetic
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competence, more time put into training, etc.). This enthusiasm diminished as scenarios became
more specific, though (e.g., asking about the utility of genetic information for anxiety disorders
compared to asking if students should be trained more in communicating genetic risk of mental
health disorders). Thus, participants held many dissonant views on the topic at hand.
Specifically, on one hand participants engage with broad translational practices in a
satisfactory way. This was most clear by the breadth and depth of collaborators that they
regularly meet with as well as actively engaging in different translational frameworks. They were
also in agreement that in the context of mental health, translation between research and practice
is important, that their field would benefit from improved translation of genetic information, and
that it is important for professionals and students to be trained on how to communicate genetic
risk. On the other hand, participants reported less favorable attitudes when asked about whether
they were willing to increase their own translational practices, whether genetic information
would impact treatment-related outcomes, or about benefits that genetic information would have
for specific DSM-5 disorders. In other words, participants appear to like the idea of translation
but when pushed further, were not willing to take steps toward improving their own translational
capacity and did not believe that translating genetic information would have large impacts on
mental health care.
This finding must be discussed in light of the findings regarding genetic knowledge
versus competence, as the dissonance noted may be rooted in moderate levels of knowledge but
lower levels of competence. Specifically, participants reported a range of experience with
genetics - about half had formal training within the last five years or were active in a field of
genetics and half had little-to-no formal genetics training. Notably, they had high levels of selfreported genetic knowledge (information known about a topic) and variable levels of competence
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(ability to apply knowledge to a new context). The more application of genetic information that
was required in a hypothetical scenario, the less competent participants felt. Interesting, there
were two exceptions to this. The areas where participants felt that genetic information would
have the greatest impact on mental health care were (a) interest in biological or pharmacological
therapies for mental health disorders and (b) disorders for which we know the most about
biologically (schizophrenia spectrum and other psychotic disorders, neurodevelopmental
disorders, and bipolar disorder). These exceptions highlight a linear perspective that echoes the
translation of genetic information related to chronic, physical conditions (Arnett et al., 2007;
Cornel & El, 2017; Ebomoyi, 2013; Vornanen et al., 2016; International Consortium for Blood
Pressure Genome-Wide Association Studies, 2011, 2011; Gil et al., 2003; Khera & Kathiresan,
2017; Macdonald et al., 2009; Norman & Brain, 2005; Phillips et al., 2006) and older views that
such frameworks would also work for psychiatric disorders (Sullivan et al., 2012; Visscher et al.,
2016). They also are examples of participants’ genetic knowledge at work, as participants were
likely taught or inferred throughout their careers that the only way genetic information can
inform care is by first uncovering underlying biological mechanisms of disease and then creating
biological or pharmacological therapies based on those mechanisms.
The lower genetic competence for more genetic-intense scenarios aligns with
participants’ disagreement that translating genetic information will have large benefits for mental
health care. This lack of competence is likely preventing participants from thinking beyond a
linear framework when answering questions related to other ways that genetic information may
be of impact (e.g., improving diagnostic clarification for affected patients with mental health
disorders) and for disorders for which the underlying molecular genomic architecture is unclear
(i.e., anxiety disorders). In other words, there is a translation-genetic competence gap in the
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context of mental health among academic stakeholders. An immediate next step along this line of
research should therefore be to examine the relationship between genetic knowledge and
competence and the translation-focused questions of this survey. It should also be examined
whether there are differences in genetic knowledge and competence among academic
stakeholders (researchers, clinicians, both, neither) as has been noted in another study that
examined attitudes about communicating the genetic risk of mental health disorders (Zhou et al.,
2014). These are explored in part 2 of this chapter. Differences in genetic knowledge and
competence among stakeholders should also be assessed for specific types of genetic information
(i.e., molecular vs. epidemiological) in a future study.
These findings reiterate two key barriers to translating genetic information broadly and in
a mental health context - education/training and proper engagement of all stakeholders (Gray &
Bonventre, 2002; Sperber et al., 2017; Sperber, Brosenitsch, Levine, & Kanter, 2008; Zhou et al.,
2014). While education/training have already been a noted barrier to the communication of
genetic risk about mental health disorders specifically (Zhou et al., 2014), the current findings
extend the literature. There is now tentative evidence that delineating genetic knowledge from
genetic competence in the context of mental health is critical to addressing barriers related to
translation. Efforts to enhance the translation of genetic information about mental health
disorders need to emphasize the difference between knowledge and competence and ensure that
stakeholders are able to generalize their knowledge to new situations, not simply know details
about genetic information (although that is still a noted barrier in past studies [Cornel & El,
2017; Dick, 2017; Howe, Breach, Brody, & Wyman, 2016; Sperber et al., 2017; Sullivan et al.,
2012; Sullivan et al., 2018; Visscher et al., 2016; Wittchen et al., 2014]). A key way for this to
occur is through non-linear translational frameworks such as D&I and prevention science that
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emphasize collaboration and communication with a socio-ecological perspective. A natural byproduct of such a shift would be an emphasis on non-molecular genetic information which may
aid in the incorporation of genetic information into mental health care.
Findings also highlight that participants have a healthy number of diverse collaborators
with whom they communicate regularly. This is to be commended, and future work needs to
leverage this information carefully. For example, the current study did not assess how
participants engage with their collaborators. It is possible that they already take a holistic
approach to collaboration or that they engage in a linear view of translation and only rely on
specific collaborators when certain areas of expertise are needed. Knowing this information
would greatly help to bridge the translation-genetic competence gap among academic mental
health stakeholders. It is critical that collaborators be engaged in all aspects of projects and
translation in a collaborative and cooperative manner. Again, overcoming these barriers is not
insurmountable, especially if shifts away from linear views of translation and molecular-only
genetic data occur occur.
Limitations
This study should be interpreted in the context of seven limitations. First, most findings
presented here are novel and thus not comparable to past literature and must be evaluated in and
of themselves. Second, these findings are likely not generalizable outside of academia, and to
that end, a large institution. The issues discussed in this paper are complex, and inquiries into
them must start somewhere; hopefully future studies will fill in gaps such as extensions to other
stakeholders. In that vein, there is no input from patients or trainees, stakeholder groups who can
also be found at large universities with a medical campus and other training facilities. Third,
inquiries into academics’ roles were restricted to asking about their degree, primary job type, and
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primary areas of research and/or clinical expertise. We were understandably not permitted to ask
specific department affiliations, although such information may have provided additional
insights. Fourth, care was taken to ensure that concepts such as genetic knowledge and genetic
competence were captured by this survey. However, psychometric analysis was limited, and the
validity of this survey is not known (see part 4). Fifth, participants were queried across a range of
genetic concepts and often, “genetic information” was used broadly in the survey. This was to
gauge participants’ views on this topic but admittedly did not directly address issues brought up
in this study – namely, that different translational approaches should be taken for molecular and
non-molecular genetic information. Sixth, the survey did not query participants on their
familiarity with prevention science, a major translational framework. Finally, a major purpose
was for this survey to be ideas-generating for future projects. This is one step of many into this
line of research. That said, this paper somewhat fell into the trap of focusing on what to do in the
future instead of what can be done in the present because of this limitation.
Conclusions
Translation has been more attainable for certain fields and types of genetic information
than others and it has become clear over the past decade that there is no one-size-fits-all
approach to the translation of genetic information (Khoury et al., 2007; Kon, 2008; Waldman &
Terzic, 2010). The current study sheds light on academic mental health stakeholders’
translational practices and attitudes as well as their genetic knowledge and competence by taking
a broad, inductive approach to studying the topic at hand. Findings extend past research and
highlight a translation-genetic competence divide that may be able to be addressed by applying
collaborative and inclusive translational frameworks to the incorporation of genetic information
in mental health care.
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Part 2: Hypotheses and research question generated from the survey
Introduction
To recap from part 1, a translation-genetic competence gap was noted. Participants
supported broad level translation but displayed lower enthusiasm for translating genetic
information related to specific mental health treatment scenarios and disorder examples. They
also reported lower competence for more genetic-intense scenarios. This indicates that genetic
competence, which is properly applying knowledge to a new context, is needed above and
beyond genetic knowledge to thoroughly assess the translation of genetic information into the
care of mental health disorders. That is because genetic knowledge likely teaches linear views of
translation and pharmacological-based views of translating genetic information with examples
that rely on chronic, physical conditions (Spencer et al., 2008; van der Laan & Boenink, 2012).
Hypotheses and Research Questions
Accordingly, there are two hypotheses and one research question designed to be a followup to part 1. They are as follows:
Hypothesis 1: There will be positive relationships between genetic competence and
questions about (a) current translational practices, (b) the importance of translation, (c)
willingness to improve own translational skills, and (d) impact on care. In other words, the
stronger participants’ genetic competence then the more they can think thoroughly about
translating genetic information.
Hypothesis 2: There will be positive relationships between genetic knowledge and
questions about (a) current translational practices, (b) the importance of translation, (c)
willingness to improve own translational skills, and (d) impact on care, but these relationships
will not be as strong as those for genetic competence. In other words, the stronger participants’
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genetic competence, then the more they can think thoroughly about translating genetic
information. Stronger genetic knowledge may prevent stakeholders from thinking in non-linear
ways about translating genetic information.
Research question 1: Are there differences in genetic knowledge and competence among
participants based on job type (researcher, clinician, both, neither)?
Methods
All methodology except the specific analyses from part 1 apply to part 2. A summated
score (Fink et al., 2017) was used to generate composite variables across questions that had
multiple components. For example, participants answered the question “which of the following
do you think will benefit from increased translation of genetic information” for 13 DSM-5
disorders. The sum score was created for a composite variable that represents overall attitudes on
“benefit of translation of genetic information for specific mental health disorders.”
Specifically, eight composite variables were created (see Table 3.5 below for details):
“experience with translational science terms,” “breadth and depth of network of collaborators,”
“genetic knowledge,” “genetic competence,” “importance of translating genetic information
about mental health disorders,” “willingness to improve own translational competency,”
“influence of translating genetic information on mental health care,” and “influence of
translating genetic information of specific mental health disorders.”
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Table 3.5. Composite variables created from the translational survey.
Original Questions

Original Answers

Experience With Translational Science Terms
Select the answer that best describes your
I have not heard of this
experience with these terms related to
I have heard of this
translational science:*
I can define this and give an
example
Research-to-practice
Research-to-policy
I actively participate in this form
Bench-to-bedside
of translation
Dissemination and Implementation
Precision Medicine
Breadth and Depth of Network of Collaborators
I do not have a network of
collaborators
Less than 10
The size of my network of collaborators is…
10 or more
20 or more
Researchers
I have collaborators that are…
Clinicians
Nurses
[check all that apply]
Teachers
Other (please specify)
Psychology
Psychiatry
Statistics
My collaborators span the following
Psychiatric and behavioral
disciplines…
genetics
Human and molecular genetics
[check all that apply]
Social and Behavioral Health
Social work
Public health
Other (please specify)
Several of us meet/consult
regularly
How often do you meet/consult with
individuals from your network of
I meet/consult with individuals on
collaborators?
an as-needed basis
Other (please specify)
Genetic Knowledge
I have never heard of this
Select the answer that best describes your
experience with each of the following content I have heard of this but cannot
areas of genetics
define it
Family history / aggregation
Heritability

I can define this and give an
example
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Score for the
Answer Option
That Went Into
Sum Score
0
1
2

3

0
1
2
3
1 point per different
type of collaborator

1 point per different
type of discipline

2
1
1
0
1
2

Gene-environment relationship (i.e.,
interaction or correlation)
Twin studies
Molecular genomics
Epigenetics

I utilize content related to this in
my everyday work
3

Genetic Competence
Rank how much you agree/disagree with the
following statements
Strongly Disagree
•

•

•

•

•

•

•

•

I feel competent discussing genetic
information regarding mental health
disorders with my network of
Disagree
1
collaborators
I feel competent discussing genetic
information regarding mental health
disorders with trainees/students
Agree
2
I feel competent discussing genetic
information regarding mental health
disorders with patients
I feel competent reading a scholarly
article that mentions genetic information
Strongly Agree
3
(i.e., in the intro or discussion as potential
implications)
I feel competent reading a scholarly
article that utilizes genetic information as
the focus of the overall purpose of the
study (i.e., heritability study, genomewide association study)
I feel competent being a CO-author on a
scholarly article where the genetics of a
mental health disorder is the focus of the
study
0
I feel competent being a LEAD author on Not Applicable
a scholarly article where the genetics of a
mental health disorder is the focus of the
study
I feel competent mentoring/advising a
trainee/student who wants to study the
genetics of a specific mental health
disorder (i.e., cumulative project, thesis,
dissertation)
Importance of Translating Genetic Information About Mental Health Disorders

Rank how much you agree/disagree with the
following statements
•

0

Translation between research and practice
related to mental health disorders is
important

Strongly disagree

0

Disagree

1
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My field would benefit from improved
Agree
translation of genetic information related
to mental health disorders
• It is important for all professionals in my
field (researchers, teachers, practitioners)
to understand the genetic risk associated
with specific mental health disorders
Strongly agree
• It is important for students to be taught
how to utilize information regarding the
genetic risk associated with specific
mental health disorders, regardless of
field
Willingness to Improve Own Translational Competency
Rank how much you agree/disagree with the
Not very likely
following statements
•

Attend a one-day in-person workshop at
Not likely
VCU
• Attend an in-person course at VCU that
Likely
meets once a week for four weeks
• Take an online training module that can
Very likely
be spread out over multiple sittings
• Attend a special 2-hour seminar
presentation at a conference you already
I already do this / have done
plan to attend
something like this
• Attend regular meetings with your
network of collaborators
Influence of Translating Genetic Information On Mental Health Care
To what extent do you believe that increased
knowledge of genetic information regarding
No influence
the basis of mental health disorders will
influence the following?
•

•
•

•
•
•
•
•
•

Discovering new and better treatments for
mental health disorders
Improving diagnostic clarification of
affected patients with mental health
disorders
Identifying asymptomatic patients at risk
of developing mental health disorders
Targeting of resources to at-risk
populations
Prenatal testing to guide reproductive
choices
Stigma of mental health disorders
Insurance to patients with a high-risk
genetic profile for mental health disorders
Interest in psychosocial therapies for
mental health disorders

2

3

0
0
1
2

3

0

Weak influence

1

Moderate influence

2

Strong influence

3
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Interest in biological or pharmacological
therapies for mental health disorders
Influence Of Translating Genetic Information Of Specific Mental Health Disorders
Which of the following do you think will
benefit the most from increased translation of
No benefit
0
genetic information?
•

•
•
•
•
•
•
•
•
•

•
•
•
•

Schizophrenia spectrum and other
psychotic disorders
Anxiety disorders (generalized, social,
panic, separation, phobias)
Bipolar disorder
Depression disorders (major depression,
melancholia)
Obsessive-compulsive disorder
Post-traumatic stress disorder
Eating disorders (anorexia, bulimia, binge
eating disorder)
Personality disorders
Neurodevelopmental disorders (autism
spectrum disorder, communication
disorders, intellectual developmental
disorder)
Sleep-Wake disorders (insomnia disorder,
narcolepsy)
Sexual dysfunction
Disruptive, impulse-control, and conduct
disorders
Substance use disorders (alcohol,
gambling, cocaine, other substances)

Some benefit

1

Moderate benefit

2

Significant benefit

3

Next, Pearson correlations were run to calculate the correlations among these eight
composite variables. This not only answered hypotheses 1 and 2 but provided some additional
information. There were three components to these two hypotheses - that genetic competence
and genetic knowledge (respectively) would be positively correlated with a) current translational
practices, b) the importance of translation, c) willingness to improve own translational skills, and
d) impact on care. Here, “current translational practices” entailed the “experience with
translational science terms” and “breadth/depth of network of collaborators” composite variables
of the survey. “The importance of translation” and “willingness to improve own translational
skills” were represented by the composite variables with the same titles (above). “Impact on
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care” was also represented by two composite variables, those related to the importance of genetic
information on mental health care scenarios and specific mental health disorders.
Finally, a 1-factor ANOVA was run to assess differences in the sum scores for genetic
knowledge and genetic competence across the ordinal variable of job type (four levels researchers, clinicians, both, and neither).
Results
Hypothesis 1: Relationship Between Genetic Competence and Translation
This hypothesis was mostly unsupported and should be rejected (see Table 3.6). Out of
the six correlations assessed, only one was significantly associated with genetic competence. The
“importance of translating genetic information about mental health disorders” variable had a
strong, positive relationship with genetic competence (r = .58; p < .01).
Table 3.6. Results for hypothesis 1 - assessing the relationship between genetic competence and
translational variables.
Importance
Influence
Influence
Experience
of translating
of genetic
Willingness of genetic
with
Breadth/
genetic
information
to improve information
translational depth of information
on specific
translational on mental
science
network about mental
mental
skills
health care
terms
health
health
scenarios
disorders
disorders
Genetic
-.20
.10
.58*
.15
.07
.00
competence
*p < .01

Hypothesis 2: Relationship Between Genetic Knowledge and Translation
This hypothesis was also mostly unsupported and should be rejected (see Table 3.7).
Two of the six correlations had a relationship with genetic knowledge, although one was in the
opposite direction. As hypothesized, the correlation between genetic knowledge and “importance
of translating genetic information about mental health disorders” was positive but not as strong (r
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= .30; p <.05) as the variable’s relationship with genetic competence. Interestingly there was a
negative relationship between genetic knowledge and “experience with translational science
terms” (r = -.29; p < .05). None of the other variables were related to genetic knowledge.
Table 3.7. Results for hypothesis 2 - assessing the relationship between genetic knowledge and
translational variables.
Importance
Influence
Influence
Experience
of translating
of genetic
Willingness of genetic
with
Breadth/
genetic
information
to improve information
translational depth of information
on specific
translational on mental
science
network about mental
mental
skills
health care
terms
health
health
scenarios
disorders
disorders
Genetic
-.29*
.07
.30*
.03
-.07
-.19
knowledge
*p < .05

Research Question 1: Differences by Job Type
There were significant differences found in genetic knowledge and competence based on
job type. See Table 3.8 for the mean scores of genetic knowledge and competence by job type.
Table 3.8. Mean scores (standard deviation) of genetic knowledge and genetic
competence by job type.
Researchers
Clinicians
Both
Neither
Genetic
11.72 (3.13)
12.05 (2.55)
14.57 (2.64)
9.67 (3.67)
knowledge
Genetic
12.04 (5.50)
12.53 (4.06)
17.14 (5.08)
9.67 (6.87)
competence
The ANOVA for genetic knowledge was significant (F = 3.570; df = 3; p < .05) and a Tukey
Posthoc test revealed that the significant differences was between those who were both clinicians
and researchers and those who were neither (see Table 3.9). A second ANOVA that removed
those who were neither (due to such individuals being the most different from the other three
categories) revealed no further significant differences (F = 2.772; df = 2; p > .05).
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Table 3.9. ANOVA results for genetic knowledge.
Researcher
F (df); p
Differences
ANOVA
3.570 (3); .020
-Researcher vs.
Clinician: .333
(p = .983)
Tukey
Posthoc

--

Researcher vs.
Both: 2.851
(p = .128)
Researcher vs.
Neither: 2.053
(p = .301)

Clinician
Differences
-Clinician vs.
Both: 2.519
(p = .238)
Clinician vs.
Neither: 2.386
(p = .212)

Both
Differences
--

Both vs.
Neither: 4.905
(p = .010)

The ANOVA for genetic competence was not significant (F = 2.736; df = 3; p > .05) however a
Tukey Posthoc test was conducted anyway for completeness (see Table 3.10). The posthoc test
revealed significant differences between those who were both clinicians and researchers and
those who were neither. A second ANOVA that removed those who were neither (due to such
individuals being the most different from the other three categories) revealed no further
significant differences (F = 2.996; df = 2; p > .05).
Table 3.10. ANOVA results for genetic competence.
Researcher
F (df); p
Differences
ANOVA
2.736 (3); .052
-Researcher vs.
Clinician: .486
(p = .990)
Tukey
Posthoc

--

Researcher vs.
Both: 5.103
(p = .119)
Researcher vs.
Neither: 2.373
(p = .655)
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Clinician
Differences
-Clinician vs.
Both: 4.617
(p = .208)
Clinician vs.
Neither: 2.859
(p = .542)

Both
Differences
--

Both vs.
Neither: 7.476
(p = .033)

Additional findings
As stated in the methods, a correlation matrix was completed for all of the variables in
the survey based on their sum scores. The full matrix is below and includes some information not
discussed in the above sections (see Table 3.11). The variables are in the same order as the
survey. Additionally, a Spearman correlation was run between the nine composite survey
variables and job type.
Table 3.11. Correlations among all composite variables and job type.
1.
2.
3.
4.
5.
1. Experience with
1
translational science terms
2. Breadth and depth of
.11
1
network of collaborators
3. Genetic knowledge
-.29* .07
1
4. Genetic competence
-.20 .10 .63**
1
5. Importance of translating
genetic information about
.00
.14 .30* .58**
1
mental health disorders
6. Willingness to improve
own translational
.00
.05
.03
.15
.20
competency
7. Influence of translating
genetic information on
.10
.00 -.07
.07
-.12
mental health care
8. Influence of translating
genetic information of
.12 -.11 -.19
.00
-.09
specific mental health
disorders
9. Job type
.26 .27* -.08
-.02
.24

6.

7.

8.

9.

1
.14

1

.08

.60**

1

-.06

-.03

.15

1

*p < .05; **p < .01; ***p < .001
Note: Job type is ordinal and thus Spearman correlations were used; all other correlations were done with Pearson
correlation. Job type was ordered in the following ascending way: researcher, clinician, both, neither.

As seen from the correlation matrix above, there were few significant correlations across
these variables. Unsurprisingly, there is a strong correlation among all genetic variables. The
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strongest correlation is between attitudes about the perceived impact of genetic information on
mental health care and mental health disorders, which is also unsurprising given that the two
variables are two components of the same topic. Finally, there was a positive correlation between
job type and breadth/depth of participants’ network of collaborators. This implies that those who
are only researchers and clinicians are least likely to have a stronger network of collaborators.
Conclusions
Despite preliminary, descriptive evidence from part 1 of a translation-genetic competence
gap among participants, there are few relationships between the translational variables from the
survey and genetic competence or knowledge. Hypotheses 1 and 2 stated that genetic
competence and knowledge, respectively, would be positively associated with translation
variables with competence having stronger relationships. Both genetic competence and
knowledge were moderately associated with how important participants viewed the overall
translation of genetic information about mental health disorders; genetic competence had the
stronger correlation. However, genetic competence was not associated with any other translation
variables and genetic knowledge was negatively associated with experience with translational
terms. Together, these results lead to the rejection of both hypotheses 1 and 2.
The two associations between the importance of translating genetic information about
mental health disorders and genetic competence and knowledge are notable. The strength of the
relationships aligns with the proposed translation-genetic competence gap from part 1. Even
though there was only an association with one translation variable, it was still stronger for
genetic competence than knowledge. This adds some evidence that genetic competence is a
bigger driving force behind thinking outside of the box and holding positive views about the
translation of genetic information into the care of mental health disorders. Genetic knowledge
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likely comes form and hence reinforces linear views of translation that hinder translation in a
mental health context. The rationale behind this gap is further reinforced by the finding that as
genetic knowledge increases, experience with translational science terms decreases.
Finally, significant differences were found between those who identify as both and
neither researchers and clinicians in regard to their amount of genetic knowledge and
competence. Those who identified as both reported higher levels of both. Otherwise, there is no
evidence that genetic knowledge or competence differ based on job type. This is especially good
to know when comparing researchers and clinicians, as differences between those two groups
would have arguably had the most implications for this line of research.
Overall, it is clear that while part 1 provides some intriguing insights into the current state
of the science regarding the translation of genetic information, there is only so much to be
gleaned from this survey. There is much more to examine about this topic, but utilizing the
survey for anything more than descriptive statistics and ideas for future projects seems fruitless.

Part 3: Analysis of key open-ended questions
Introduction & Methods
Finally, there were several open-ended questions in the survey. Many of these were
options for participants to give responses if they selected “other” for a question, but a few were
purposeful and will be discussed in turn. These question was analyzed using the qualitative
content analysis approach of open coding whereby the responses were read, ideas were labeled,
codes were created, and themes were identified across responses (Strauss & Corbin, 1998).
Current Translational Experiences
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At the end of the Professional Translational Experiences section of the survey,
participants were asked “What else should I know about your current professional behaviors and
experiences related to translational science (i.e., organizations you are a part of, specific details
of your collaborative efforts, ways you integrate science, practice, and teaching, etc.)?” Fifteen
people responded to this question and two key themes emerged. First, most people who answered
this question clearly felt that they were meeting translational expectations and doing the right
thing within their respective fields, whether it be research- or clinical-related. On the research
side, participants cited grants, research studies, reading articles, mentorship, and being a
reviewer for journals as translational activities that they engage in. On the clinical side, many
cited efforts to improve service, increase evidence-based practice, and develop new programs.
The second and more surprising theme was the discussion of bridging the research-to-practice
gap via collaborations, committees, and interdisciplinary relationships. No matter the
translational framework utilized, this is the end goal of translational science.
Influence On Mental Health Care
Toward the end of the final section of the survey, Translational of Genetic Information to
Mental Health, participants were asked “What are other ways you think genetic information can
influence mental health?” Only four participants answered this question but their responses were
all along the same theme and are worth mentioning. Specifically, each response discussed the
negative consequences of utilizing genetic information in clinical care - consequences such as
stigma, insurance concerns, and additional barriers. It should be noted that such a theme implies
that participants assumed that the genetic information that would be translated to the care of
mental health disorders is molecular genetic information. Most of these negative consequences
would not be a concern when translating non-molecular genetic information. Additionally, one
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participant mentioned a positive influence could be policy changes to support increased research
related to this topic.
Final Thoughts About Given Topic
At the end of the survey, participants were asked two questions. The first was “What are
your final thoughts about the translation of the genetic information to the clinical care of mental
health disorders?” Thirteen participants answered this question and three themes emerged from
the responses. First, participants thought that there was a strong need to consider the ethical and
moral implications as we continue to examine the genetic etiology and eventual clinical
implementation of such data into the care of mental health disorders. This echoes responses from
the previous question (“What are other ways you think genetic information can influence mental
health?”). Second, on a more positive note, participants were hopeful that translating genetic
information would help overcome barriers to care, such as medication adherence, less selfblame, and overall benefits. Finally, participants were vocal about the fact that so far, there is no
evidence that genetic information will help with mental health disorders due to few findings that
are potentially translatable (again, a molecular-only perspective is implied in such responses only one person explicitly mentioned heritability). Many participants were negative about the
potential utility while many held out hope that future research will lead to findings that can
positively impact care.
Translational Science Definition
The second question asked at the end of the survey was “I carefully avoided giving you a
specific definition of translational science during this survey. Please let me know what
translational science means to you in one sentence.” A definition of translational science was
purposefully not provided during the survey. Twenty-seven participants responded and despite
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this being the most-answered open-ended question, only one major theme was present. That
theme was that translational science is the application of basic science to clinical practice and
policy in a linear fashion. Across these responses, key words such as “disseminate,”
“implement,” and “research-to-practice” were used but in a linear context. Variations of the word
“translation” were also often used in the definition. One response did not give a definition of
translation science and instead stated that it is an over-used term. Another participant stated that
translational science is broader in scope and is the application of knowledge across fields. It must
be noted that other than this one response, a participatory / collaborative perspective of
translation was not upheld by participants. Discussion of collaborators and effective
communication were missing, as well as ways to think outside of the box and use socioecological perspectives to implement non-molecular information (for example).
Conclusions
Analysis of the open-ended questions reaffirmed that participants hold a very linear view
of translation and assume that the “genetic information” to be translated into mental health care
is molecular genetic information. This aligns with findings from chapters 2 and 3 that
participants hold more knowledge than competence and future studies will have to examine that
further.

Part 4: Limited psychometrics of the translational survey
Introduction
As a reminder, this section is included for completeness. The survey was designed to be
hypothesis-generating and inductive, not deductive. The purpose was never to create a permanent
measure but set the groundwork for a future line of research that eventually includes an updated
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survey. This would require overhauling the current survey, administering it to a larger sample
size, and conducting proper psychometric analyses. Thus, the current analyses are what could be
performed given limitations of the current survey.
Typically, psychometric evaluation of a measure includes assessing reliability, validity,
and factor structure. These will be discussed in turn.
Reliability
Reliability is the extent to which a measure produces consistent results. Internal
consistency was calculated for individual sections of the survey as well as the composite
variables via Cronbach’s alpha. Results are in Table 3.12. Overall, both the sections and
composite variables are reliable throughout the survey with the exception of section 1, which has
low internal consistency.
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Table 3.12. Internal consistency for the three sections of the survey and their eight
associated composite variables.
Cronbach’s alpha
(confidence interval)
Section 1: Professional Translational Practices
Overall section
.31 (.09 - .53)
Experience with TS terms*
-Network
.54 (.40 - .68)
Section 2: Genetic Knowledge and Competence
Overall section
.85 (.80 - .90)
Genetic knowledge
.84 (.78 - .89)
Genetic competence
.81 (.75 - .88)
Section 3: Translation of Genetic Information to Mental Health Care
Overall section
.88 (.84 - .93)
Importance of translating MH
.80 (.72 - .88)
Willingness to improve translation of MH
.73 (.62 - .83)
.82 (.76 - .89)
Influence translation of genetic info will have on MHC
Benefit translation of genetic info will have on specific
disorders

.88 (.84 - .92)

TS = translational science; MH = mental health; MHC = mental health care
*Cannot assess reliability for one question

Due to the structure and nature of how the survey was constructed and administered, it was not
possible to assess inter-rater reliability or test-retest reliability.
Validity
Validity is how well a measure assesses what it is supposed to assess. While content and
face validity can be measured to a certain degree, establishing criterion validity would have more
of an impact for the survey. Unfortunately, there are no comparable measures to the current
survey by which to show criterion validity (i.e., convergent and/or divergent validity).
Subjectively, the survey has face validity. It includes one section for each key topic in question translation, genetics, and the intersection of those two in a mental health context. It is likely that
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the content validity is weaker than the face validity. The survey could have included different
types of questions about translation and genetics especially. For example, both of those sections
of the survey ask participants to rank their familiarity with translation and genetics terms but
those terms are never defined for participants nor used again in the survey. There are likely better
ways to assess experience with translational science and genetic knowledge and competence.
Factor Structure
Factor structure is important to know because it is possible that there are redundant
responses in a measure, items do not load the way the measure’s creators think that they do, and
so on. Ways to assess this include an exploratory factor analysis (EFA), confirmatory factor
analysis (CFA), and item response theory (IRT) modeling. Unfortunately, none of these options
were appropriate for the data in the survey. The survey comprised three sections, nine key
composite variables, and dozens of individually coded questions. These questions were asked in
different ways (i.e., check all that apply, Likert) that made conducting an EFA or CFA
impossible. Additionally, the purpose of IRT modeling such as an item characteristic curve is to
describe the relationship between a latent ability and performance on a test item. The purpose of
this survey was not to gauge “right” or “wrong” responses about the translation of genetic
information into the care of mental health disorders. Thus, there were no “right” or “wrong”
answers by which to discriminate and the parameters of an IRT model do not apply to this survey
(ability level, correct response, discrimination, difficulty, guessing).
Conclusions
Limitations of assessing the psychometrics of this survey were discussed along with the
few results. Overall, this survey served its purpose in being hypothesis-generating but strong
conclusions should not be made. Given the plentiful limitations (essentially the lack of any
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psychometrics except for internal consistency), the descriptive results from this survey are the
only informative results. Future studies should build upon what this survey attempted to do by
being more targeted, conducting focus groups before creating the survey, doing more pilot
testing, and putting measures in place to be able to thoroughly assess the psychometrics of the
measure (e.g., consistently asking questions the same way to be able to conduct an EFA, A/B
testing or testing in waves to assess reliability more thoroughly, including some questions for
which IRT modeling would be appropriate)

Part 5: Global discussion - What have we learned about the translation of genetic
information into the care of mental health disorders?
Impressive progress has been made to document the role that genetic information plays in
the risk reduction, identification, prevention, and treatment of physical, chronic conditions such
as cardiovascular disease (Arnett et al., 2007; Ebomoyi, 2013; Khera & Kathiresan, 2017;
International Consortium for Blood Pressure Genome-Wide Association Studies, 2011;
Vornanen et al., 2016), breast cancer (Cornel & El, 2017; Gil et al., 2003; Macdonald, Sarna,
Weitzel, & Ferrell, 2009; Norman & Brain, 2005; Phillips et al., 2006), macular degeneration
(Black & Clark, 2016), and other similarly complex disorders. While it has long been assumed
that such linear ways of translating genetic information would carry over to psychiatric disorders
(Sullivan et al., 2012), that has not occurred (Sullivan et al., 2018; Visscher et al., 2016). The
current dissertation aim was a way to gauge attitudes and practices surrounding the translation of
genetic information into the care of mental health disorders. Findings shed light on a translationgenetic competence gap among participants that likely stems from the fact that many (if not all)
hold a linear view of translation. This view communicates that molecular information is the
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“genetic information of choice” and given the state of the science (Visscher et al., 2016), we are
decades away from any level of implementation. Relatedly, participants like the idea of
translation but do not seem quite sure how to act upon that.
Despite a lack of depth to this area of research, survey results somewhat align with the
dearth of extant literature and serve to push the field forward. This is all discussed in the context
of three barriers to translating the genetic information of mental health disorders: (1) Whether
explicitly or implicitly stated, linear frameworks of translation abound when discussing any
disorder, even those of a psychiatric nature. (2) The lack of training and continuing education
across academic fields related to the ever-changing field of genetics and its sub-fields
(psychiatric, behavioral, human, molecular, counseling). (3) The exclusion of mental health /
psychiatry from widespread discussion of translational practices.
First, as already stated, linear frameworks abound when discussing any form of
translation in a genetic context because it is assumed that “genetic information” equals
“molecular genetics.” This is misleading because there are many types of genetic information
that may be useful to clinicians and health educators that are not molecular (e.g., heritability,
family history, gene-environment interplay, the concept of genes vs. environment involved in a
disorder). It is likely that such linear ways of thinking stem from stronger genetic knowledge
than genetic competence. It has been hypothesized during this chapter that genetic competence is
necessary for the type of translation that is necessary to integrate non-molecular genetic
information into the clinical care of mental health disorders. It is time that we move beyond
waiting for science to catch up with practice and find new, collaborative, communicative, and
socio-ecological frameworks that allow us to ask the next set of questions about incorporating
genetic information into the clinical care of mental health disorders.
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Second, despite moderate self-reported levels of genetic knowledge, participants largely
did not report having much genetic experience. This is in line with oft-cited barriers to
translation (both general translation and translation specific to genetics) - training and education.
On one hand, continuing education, workshops, and other outlets are necessary to assist mid-tolate career professionals with simply discussing the translation of non-molecular information into
mental health care, let alone actually doing the translation. Increased education would likely lead
to increased communication among stakeholder groups (Sperber et al., 2017). Getting
participants to come to these events may be difficult, though, as the survey showed.
On the other hand, translation, genetics, and mental health need to be taught together. For
example, if an individual is earning a master’s in genetic counseling, they should be taught about
the risks of psychiatric conditions and how to inform patients, collaborate with psychiatrists, and
so on. If a person is earning a doctorate in clinical psychology, a program which already
emphasizes translation via evidence-based practice, then genetics should also be part of that
training. Finally, more programs that specialize in training the next generation to be translational
specialists are necessary. One study found that translational training (especially as it related to
behavioral health) need to be organized into research-related, translational, and societal impacts
(Baldwin et al., 2017). Such broadening frees stakeholders from the traditional linear viewpoints
that are associated with the term “translational science.”
Finally, mental health conditions have been largely overlooked in translational efforts.
For example, the White House’s Precision Medicine Initiative (Collins & Varmus, 2015) clearly
leaves mental health conditions out of national efforts to broadly apply precision medicine with a
top-down, federal initiative. Additionally, the National Center for Advancing Translational
Science focuses on GWAS for physical, chronic conditions (Collins, 2011). It does not focus
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heavily on non-molecular approaches or psychiatric disorders. There is widespread agreement
that the translation of basic scientific findings to the benefit of public health represents a critical
goal in scientific research (Centers for Disease Control, 2007; Collins & Varmus, 2015; Sullivan,
Daly, & O’Donovan, 2012). To accomplish that goal, some have argued for the importance of
integrating multiple perspectives across disciplines (psychiatry, psychology, social work,
genetics, statistics) and stakeholders (e.g., researchers, clinicians, patients, administrators, policy
makers) (Kon, 2008; Waldman & Terzic, 2010). Those efforts should naturally include nonmolecular information and mental health care. Through an appreciation of such diverse
perspectives, multi-faceted, targeted translation plans can be developed reflecting the expertise
and needs of the stakeholders involved.
Limitations
Limitations have been discussed throughout each part of this chapter and will not be
repeated here. However, a few words must be given to what is simultaneously the survey’s
biggest strength and limitation. The survey purposefully did not provide participants with
definitions of “genetic information” or “translational science.” On one hand, this decision likely
contributed to ambivalence and negativity about exactly how translation could impact mental
health care and participants’ hypothetical roles in this process. On the other, this lack of direction
also meant that little creator bias was introduced into the survey, thus it represents the state of the
science.
Similarly, the survey tackled abstract concepts that participants might not have previously
thought much about. It is possible that the pattern of results in parts 1 and 2 are due to a general
misunderstanding of the topic at hand and not true genetic knowledge / competence or
translational attitudes / practices. This is why the most attention was given to the descriptive part
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1 - it would be foolish to read too much into the results from the quantitative part 2 or to dig any
deeper without proper input from stakeholders. Thus, the broad scope of the survey was
simultaneously a necessary first step toward examining this topic area and also a major
limitation. Future studies need to seek stakeholder input in the creation of a survey (with focus
groups or interviews preceding it) and find a way to give more context to the survey. This might
mean focusing specifically on one psychiatric disorder, defining key terms from the beginning,
and/or finding new ways to assess knowledge and competence.
Final Thoughts
This survey served as the first step toward the integration of non-molecular information
into mental health care. Such integration is a multi-step process and will require first examining
even if such a step should be taken by consulting with a wider range of stakeholders. Current
findings support moving forward with this line of research. See chapter 9 for a more thorough
discussion of next steps.
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Chapter 4: Pediatric Social Anxiety: Etiology, Risk Factor Models, and Best Treatment
Practices
Overview
This chapter is a transition from discussing translational science in a broad manner
(chapters 2 and 3) to a specific manner via social anxiety. In this context, the translational endgoal will be the creation of a risk factor model (presented in chapter 9) based on the work done
in the next few chapters. Chapters 4 through 8 thus include aims 2 and 3 from the dissertation
with a chapter dedicated to an overview of social anxiety (current chapter) and summative
methodology chapter (chapter 5).
Introduction
Social anxiety disorder is a major public health concern affecting 9.1% (Merikangas et
al., 2010) of adolescents, 6.8% of adults (Kessler et al., 2005), and has up to 13% lifetime
prevalence (Rapee & Spence, 2004). The mean age of onset is 10-13 years (Rapee & Spence,
2004) and so logically, symptoms often present throughout childhood and pre-adolescence.
Social anxiety is a complex disorder meaning that its etiology is an uncertain mix of a multitude
of genes, environment, and likely the interplay between the two. The heritability of social
anxiety is 52-55% in pre-adolescents (Lahey et al., 2011; Ogliari et al., 2006) and remains stable
into adulthood (Hettema et al., 2001), implying a lack of genetic attenuation. This complex
etiology highlights the need to study both genetic and environmental risk factors associated with
the disorder and ultimately mitigate its onset.
Social anxiety can lead to negative outcomes such as attentional and cognitive biases
toward negative stimuli (Heinrichs & Hoffman, 2001), social deficits (Chansky & Kendall, 1997;
Erath, Flanagan, & Bierman, 2007; Spence, Donovan, & Brechman-Toussaint, 1999), and peer
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victimization (Erath et al., 2007). Without treatment, symptoms typically do not abate and can
result in continued social anxiety and adult-onset comorbid disorders such as alcohol misuse and
major depression (Axelson & Birmaher, 2001; Bosquet & Egeland, 2006; Carrigan & Randall,
2003; Kendall, Safford, Flannery-Schroeder, & Webb, 2004; Kessler, Stang, Wittchen, Stein, &
Walters, 1999; Weichold, Weisner, & Silbereisen, 2014; Wittchen et al., 2000). A lifetime
struggle with social anxiety has been shown to lead to disability in routine functions, reduced
quality of life, and suicide (Wittchen et al., 2000; Stein & Kean, 2000; Weiller et al., 1996). To
best understand the risks that may lead to social anxiety as an adult, studying its onset and related
problems in childhood and pre-adolescence are key steps.
Existing Risk Factor Models
To date, few risk factor models exist for pediatric social anxiety despite the public health
risk that it poses. Those that do exist each have their strengths and weaknesses which will be
discussed in turn. Rapee and Heimberg (1997) presented a comprehensive but less detailed risk
factor model for social phobia (see Figure 4.1). This broad model includes cognitive processes
such as allocation of attentional resources, negative valence systems, and overall perception of
external factors (i.e., audience, cues). Its core includes one’s self perception of how others view
them which eventually can lead to behavioral, cognitive, and physical symptoms. The cognitive
focus of this model is likely due to it being published at the beginning of the implementation of
the Diagnostic and Statistical Manual – 4th edition (DSM-IV) (American Psychiatric Association,
2000). The DSM-IV included a name change from “social phobia” to “social anxiety disorder”
as well as generalized and specific versions of the disorder. Thus, such a model should be seen as
an opportunity to legitimize newer conceptualization of social anxiety (Rapee & Heimberg,
1997). Overall this model is vague; for example, it lists “external indicators of negative valence”
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but does not specify what those indicators are. Further, no environmental or genetic factors are
discussed, nor are the sources of covariance between the model’s elements.

Figure 4.1. Rapee and Heimberg’s (1997) cognitive behavioral model of social phobia.

Rapee and Spence revised their risk factor of social anxiety disorder to include more
external risks and broad genetic influences conceptualized along a continuum of social anxiety
disorder (Rapee & Spence, 2004). It is a more comprehensive model, however, specific
influences are still lacking (see Figure 4.2). For example, it is unclear from the model what is
meant by “parent influences” or “peer influences.” These influences are explained well in the
accompanying manuscript, but clinical or public health applications of this work based on the
model alone are unclear.
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Figure 4.2. Rapee and Spence’s (2004) risk factor model for social anxiety disorder, highlighting
broad development of the disorder.
While taking a slightly different approach, Ollendick and Benoit (2012) created a model
centered on the parent-child relationship. This served to focus the risk factor model and make it
less broad than past models (see Figure 4.3). The model identifies processes, including
behavioral inhibition and parental practices (bonding), which can increase the risk of developing
pediatric social anxiety disorder. This dissertation will focus this risk factor even more,
highlighting the nuances of the relationships between behavioral inhibition and parental bonding
with social anxiety disorder in order to create a pointed risk factor model (see Chapter 9).
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Figure 4.3. Ollendick and Benoit’s (2012) risk factor model for social anxiety disorder,
highlighting a parent-child interactional process.
Finally, Degnan and colleagues (2010) focused specifically on the relationship between
behavioral inhibition and anxiety in their risk factor model for anxiety (see Figure 4.4). They
were careful to be specific in the focus of this model by zoning in on this relationship. Yet,
within the context of behavioral inhibition and anxiety, the model is quite comprehensive. It
includes risk factors such as parenting styles, caregiving contexts, and peer relationships. It also
includes the possibility of mediation and moderation of the causal pathways to social anxiety.
Their model emphasizes the need to examine how these risk factors combine to elevate the risk
of social anxiety, which is where the present aims come into play.

Figure 4.4. Degnan and colleagues’ (2010) risk factor model for social anxiety disorder,
highlighting its relationship with behavioral inhibition and intermediate factors.
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Developing a New Risk Factor Model
A more exhaustive and plausible risk factor model ought to include biological
information, namely genetic and neurophysiological information. Apart from helping to predict
future behavior, the purpose of a risk factor model is to be translational by informing clinical
intervention and prevention efforts and conversely, include new research ideas and updates to the
model via clinical findings (Zvolensky, Schmidt, Bernstein, & Keough, 2006). While many
prevention efforts exist for internalizing problems (Aune & Stiles, 2009; Spence et al., 2000;
Zvolensky et al., 2006; O’Leary-Barrett et al. 2013) and social anxiety specifically (Aune &
Stiles, 2009; Hirshfeld-Becker et al., 2010; Bayer et al., 2010), none include detailed genetic
epidemiological nor neurophysiological information.
To date, prevention efforts for pediatric social anxiety focus on universal, selective, and
indicated populations, ideally in the preschool years (Bayer et al., 2010). Universal approaches
are given to all children regardless of risk. Selective prevention efforts are aimed at children with
etiological risks for anxiety while indicated efforts are reserved for children who have some
symptoms of anxiety but do not yet meet diagnosable criteria (Bayer et al., 2010). An example of
a selective program includes one by Rapee (2002) which educated parents of children with
elevated behavioral inhibition over several sessions by teaching them about inhibition, anxiety,
and parenting behaviors (namely overprotection). This education reduced children’s anxiety
symptoms and later internalizing disorders. This (Rapee, 2002) and similar programs (Bayer et
al., 2010; Kennedy, Tapee, & Edwards, 2009) have been shown to be effective in reducing
anxiety symptoms when compared to control groups who received no prevention sessions.
Effective intervention efforts utilize cognitive behavioral therapy (CBT) and occasionally
medication, although the former has been found to be more effective than the latter in the pre-
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adolescent age group when treating anxiety (Aune & Stiles, 2009; Gould et al., 1997; Rapee,
Schniering, & Hudson, 2009). There are many CBT options, including skill-based learning,
exposure therapy, and cognitive restructuring (Gould et al., 1997; Rapee et al., 2009). Most
styles are individual or group therapy, although some CBT sessions have a family-based focus
(Rapee et al., 2009).
The specifics of prevention and intervention efforts for pediatric anxiety are outside the
scope of this dissertation. However, they are relevant because risk factor models inform these
efforts via translational science. Temperament and parental bonding have robust associations
with social anxiety (Shamir-Essakow, Ungerer, & Rapee, 2005; Rapee et al., 2009; Fox et al.,
2005) and are even included in some prevention (Kennedy et al., 2009; Rapee, 2002) efforts for
anxiety and internalizing disorders broadly. However, the field would benefit from a concerted
focus on building a risk factor model for pediatric social anxiety - specifically pre-adolescent
social anxiety - that includes temperament and parental bonding that can potentially be widely
included in eventual prevention and intervention efforts which includes delineations of genetic,
environmental, and neurophysiological risk. The choice of temperament and parental bonding
are purposeful. Temperament, specifically behavioral inhibition (BI), is predominantly a
genetically influenced risk factor that may have neurophysiological ties to social anxiety (Fox et
al., 2005). Parental bonding is a predominantly environmental risk factor (Kendler, 1996; Otowa,
Gardner, Kendler, & Hettema, 2013; see Chapter 5) that does likely interplay with genetic
factors (correlation and interaction) in its risk for a child’s social anxiety development and
maintenance. Together, these encompass significant etiological risk.
Behavioral Inhibition
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One temperament which serves as a significant developmental risk factor for pediatric
social anxiety is behavioral inhibition (BI), where children express significant fear or distress
toward novel people, places, or environments (Rapee & Spence, 2004; Biederman et al., 2001;
Chronis-Tuscano et al., 2009; Clauss, Avery, & Blackford, 2015; Clauss & Blackford, 2012;
Coll, Kagan, & Reznick, 1984; Essex et al., 2009; Fox, et al., 2005; Hirshfeld-Becker et al.,
2007; Hirshfeld-Becker, Micco, & Simoes, 2008; Muris, van Braken, Arntz, & Shouten, 2011;
Rapee, 2014; Schwartz, Snidman, & Kagan, 1999). BI occurs in 10-15% of children (Muris et
al., 2011), 43% of whom later develop SOC (Coll et al., 1984). It has also appeared in many
discussions of social anxiety disorder (Fox et al., 2005; Degnan et al., 2011; Ollendick and
Benoit, 2012). Unfortunately, the genetic and environmental covariance and the direction of
causation between social anxiety and BI remain unknown. These questions are examined in this
dissertation (see Chapter 6).
There are also significant knowledge gaps surrounding the underlying neurophysiological
mechanisms in this relationship. Specifically, adults with social anxiety show a robust
heightened emotion reactivity (as assessed via amygdala activation) specific to threatening
(fearful, angry, sad) faces (Birbaumer et al., 1998; Cooney et al., 2006; Evans et al., 2008; Phan
et al., 2005; Stein et al., 2002; Stein, Simmons, Feinstein, & Paulus, 2007). This effect has only
been shown in a single study of adolescents with social anxiety (Killgore & Yurgelun-Todd,
2005) and not in pre-adolescents. The strong risk that childhood BI poses for later social anxiety
implies that in addition to underlying genetic mechanisms, there might be similar
neurophysiological mechanisms linking the two - specifically amygdala activation (Fox et al.,
2005). However, associations between BI and emotion reactivity have been mixed in adult and
adolescent samples, with significant findings not specific to an emotion but faces in general
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(Clauss, Benningfield, Rao, & Blackford, 2016; Perez-Edgar et al., 2007; Schwartz et al., 2003).
Thus, not only has a direct assessment of the relationship between emotion reactivity and
childhood BI not been conducted, but neither has the potential moderating effect of emotion
reactivity between BI and social anxiety. There are two possible explanations for the
neurophysiological developmental mechanisms between BI and social anxiety: (1) individuals
with a history of BI eventually become more selective toward threatening faces or (2) individuals
with social anxiety who have a history of BI generally show broader emotional responses, but
extant studies have not been sufficiently sensitive to differentiate those individuals.
Parental Bonding
Parental bonding is highly associated with both BI (Fox et al., 2005) and pediatric social
anxiety (Rapee & Spence, 2004; Bayer et al., 2010; Bayer, Sanson, & Yemphill, 2006) and has
been shown to be a key moderating factor between the two (Rubin, Burgess, & Hastings, 2002).
It includes the domains of overprotection, coldness, and authoritarianism, with high levels of
each broadly associated with internalizing problems (Bayer et al., 2006). The mechanisms of the
relationship between BI, parental bonding, and social anxiety in adolescents have never been
determined. Such information will serve to create a targeted risk factor model for social anxiety
disorder that focuses on depth (Ollendick & Benoit, 2012), not breadth (Rapee & Heimberg,
1997; Rapee & Spence, 2004).
Translating Risk Factor Models
There is little point to creating an abundance of risk factor models for common disorders
if there is no plan for how to utilize such information. Unfortunately, there is no clear consensus
on the best practice for translating these models. As already discussed, there are many
translational frameworks that need to be utilized in the appropriate context for a given disorder
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(see Chapters 2-3). Specific to pediatric health, as with psychiatric disorders broadly, linear
frameworks such as that by Szilagyi (2009) are common. Szilagyi’s specific framework includes
bi-directional but still linear pathways between potential application, efficacy, effectiveness, and
population-based stages, reminiscent of Khoury and colleagues’ (2007) T1-T4 stages of
translation. In regard to BI and social anxiety, we have already moved into an efficacy stage with
prevention programs such as the Turtle Program (Chronis-Tuscano et al., 2015) and others
(Hirshfeld-Becker et al., 2008; Rapee et al., 2010). The goal of this dissertation is to demonstrate
that even the linear nature of basic science where such risk factor models are created can actually
be non-linear (i.e., collaborative and socio-ecological) (see Chapters 2 and 3). By including
detailed genetic, neurophysiological, and environmental risk factors, such a risk factor model
may be more informative for clinicians. This cannot be assumed, though, and the global
discussion of this dissertation (chapter 9) will review this more thoroughly.
Conclusion
The translation of basic science findings into clinical practice has not been addressed
systematically in mental health fields (Glasgow et al., 2012). Translation should be collaborative
and socio-ecological in focus, but it still must begin with basic science. The next four chapters
will use pre-adolescent social anxiety to highlight the first steps toward true translation from a
field that historically solely relies on bench-to-bedside and precision medicine translational
frameworks (Sullivan et al., 2012; Visscher et al., 2016; Sullivan et al., 2018). This will be done
by using key genetic, neurophysiological, and environmental risk factors for social anxiety to
create an updated risk factor model. Not only will individual findings and the risk factor model
as a whole be novel, but it offers suggestions for how to move this line of work forward within a
new translational framework is unprecedented.
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Chapter 5: Methodology of the Juvenile Anxiety Study and Measures Used in the Current
Dissertation
Introduction
Aims 2 (chapters 6 and 7) and 3 (chapter 8) of this dissertation draw from the same
dataset, the Juvenile Anxiety Study (JAS). Thus, this chapter is dedicated to providing details
about the JAS such that all chapters hereafter will only reference it. This chapter will also serve
to provide details on the specific measures from the JAS that were used in this dissertation.
Many psychometric examinations of these measures were conducted that, while outside the
immediate scope of aims 2 and 3, directly influenced how these aims were conceptualized.
Additionally, this chapter will serve as a thorough review of biometrical modeling. This type of
modeling is frequently used to assess the psychometric properties of included measures as well
as in aim 2. All analyses were conducted in R (R Development Core Team, 2008). Biometrical
genetic structural equation models (SEM) were completed in the OpenMx package (Neale et al.,
2016).
This chapter is presented in three parts. Part 1 presents an overview of the JAS, including
its purpose, information on the sample, and brief overview of included measures. Part 2 provides
an overview of biometrical modeling, one of the main analyses used in the rest of this
dissertation. Part 3 then gives details about preliminary analyses on the JAS measures used in
this dissertation, most of which utilize biometrical modeling. This part also includes a brief
discussion.
Part 1: Overview of the Juvenile Anxiety Study
The Juvenile Anxiety Study
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The purpose of the JAS was to study the relationship between measures related to
negative valence systems (NVS) and symptoms of internalizing disorders (Carney et al., 2016).
NVS constructs include acute threat (fear), potential threat (anxiety), sustained threat, loss, and
frustrative non-reward (Cuthbert & Insel, 2013). Additional constructs included in the JAS that
are not strictly NVS constructs were temperament, risk/protective factors, and demographics
(sex, age). Specific phenotypes of interest for this dissertation were anxiety symptoms,
behavioral inhibition (BI), parental bonding, and emotion reactivity (see Part 3 below for an
explanation of preliminary analyses involving all measures except emotion reactivity; see
chapter 8 for an explanation of the neuroimaging protocol). Measures were a combination of
questionnaires, experimental paradigms, and neuroimaging paradigms (see Table 5.1). The JAS
is a cross-sectional study.
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Table 5.1. Overview of measures in the JAS.
Construct
Paradigm
Measure
Fear Survey Schedule for Children - Revised
Threat and Fearlessness Questionnaire - 20 item
version
Questionnaire
Kiddie Schedule for Affective Disorders and
Schizophrenia - Present and Lifetime Version
Acute Threat
(phobias)
Child Behavior Checklist*
Experimental
Fear Potentiated Startle
Skin Conductance Response
Neuroimaging
Emotion Face Matching Task*
Screening for Childhood Anxiety Related Disorders*
Kiddie Schedule for Affective Disorders and
Questionnaire
Potential threat
Schizophrenia - Present and Lifetime Version
(anxiety)
Experimental
Baseline Startle
Kiddie Schedule for Affective Disorders and
Questionnaire
Schizophrenia - Present and Lifetime Version (posttraumatic stress disorder)
Sustained
Experimental
Face-Emotion Processing (threat)
threat
Facial Expression Labeling Task
Experimental and
Extinction Recall
Neuroimaging
Short Mood and Feelings Questionnaire
Kiddie Schedule for Affective Disorders and
Questionnaire
Loss
Schizophrenia - Present and Lifetime Version
(depression)
Experimental
Face-Emotion Processing (sadness)
Questionnaire
Affective Reactivity Index
Frustrative
Experimental and
non-reward
Affective Posner 2
Neuroimaging
Junior Eysenck Personality Questionnaire
Childhood Anxiety Sensitivity Index
Behavioral Inhibition Questionnaire (retrospective)*
Temperament
Questionnaire
Behavioral Inhibition System / Behavioral Activation
System
Inventory of Callous-Unemotional Traits
Parental Bonding Instrument*
Risk /
Multidimensional Peer Victimization Scale
protective
Questionnaire
Traumatic Events Screening Inventory - Parent Report
factors
Revised
Pubertal status
Age*
Demographics Questionnaire
Sex*
* Indicates measure used in this dissertation
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Protocol
Data collection occurred from February 2013 to March 2016. Participants were recruited
from the Mid-Atlantic Twin Registry (MATR), a database of twins, other higher order multiples,
and their family members (Lilley & Silberg, 2013). Specifically, research assistants were
provided with the contact information of individuals on the MATR registry. These individuals
were called up to three times by the research assistants for recruitment. If they agreed to be in the
study, a time was scheduled for Visit 1. It was at Visit 1 when full consent was obtained per
Institutional Review Board protocol. During Visit 1, participants completed a full set of
questionnaires and laboratory paradigms. A portion of the families were invited back for a
second visit 2 to 4 weeks later to collect reliability data on a subset of the protocol measures
(reported for the measures of interest for this dissertation below in Part 3). Twins and parents
were separated during Visits 1 and 2. Protocols were counter balanced across twins, who
completed all procedures in separate rooms. Parents completed questionnaires about themselves
and their children in a waiting area away from their children. Neuroimaging data was collected
during a third visit on a small subset of participants who met eligibility criteria (see chapter 8 for
more details). The criteria included not having braces or other metal attached to the body,
behaviorally able to sit still and not cause motion artifacts, overall willingness (lack of
claustrophobia, not afraid of task, etc.).
Participants
Families with twins ages 9-13 and at least one parent (Nfamilies = 398, Nchildren = 796) were
surveyed as part of the JAS. They were administered an array of measures which included
experimental tasks and dimensional questionnaires (see above). In total, there are data on 796
twins (Npairs = 398; monozygotic [MZ] = 128; dizygotic [DZ] = 245; unknown zygosity = 21;
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Mage = 11.20; female = 52.6%) available for the proposed analyses, all of whom were Caucasian.
Note that at the time these analyses were run, there were 21 individuals with unknown zygosity.
Since that time, the zygosity of these individuals is now known but due to timing, those
individuals were still left out of the sample used in these analyses. Zygosity was measured via
parent report and an algorithm calculated similarity within a twin pair based on the parent report
(Carney et al., 2016). There some few pairs for whom the parent report of zygosity was
incomplete and those twins’ blood samples were tested using molecular genomic methods to
confirm zygosity.
Eleven percent of the sample included reports from fathers. Father’s reports of their
children consistently correlate lower with actual child behavior / mental health than mother’s
report (e.g., Bishop, Spence, & McDonald, 2003) and were removed from all analyses.
Additionally, except when assessing reliability, only data from Visit 1 was utilized. Thus, in all
analyses for this dissertation, only data from child and maternal reports from Visit 1 were
utilized. For the preliminary analyses of the measures used, the final analytical sample included
352 families and 704 children (Mage = 11.22; standard deviation [SDage] = 1.41; female = 53%;
MZ = 114 pairs; DZ = 238 pairs; 88% of full sample).
Measures of Interest
Measures from the JAS that are used in either primary or preliminary analyses for this
dissertation include the following: Screen for Child Anxiety Related Disorders (SCARED;
Birmaher et al., 1997), Child Behavior Checklist (CBCL; Achenbach & Rescorla, 2001),
Behavioral Inhibition Questionnaire (BIQ; Bishop et al., 2003) and Parental Bonding Instrument
(PBI; Parker, Tupling, & Brown, 1979; Parker, 1990). See Part 3 for details of the preliminary
analyses performed using these measures before the primary analyses (see chapters 6-8).
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Part 2: Biometrical modeling overview
Introduction
Before explaining details of the measures included in this dissertation and the preliminary
analyses conducted on them, an overview of biometrical modeling must be presented. This is for
simplicity and ease of readership. Biometrical modeling is used in several preliminary analyses
and it is easier to provide an overview in Part 2 below and then present the preliminary analyses
in part 3.
Biometrical Modeling Premise
Biometrical structural equation modeling (SEM; Neale & Cardon, 1992) was performed
at various times during this dissertation to analyze the JAS data. In this process, the variance in
each phenotype is decomposed into additive genetic (A), shared (familial) environmental (C),
and unique environmental (E) risk factors. The A variance reflects the additive effect of
individual alleles at genetic loci influencing a trait. On average, MZ twins share 100% of their
segregating genes whereas DZ twins share 50%. In phenotypes where familial aggregation is
entirely explained by additive genetics, MZ twin pair correlations will be twice their DZ
counterparts. The C variance reflects environmental influences that make family members more
alike compared to random pairs of individuals. Consequently, where familial aggregation is
entirely explained by common environmental risks, MZ and DZ twin pair correlations will be
equal or non-significantly different or the DZ correlation will be more than half of the MZ
correlation. The E variances are uncorrelated between twins and reflect aspects of the
environment that are specific to each individual including measurement error.
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In standard analyses, the approach is to begin by testing for equal means across twin
order, equal means and variance across twin order, and then equal means and variance across
twin order and zygosity. This ensures that there is no bias in the data and that all basic
assumptions are met. The assumptions of all biometrical modeling are: equal environments of
MZ and DZ pairs, random mating, no gene-environment interplay, no age or sex effects (Neale
& Cardon, 1992).
Next, all three components of variance (ACE) are tested, known as saturated model
fitting. Finally, a series of nested submodels are tested in which A, C, or both are constrained to
zero to examine the significance of their contributions to phenotypic variation. Model fit is
compared using the likelihood ratio test (LRT) (Wilks, 1938) and Akaike information criteria
(AIC) statistic (Akaike, 1987). These statistics test whether there is a significant decrease in
model fit after parameters in the full model are constrained to zero, indicative of the importance
of the constrained parameter(s).
Models that were fit in this dissertation include univariate, multivariate, common
pathway, and independent pathway. Each of these will briefly be discussed in turn (Neale &
Cardon 1992).
Univariate Biometrical Modeling
Univariate biometrical models entail decomposing the variance of a single phenotype into
A, C, and E (see Figure 5.1). The purpose of such a model is to calculate the proportion of
variance due to genetic versus environmental factors of a single phenotype.
This model was fit in this dissertation to examine the structure of the PBI (see Part 3
below).
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A1

C1

E1

A2

Phenotype 1
Twin 1

C2

E2

Phenotype 1
Twin 2

Figure 5.1. Example of a univariate biometrical model (variance paths left out for simplicity). Ra
= 1.00 for MZ twins and .50 for DZ twins. Rc = 1.00 for all twins. A1/C1/E1 = factors for
phenotype 1.
Multivariate Biometrical Modeling
Multivariate biometrical models allow for the examination of covariance between two or
more phenotypes. In the absence of any theory explaining covariance structure, this is typically
achieved by fitting a lower triangular Cholesky decomposition (Neale & Cardon, 1992). They
allow for the genetic versus environmental variance to be decomposed across phenotypes,
showing how much of which type of variance is shared among the phenotypes. In other words, it
is possible to see how much of one phenotype’s variance is due to shared genetic or
environmental factors with another phenotype - if the two phenotypes are related at all.
Alternative theoretical models or, if there is evidence to suspect a more complicated relationship
across the phenotypes, include common pathway and independent pathway models can also be
explored (see below).
Multivariate biometrical models were used in this dissertation to assess the relationship
between BI and various pre-adolescent anxiety clusters (generalized, social, panic, separation) in
aim 1 (chapter 6) as well as to estimate the heritability of each construct. The latter was done
using multivariate instead of univariate to avoid running multiple univariate models because
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heritability can be calculated for each phenotype in a multivariate model by adding all of its
additive genetic variance (both unique and shared). Multivariate modeling was also used to
examine the relationship between BI, overprotectiveness, and social anxiety (chapter 7).
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A2

C2

E2
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Twin 2

Figure 5.2. Example of a multivariate biometrical model (variance paths left out for simplicity).
Ra = 1.00 for MZ twins and .50 for DZ twins. Rc = 1.00 for all twins. A1/C1/E1 = factors for
phenotype 1. A2/C2/E2 = factors for phenotype 2.
Common Pathway Biometrical Model
A common pathway biometrical model allows for the measured phenotypes to load onto
one ore more common (hierarchical), latent variables that are decomposed into A, C, and E
sources of variance (see Figure 5.3). Specific A, C, and E variances are allowed to load into
individual phenotypes to account for residual variance. This model is useful when examining
whether there is a higher level, latent construct through which the genetic and environmental
factors load and which account for the variance of multiple phenotypes at once. It is also helpful
when examining if there are multiple indicators for a variable.
In the current dissertation, this type of model was fit twice in preliminary work (see Part
3). First, it was used to assess whether there was a common / latent phenotype that subsumed
child and parent scores on the SCARED subscales. Second, it was used to examine whether
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scores from the three PBI scales could be loaded onto a larger “parent” factor (similar to
Gillespie et al., 2003).
A1

C1

E1

A2

Latent Construct 1

C2

E3

C3

A3

E3

Latent Construct 3

Latent Construct 2

Phenotype 1

Phenotype 2

Phenotype 3

Phenotype 4

Phenotype 5

Phenotype 6

Phenotype 7

Phenotype 8

Phenotype 9

As Cs

As Cs

As Cs

As Cs

As Cs

As Cs

As Cs

As Cs

As Cs

Es

Es

Es

Es

Es

Es

Es

Es

Es

Figure 5.3. Example of a common pathway biometrical model (single twin only; variance paths
left out for simplicity). A1/C1/E1 = factors for latent construct 1. A2/C2/E2 = factors for latent
construct 2. A3/C3/E3 = factors for latent construct 3. As/Cs/Es = specific factors not shared
with the other phenotypes.
Independent Pathway Biometrical Model
Independent pathway biometrical models allow for measured phenotypes to load onto
multiple A, C, and E latent variables directly instead of going through latent phenotypes (see
Figure 5.4). This model is useful in examining whether there are a unique number of genetic and
environmental factors influencing the phenotypes. In univariate and multivariate models, there
are the same number of A, C, and E variance estimates in the models. In an independent pathway
model, different numbers of A, C, and E factors are tested until the best fitting model is found.
Each factor may load onto one or more phenotypes, adding more nuance to the final model.
This model was used to examine the structure of the PBI (similar to Gillespie et al.,
2003).
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Figure 5.4. Example of an independent pathway model (single twin only; variance paths left out
for simplicity). A1/A2/A3 = the three distinct additive genetic factors in this model. C1/C2 = the
two distinct familial environmental factors in this model. E1 = the one distinct unique
environmental factor in this model. As/Cs/Es = specific factors not shared with the other
phenotypes.

Part 3: Preliminary analyses
The Screen for Child Anxiety Related Disorders
The Screen for Child Anxiety Related Disorders (SCARED) is a 41-item scale that
assesses various recent anxiety disorder symptoms in children that breaks down into five clinical
subscales (generalized anxiety, panic, separation anxiety, social phobia, school avoidance)
(Birmaher et al., 1997). Subjects rated statements regarding their own and their children’s
behavior in the past three months on a scale from 1 (“not true or hardly ever true”) to 3 (“very
true or often true”). Example questions include “My child worries about how well he/she does
things” or “I am shy”. The SCARED has strong internal consistency (α = .90 - .94) and testretest reliability (r = .70 - .90) in both prior studies and the current one (Birmaher et al., 1997;
Carney et al., 2016). Both parent and child responses to the SCARED were collected because
both types of reporting by themselves are limited and potentially biased (De Los Reyes &
Kazdin, 2005). In order to confirm whether or not one or both raters were necessary for primary
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analyses, a common pathway model (i.e., multiple rater model) was tested to examine and
account for potential rater bias (if necessary). As already discussed in Part 2 above, this model
allows for the hierarchical testing of latent factors. In this model, that is child and parent scores
on the SCARED. Different submodels of this model could be tested - one where child and parent
scores were allowed to freely load and one where they were constrained to be equal.
Data Analysis: The SCARED
Parent and child SCARED scores were included as indicators for a latent “anxiety”
variable in multivariate SEM. This was done for each anxiety symptom cluster (social,
generalized, separation, panic), and two models per cluster were tested: one where parent and
child scores were allowed to freely load on the latent variable and another where they were
constrained to be equal (i.e., the variances were constrained) (see Figure 5.5). The best-fitting
model (as determined via AIC fit statistic; see Part 2 above) was used in all further analyses to
index each anxiety symptom cluster, respectively. Additionally, sex was treated as a covariate in
all biometrical models due to its known association with various anxiety domains (Hettema et al.,
2005; Rapee, 2004).
E1

A1

Anxiety

SCARED-C

As

SCARED-P

Es

As

Es

Figure 5.5. Example of the common pathway model used to test for parent and child anxiety.
Variance estimates left off for simplicity.
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Results: The SCARED
For all anxiety clusters, parent and child SCARED scores could be constrained to be
equal in their common pathway / multiple indicator models (see Table 5.2). In other words, the
average of the parent and child SCARED sum scores provided a reasonable representation of
these anxiety domains for analyses with parent-rated BI and were used in all analyses.

Table 5.2. Model fit statistics from common pathway (CP) analyses assessing child and
parent indicators on each anxiety symptom cluster
Model
EP
-2 LL
DF
AIC
Δ LL Δ DF
p
Social Anxiety
Full CP model with child
and parent indicators set to
17 6651.303 1265 4121.303
be free
CP model with child and
parent indicators constrained
16 6651.465 1266 4119.465
.162
1 .687
to be equal *
Generalized Anxiety
Full CP model with child
and parent indicators set to
17 6859.450 1265 4329.450
be free
CP model with child and
parent indicators constrained
16 6859.450 1266 4327.450 <.001
1 .999
to be equal *
Separation Anxiety
Full CP model with child
and parent indicators set to
17 6252.353 1264 3724.353
be free
CP model with child and
parent indicators constrained
16 6252.597 1265 3722.597 <.001
1 .999
to be equal *
Panic
Full CP model with child
and parent indicators set to
17 6421.260 1264 3893.260
be free *
CP model with child and
parent indicators constrained
16 6421.260 1265 3891.260
.245
1 .621
to be equal *
* Indicates best-fitting model(s) from that series of nested sub-models
EP = Estimated Parameters; -2LL = twice the negative log likelihood; DF = degrees of freedom; AIC =
Akaike Information Criteria; p = p-value statistic; delta (triangle) = change in
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The Child Behavior Checklist
The Child Behavior Checklist (CBCL) provides an overall snapshot of current child
behavior with 112 questions divided into eight subscales, four of which were used in the current
study (anxious/depressed, withdrawn/depressed, somatic complaints, social problems;
Achenbach & Rescorla, 2001). Parents rate behaviors that describe their children in the past 6
months on a scale of 1 (not true) to 3 (very true or often true). Example items include “Acts too
young for his/her age” and “Fears he/she might think or do something bad.” Subscales used in
the current analyses have good internal consistency (Cronbach’s alpha = .82) and test-retest
reliability (r = .81). The CBCL was used in this dissertation to assess validity of the BIQ (see
below).
The Retrospective Behavioral Inhibition Questionnaire
The BIQ is a 30-item Likert-style measure given to parents to assess their child’s
behaviors related to inhibition. It has previously demonstrated reliability and validity (Bishop et
al., 2003; Broeren & Muris, 2010) and adequate correlation with the gold standard behavioral
assessment of BI (r = .46 among maternal raters, Bishop et al., 2003; 74% agreement rate,
Hudson & Dodd, 2012). The BIQ has been successfully used in multiple studies of inhibition and
anxiety in childhood, including assessing their neurophysiological and cognitive underpinnings
(Clauss, Benningfield, Rao, & Blackford, 2016; Fu, Taber-Thomas, & Perez-Edgar, 2015;
Morales, Taber-Thomas, & Perez-Edgar, 2016; Taber-Thomas, Morales, Hillary, & Perez-Edgar,
2016), predicting anxiety symptoms (Edwards, Rapee, & Kennedy, 2010) and evaluating early
interventions (Kennedy, Rapee, & Edwards, 2009).
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It is typically given to parents to assess concurrent behavior when their child is between
the ages of 2-6 (toddlerhood through early childhood). However, given the pre-adolescent nature
of the JAS sample, the BIQ was altered to be retrospective. Wording of the instructions and
questions were changed such that parents reported on behaviors related to BI when their child
was 2-6 years old. Past studies of the BIQ have shown moderate correlation with the gold
standard behavioral assessment of BI (r = 0.46, Bishop et al., 2003; 74% agreement rate, Hudson
& Dodd, 2012). However, a recent study in older children and adolescents reported a modest but
significant correlation of total parent-report retrospective BIQ score with BI defined by
observational laboratory protocols at ages 2-6 (r = .21; p = .05) and individual subscales of the
retrospective BIQ showed similar correlations (r = 0.22-0.32, p <.05, Hirshfeld-Becker et al.,
2016). However, the psychometric characteristics of this retrospective BIQ in a normative
sample of developing children have not been examined. Preliminary examination of this version
of the BIQ examined its (1) reliability, (2) validity, and (3) factor structure.
Data Analysis: The Retrospective BIQ
Reliability. Reliability was assessed in two ways. Internal consistency was estimated via
Cronbach’s alpha for Visit 1 data, and test-retest reliability was estimated via intraclass
correlation between data from Visits 1 and 2.
Validity. Construct validity was assessed via correlations between sum scores of the total
retrospective BIQ and subscales of the SCARED parent subscales (SCARED-P for simplicity)
and CBCL using the R software package. Spearman correlations were chosen due to the positive
skew of the SCARED-P and CBCL scores.
Factor Structure. To examine the factor structure of the retrospective BIQ and assess
whether this version of the measure aligns with past BIQ iterations, exploratory factor analyses
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(EFA) and confirmatory factor analyses (CFA) were conducted in Mplus (MPLUS, version 7)
using a randomized split-sample procedure, and twins were clustered within families. Where
appropriate, BIQ items were reverse-coded to have positive factor loadings. To maximize the
power to estimate model parameters, the final CFA models included data from the full analytical
sample. Two models were tested: (1) oblique, geomin rotated correlated factor model (simple
structure); and (b) orthogonal, bifactor model. The correlated model is consistent with previous
analyses exploring the psychometric properties of the BIQ (Bishop et al., 2004; Broeren &
Muris, 2010; Kim et al., 2011; Vreeke et al., 2012). The bifactor model consists of one overall
factor capturing the common aspects of BI across all of the indicators plus uncorrelated, residual
factors that capture the specific components (Reise, 2012). The bifactor model was chosen as a
potential model because it is well-suited for representing broad constructs simultaneously with
distinct domains that may be present in the data (Reise, 2012). However, it does not allow for the
domains to correlate with each other or with the general domain due to its orthogonal nature,
presenting a potential limitation of the model (e.g., correlations that may be present in the data
across domains are not captured). While a structure that had not been tested in previous analyses
of the BIQ, the bifactor structure is a common psychometric model (Reise, Moore, & Haviland,
2010). See Figures 5.7 and 5.8 for an abbreviated correlated factors and bifactor CFA from the
BIQ.
Items with loadings above 0.3 in the EFA were chosen for inclusion in the preliminary
CFA model. Item information curves were examined following the first iteration of the CFA
such that items providing little information were deleted from the model to see if fit would
improve. To assess model fit, χ2, Root Mean Square Error of Approximation (RMSEA),
Comparative Fit Index (CFI), and Tucker-Lewis Index (TLI) were used. Specifically, we applied
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the recommendations for RMSEA < 0.08 and CFI/TLI > 0.95 (Hu & Bentler, 1999). Finally,
reproducibility of the final factor structure model across sexes was conducted via tests for
configural (same loading pattern across groups), metric (same meaning assigned to latent
constructs, and hence same responses, across groups), and scalar (the relationship between latent
constructs and observed variables is the same across groups) invariance (Hong, Malik, & Lee,
2003).
Reliability (internal consistency) then was assessed for each factor of the best-fitting
model via Cronbach’s alpha from the full sample CFA. Finally, the validity of the best-fitting
model from the full sample CFA was assessed using SEM. Representative items were selected
from the SCARED (parent version) that had similar content to each of the factors in the final
model. Using SEM, each selected item was correlated with each factor to test discriminant
validity (criterion via predictive validity and content via convergent and divergent validity). In
addition, one item was chosen for the overall model to test convergent validity.
Results: The Retrospective BIQ
Reliability. Reliability for the overall retrospective BIQ was estimated in two ways:
Cronbach’s alpha was 0.96 (excellent) for the overall BIQ suggesting high levels of internal
consistency for the measure as a whole. The intraclass correlation used to estimate test-retest
reliability between Visits 1 and 2 was also high (ICC = 0.87; CI = 0.84 – 0.89).
Validity. Content validity was tested via convergent and divergent validity for the BIQ’s
sum score was assessed via correlations with the CBCL and SCARED-P subscales. A forest plot
of the correlations is presented in Figure 5.6. As expected, the retrospective BIQ was most highly
correlated with measures related to social anxiety, such as the SCARED-P social anxiety and
CBCL social problems subscales, and only modestly correlated with subscales related to other
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forms of anxiety, depression, or somatic complains, such as the SCARED-P school avoidance or
CBCL somatic complaints subscales. Importantly, the two social anxiety constructs had
significantly higher correlations with the BIQ than the non-social anxiety constructs, with the
exception of the CBCL-anxious/depressed facet and the SCARED-P total sum (which includes
the social anxiety subscale items).

Figure 5.6. Forest plot of the correlations between the retrospective BIQ and other parent report
measures. Error bars depict 95% confidence intervals. All correlations are significant at
minimum p < 0.05.
Notes on Fit Indices. For the next several sections, many fit indices will be referred to
(Hu & Bentler, 1999). RMSEA measures how well a model with ideal parameters would fit a
variance-covariance matrix. The lower the number, the better; anything below 0.70 is considered
a good fit, 0.80-1.00 is a mediocre fit, and more than 1.0 is a bad fit. χ2 shows the discrepancy
between different submodels and a significant p-value indicates a change in model fit. A
significant p-value typically indicates a decrease in model fit. GFI is an alternate to χ2 and
provides the proportion of variance and covariance accounted for by the model. A score more
than 0.90 is considered a good fit. TLI/NFI compare the model χ2 to the null χ2 and values more
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than 0.95 are considered a good fit. CFI takes sample size into account with TLI/NFI and again,
values more than 0.95.
Correlated Factor Model. Consistent with previous studies that have validated a 6-factor
solution for the BIQ, EFAs with 1-4 factors did not achieve acceptable fit. While the correlated
EFAs for 5-7 factors provided increasingly improved fit, models with more than 5 factors did not
provide interpretable solutions. Applying Kaiser’s rule to the scree plot of keeping factors with
eigenvalues greater than 1 (Kaiser, 1960), a 5-factor solution was supported (eigenvalues =
15.97, 2.80, 2.19, 1.13, 1.04). It was the only model with reasonable fit and a valid factor
structure for the correlated EFA (χ2 = 950.676, df = 295; p < 0.001; RMSEA = 0.081; CFI =
0.969; TLI = 0.954). All items had loadings above 0.3 and clustered according to Bishop and
colleagues’ (2003) BIQ subscales with the exception of “Unfamiliar Situations.” This scale did
not define its own factor; instead, its items loaded onto all remaining factors except
“Performance.” See Figure 5.7 for an abbreviated version of this model.

Physical Challenges

Item 1

Item 2

Item 3

Unfamiliar Adults

Performance

Separation

Item 4

Item 5

Item 6

Item 7

Peers

Item 8

…Item 30

Figure 5.7. Abbreviate correlated CFA from the BIQ.
CFA performed in the other half of the sample using the item loadings from the EFA
revealed a slightly worse fit (χ2 = 2544.176, df = 395; p < 0.001; RMSEA = 0.127, CI = 0.122 –
0.132; CFI = 0.899; TLI = 0.800). However, the model had interpretable factor structure with
strong item loadings. The item information curves revealed only item 14 as potentially
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uninformative. When the model fit was assessed without this item, the fit worsened (χ2 =
3850.588, df = 396; p < 0.001; RMSEA = 0.161, CI = 0.156 – 0.165; CFI = 0.838; TLI = 0.822),
so all items were retained in the correlated 5-factor model. The CFA performed using the full
sample yielded a similar fit to the preliminary CFA (χ2 = 4650.863, df = 395; p < 0.001; RMSEA
= 0.126, CI = 0.123 – 0.123; CFI = 0.880; TLI = 0.868), with identical items as factor indicators
(see Table 5.3).
Table 5.3. Item indicators for the original BIQ (Bishop et al., 2003) and the Retrospective BIQ
(current study).
BIQ
Number of
Broad Domains
Specific Categories
Items (Question Numbers)
Items
Unfamiliar Adults
4
3, 16, 26, 30
Social Novelty
Approaching Peers
6
2, 7, 8, 12, 19, 20
Performance
4
6, 10, 21, 28
Unfamiliar Situations
8
1, 5, 14, 15, 22, 23, 24, 25
Situational Novelty
Separation/School
4
9, 11, 18, 27
Novel Physical Activity
Physical Activities
4
4, 13, 17, 29
Retrospective BIQ
Number of
Model
Factors
Items (Question Numbers)
Items
Peers
8
1, 2, 7, 8, 12, 19, 20, 24
Physical Challenges
6
4, 13, 17, 22, 23, 29
5-factor Correlated
Separation
7
9, 11, 14, 15, 18, 25, 27
Performance
4
6, 10, 21, 28
Unfamiliar Adults
5
3, 5, 16, 26, 30
General Factor
30
All Items
Physical Challenges
4
4, 13, 17, 29
5-factor Bifactor*
Separation
6
9, 11, 14, 15, 18, 27
Performance
4
6, 10, 21, 28
Unfamiliar Adults
4
3, 16, 26, 30
* Indicates final model in current study

Bifactor Model. Consistent with information from the prior analysis, bifactor EFAs were
run only for the 5-, 6-, and 7-factor models. Again, the 5-factor solution had the best combination
of theory-driven loadings and fit (χ2 = 950.676, df = 295; p < 0.001; RMSEA = 0.081, CI = .075 -
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.087; CFI = 0.969; TLI = 0.954). All items had loadings above 0.3 and also clustered according
to Bishop and colleagues’ (2003) BIQ subscales with the exception of “Unfamiliar Situations”
and “Approaching Peers.” These items were absorbed into the “General” and “Separation”
factors. See Figure 5.7 for an abbreviated version of this model.
Physical Challenges

Item 1

Item 2

Item 3

Item 4

Unfamiliar Adults

Performance

Separation

Item 5

Item 6

Item 7

Item 8

…Item 30

General Factor

Figure 5.8. Abbreviated bifactor CFA from the BIQ.
CFA performed with the other half of the split sample revealed a similar fit (χ2 =
1463.216, df = 387; p < 0.001; RMSEA = 0.091, CI = .086 – 0.96; CFI = 0.950; TLI = 0.943)
with a highly interpretable factor structure that confirmed the results from the EFA. The item
information curves revealed items 3, 14, and 15 as potentially uninformative. Again, when the
model fit was assessed without these items, the fit worsened (χ2 = 1724.585, df = 390; p < 0.001;
RMSEA = 0.101, CI = 0.096 – 0.105; CFI = 0.937; TLI = 0.930), so all items were retained in the
5-factor bifactor model.
The CFA performed using the full sample yielded a similar fit to that of the preliminary
CFA (χ2 = 2426.747, df = 387; p < 0.001; RMSEA = 0.088, CI = .085 – 0.92; CFI = 0.942; TLI =
0.935) (see Table 5.4) with identical items as factor indicators (Table 5.3).
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Table 5.4. Factor structure fit indices from studies exploring the psychometrics of the BIQ and
Retrospective BIQ (current study).
χ2, df

df

χ2/df

p

RMSEA

CFI

TLI/NFI

GLI

N

Bishop et al., 2003

1835

390

--

<0.001

0.08

0.88

0.87

--

613

Broeren & Muris, 2010

--

0.070.08

0.880.91

--

--

531

Kim et al., 2011

1382.610

Vreeke et al., 2012*

--

Study
Previous Studies

1.742.34
390

--

<0.001

0.075

0.903

--

--

495

--

--

0.05

0.98

0.96

0.97

2,343

Current Study
5-factor Correlated Model

4650.863

395

--

<.001

0.126

0.880

0.868

--

681

5-factor Bifactor Model**

2462.747

387

--

<.001

0.088

0.942

0.935

--

681

*Indicates that a short version of the BIQ was used. **Indicates final best-fitting model in the current study.

This fit was better than that obtained for the correlated factor model; as such, the 5-factor
bifactor model was chosen as the final model (see Table 5.5). Tests for configural, metric, and
scalar invariance were significant (ps < 0.001), implying that the bifactor model fit results are
equal across sex in this sample. Configural invariance assesses whether there is the same pattern
of factors and loadings across groups. Metric invariance tests whether the factor loadings are the
same across factor loadings. Scalar invariance determines if the residual variances are also the
same across loadings (Waldaman & Reise, 1997).
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Table 5.5. Model loadings (SE) for the best-fitting 5-factor bifactor CFA model using the full sample – all are significant at p<0.001.
Physical
Unfamiliar
Items
General
Separation Performance
Challenges
Adults
1.

Approached new situations or activities very hesitantly

.781 (.018)

2.

Would happily approach a group of unfamiliar children to join in their
play

-.851 (.013)

3.

Was very quiet around new (adult) guests to our home

.753 (.020)

4.

Was cautious in activities that involved physical challenge (e.g.,
climbing, jumping from heights)

.437 (.032)

5.

Settled in quickly when we visited the homes of people we didn’t
know well

-.807 (.016)

6.

Enjoyed being the center of attention

-.681 (.022)

7.

Was comfortable asking other children to play

-.865 (.012)

8.

Was shy when first meeting new children

.852 (.012)

9.

Happily separated from parent(s) when left in new situations for the
first time (e.g., kindergarten, preschool, childcare)

-.506 (.032)

10. Was happy to perform in front of others (e.g., singing, dancing)

-.692 (.022)

11. Quickly adjusted to new situations (e.g., kindergarten, preschool,
childcare)

-.558 (.028)

12. Was reluctant to approach a group of unfamiliar children to ask to
join in

.816 (.014)

13. Was confident in activities that involved physical challenge (e.g.,
climbing, jumping from heights)

-.474 (.029)

14. Was independent

-.576 (.028)
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.425 (.026)
.743 (.023)

-.483 (.025)

-.733 (.023)
-.591 (.023)
-.683 (.023)

-.770 (.023)
-.333 (.031)

15. Seemed comfortable in new situations

-.847 (.013)

16. Was very talkative to adult strangers

-.752 (.022)

17. Was hesitant to explore new play equipment

.540 (.027)

18. Got upset at being left in new situations for the first time (e.g.,
kindergarten, preschool, childcare)

.489 (.032)

19. Was very friendly with children he or she had just met

-.752 (.022)

20. Tended to watch other children, rather than join in their games

.772 (.016)

21. Disliked being the center of attention

.687 (.022)

22. Was clingy when we visited the homes of people we didn’t know well

.780 (.017)

23. Happily approached new situations or activities

-.864 (.012)

24. Was outgoing

-.875 (.011)

25. Seemed nervous or uncomfortable in new situations

.853 (.013)

26. Happily chatted to new (adult) visitors to our home

-.732 (.022)

27. Took many days to adjust to new situations (e.g., kindergarten,
preschool, childcare)

.581 (.029)

28. Was reluctant to perform in front of others (e.g., singing, dancing)

.662 (.023)

29. Happily explored new play equipment

-.635 (.028)

30. Was very quiet with adult strangers

.741 (.022)
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-.269 (.019)
-.554 (.027)
.432 (.026)
.782 (.021)

.507 (.022)

-.561 (.025)
.690 (.025)
.631 (.022)
-.516 (.027)
.563 (.026)

Factor Structure Reliability. Cronbach’s alpha was calculated for the final bifactor
model. Since the first factor of this model included all items, that reliability is the same as for the
overall retrospective BIQ previously reported (alpha = 0.96). Reliability for the sub-factors was
also quite good and was as follows: “Physical Challenges” (alpha = 0.81), “Separation” (alpha =
0.91), “Performance” (alpha = 0.89), “Unfamiliar Adults” (alpha = 0.94).
Factor Structure Validity. To assess the criterion and content validity of the final bifactor
model, four items from SCARED-P were identified that are uniquely representative of each
factor; an appropriate item could not be identified for “Physical Challenges”. The correlation
coefficients from the SEM are presented in Table 5.6. It was expected that each factor would
correlate with one specific SCARED-P item to demonstrate discriminant (predictive and
divergent) and convergent validity. In addition, the item chosen for the “General” factor was also
used to show convergent validity for the BIQ as a whole. All factors were included in each
structural equation model as covariates (estimates not shown).
As expected, the “Separation” factor alone correlated with the SCARED-P item “My
child follows his/her parents everywhere they go” (r2 = 0.204; SE = 0.067; p < 0.01) while the
other factors were not significantly associated with this item. Similarly, the “Unfamiliar Adults”
factor correlated with the item “It is hard for my child to talk with people he/she doesn’t know
very well” (r2 = 0.255; SE = 0.046; p < 0.001), while the “Performance” factor correlated with
the item “My child feels nervous when he/she is with other children or adults and he/she has to
do something while they watch him/her” (r2 = 0.236; SE = 0.044; p < 0.001). Finally, all of the
factors except “Physical Challenges” correlated with the item “My child is shy,” with the
“General” factor having the strongest relationship (r2 = 0.659; SE = 0.030; p < 0.001).
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Intriguingly, the “Separation” factor negatively correlated with this item, indicating possible
multicollinearity with the “General” factor.
Table 5.6. Discriminant and convergent validity for each factor of the final 5-factor bifactor
model. Values represent SEM correlation estimates (SE).
My child feels nervous
My child
It is hard for my
when he/she is with
follows his/her
child to talk
other children or adults
Factor
parents
with people
My child is shy
and he/she has to do
everywhere
he/she doesn’t
something while they
they go
know very well
watch him/her
General

.182 (.052)***

.626 (.031)***

.497 (.036)***

.659 (.030)***p,c

Physical
Challenges

.041 (.055)d

-.092 (.041)*d

.057 (.041)d

-.020 (.041)d

Separation

.204 (.067)**p

-.163 (.044)***d

.056 (.047)d

-.177 (.041)***

Performance

-.089 (.057)d

.079 (.042)d

.236 (.044)***p

.150 (.040)***c

Unfamiliar
Adults

-.019 (.060)d

.255 (.046)***p

-.007 (.046)d

.207 (.045)***c

Notes: p = predictive; d = divergent; c = convergent
* p < 0.05; ** p < 0.01; *** p < 0.001

The Parental Bonding Instrument
The PBI is an instrument designed to assess overall relationship or bond between parents
and children using three scales: authoritarianism (discouragement of independence in child),
coldness (distance from and affection toward child), and overprotectiveness (control of child)
(Kendler, 1996; Parker, 1990; Parker, Tupling, & Brown, 1979). The original version of the PBI
was intended to be administered to children and had two scales, care (now coldness) and
overprotectiveness (now split into authoritarianism and protectiveness) (Parker, 1990; Parker et
al., 1979). The version used in the current dissertation is a reduced, 16-item scale (Kendler,
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1996). This reduced scale was originally developed with the purpose of administering the PBI to
parents instead of to children, which aligns with how it was administered in the JAS, although it
has been administered to a variety of contexts (i.e., adults giving a retrospective account,
children, etc.) (Kendler, 1996; Otowa, Gardner, Kendler, & Hettema, 2013; see Gillespie et al.,
2003 for a slightly different 14-item scale). In the current sample, the three PBI scales have
appropriate inter-item reliability (α = .63-.74) and test-retest reliability (r = .57-.68) (Carney et
al., 2016). The sum scores for each scale were utilized in all analyses.
Biometrical Analyses. Past analyses have examined the biometrical structure of the
shortened PBI with mixed results (see Table 5.7). Kendler (1996) first examined the overall
genetic epidemiology of parental bonding using the PBI. This was done by first conducting a
factor structure of the PBI, revealing three scales (authoritarianism, coldness,
overprotectiveness). Next, they examined the best-fitting univariate biometrical model for each
scale for several different informants (fathers, mothers, co-twin, self), of whom only the mother
was relevant to the current studies. Gillespie and colleagues (2003) went a step further to
examine the structure of the PBI using adult female informants to retrospectively report on their
childhood bonding with their parent. These analyses revealed that the factor structure of the PBI
is indeed three factors, unlike Parker’s original two (note – Gillespie and colleagues named the
factors autonomy, coldness, and overprotection which map onto Kendler’s authoritarianism,
coldness, and protectiveness). However, when analyzed as a whole composite representation of
parental bonding, a common pathway model fit the data better than an independent pathway.
This provides evidence for a universal “parenting” latent factor that holds all three scales of the
PBI together. Finally, Otowa and colleagues (2013) examined the univariate structure for each
PBI scale in adult male twins who were also retrospectively reporting on their past parental
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bonding. Both twins and co-twins served as informants in that co-twins also reported on bonding
for their sibling; only the former is reported below. Otowa and colleagues’ results somewhat
differed from the previous two studies (see Table 5.5).
Table 5.7. Proportion of variance accounted for by genes and environment from the
best-fitting models for the PBI scales across studies, including the current analyses
(95% confidence intervals).
Study
Informant
A
C
E
Authoritarianism
Kendler, 1996
Mother
.00
.85
.15
Gillespie et al., 2003
Self (female)
.33
.17
.51
.31
.00
.60
Otowa et al., 2013
Self (male)
(.14 - .37)
(.00 - .14)
(.63 - .76)
.76
.24
Current analyses
Mother
-(.71 - .80)
(.20 - .29)
Coldness
Kendler, 1996
Mother
.12
.71
.17
Gillespie et al., 2003
Self (female)
.61
.00
.39
.30
.09
.62
Otowa et al., 2013
Self (male)
(.09 - .45)
(.00 - .26)
(.55 - .69)
.25
.58
.16
Current analyses
Mother
(.11 - .41)
(.44 - .70)
(.12 - .22)
Overprotectiveness
Kendler, 1996
Mother
.05
.83
.12
Gillespie et al., 2003
Self (female)
.22
.24
.54
.07
.26
.67
Otowa et al., 2013
Self (male)
(.00 - .30)
(.06 - .37)
(.61 - .73)
.81
.19
Current analyses
Mother
-(.77 - .84)
(.16 - .23)
Notes: A = additive genetic latent factor; C = familial environment latent factor; E = unique environment
latent factor.
Bold indicates current analyses.

Given the variation in informants and results, similar analyses to Kendler (1996),
Gillespie and colleagues (2003), and Otowa and colleagues (2013) were conducted on the PBI
using the current sample of pre-adolescent twin and their mothers. Note that only one previous
study (Kendler, 1996) also examined mothers as informants about their bonding with their
children. Specifically, preliminary analyses for this dissertation examined the PBI in two ways:
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first with the scales separate (per Kendler, 1996, Gillespie et al., 2003, and Otowa et al., 2013)
and then with them combined (per Gillespie et al., 2003). After confirming equal means and
variances across twins and zygosity, univariate Cholesky decompositions were fit to the
authoritarianism, coldness, and protectiveness scales. It was found that a CE fit the data best for
authoritarianism (C = .76; E = .24), ACE for coldness (A = .25; C = .58; E = .06), and CE for
protectiveness (C = .81; E = .19). These results most closely follow Kendler (1996), which is
logical since the informants are the same for these two inquiries into the PBI. See Table 5.7 for
comparison of these results to other studies and Table 5.8 for full model fit statistics.
Table 5.8. Model fit statistics for univariate Cholesky models assessing PBI scales Models
Model

EP

-2 LL

Full
Drop C
Drop A *
Drop A and C

5
4
4
3

2548.625
2632.249
2550.021
2877.552

Full *
Drop C
Drop A
Drop A and C

5
4
4
3

2457.329
2496.699
2468.142
2726.321

Full
Drop C
Drop A *
Drop A and C

5
4
4
3

2435.652
2501.021
2436.121
2696.346

DF
AIC
Overprotectiveness
613 1322.625
614 1404.249
614 1322.021
615 1647.552
Coldness
613 1231.329
614 1268.699
614 1240.142
615 1496.321
Authoritarianism
613 1211.652
614 1275.021
614 1210.121
615 1468.346

Δ -2LL

Δ DF

p

83.624
1.295
328.927

1
1
2

<.001
.237
<.001

39.370
10.813
268.992

1
1
2

<.001
.001
<.001

65.368
.469
260.694

1
1
2

<.001
.494
<.001

Notes: EP = Estimated Parameters; -2LL = twice the negative log likelihood; DF = degrees of freedom;
AIC = Akaike Information Criteria; p = p-value statistic; delta (triangle) = change in
* Indicates final model in that section

To assess whether an overall latent “parent” factor is present in the current sample,
multivariate Cholesky, independent pathway (IP), and common pathway (CP) models were fit to
the data. The final fit of each model type were not distinguishable from one another based on
AIC values (see Table 5.9) and thus, there is no evidence for a latent “parent” factor in the
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current data. The study that found that utilized a different informant, which might explain this
discrepancy.
Table 5.9. Model fit statistics across the multivariate models tested for the PBI.
Δ
-2LL
DF
AIC
Δ -2LL DF
p
Cholesky
1a. Full
22 7392.051 1831
3730.051
1b. Drop A
16 7579.378 1837
3905.378 187.327
6
<.001
1c. Drop C
16 7405.159 1837
3731.159
13.108
6
.041
1d. Drop A and C
20 8237.043 1843
4551.043 844.992 12
<.001
1e. Drop all shared parameters
13 7443.611 1840
3763.611
51.560
9
<.001
1f. Drop shared A
19 7392.362 1834
3724.362
0.311
3
.958
1g. Drop shared C
19 7420.240 1834
3752.240
28.189
3
<.001
1h. Drop shared E
19 7396.305 1834
3728.305
4.254
3
.235
1i. Drop shared A and E *
16 7402.797 1837
3728.797
10.746
6
.966
Independent Pathway
2a. Full model
21 7393.553 1832
3729.553
2b. Full model drop latent A
18 7394.050 1935
3724.050
.497
3
.920
2c. Full model drop latent C
18 7422.945 1835
3752.945
29.392
3 <.001
2d. Full model drop latent E
18 7397.787 1835
3727.787
4.234
3
.237
2e. Full model drop latent A, latent E *
15 7404.678 1838
3728.678
11.125
6
.085
2e1. Drop specific A
12 7417.431 1841
3735.431
12.953
3
.005
2e2. Drop specific C
12 7511.981 1841
3829.981 107.302
3
<.001
2e3. Drop specific A and C
9 7962.552 1844
4274.552 557.874
6
<.001
Common Pathway
3a. Full model
18 7402.858 1836
3730.858
3b. Full model drop common A
17 7402.858 1837
3728.858
<.001
1 1.000
3c. Full model drop common C
17 7427.113 1837
3753.113
24.155
1 <.001
3d. Full model drop common E
17 7404.143 1837
3730.143
1.284
1
.257
3e. Full model drop latent A, latent E *
16
7404.68 1838
3728.678
1.820
1
.403
3e1. Drop specific A
13
7417.43 1841
3735.431 12.7530
3
.005
3e2. Drop specific C
13
7511.98 1841
3829.981 107.302
3 <.001
3e3. Drop specific A and specific C
10
7962.55 1844
4274.552 557.874
6 <.001
Notes: EP = Estimated Parameters; -2LL = twice the negative log likelihood; DF = degrees of freedom; AIC =
Akaike Information Criteria; p = p-value statistic; delta (triangle) = change in
Model

EP

Models 2e1, 2e2, and 2e3 were compared to model 2e, not 3a and 3e1, 3e2, and 3e3 were compared to model 3e,
not 3a.
* bold indicates final model of for a given model type

Discussion
Multiple models were utilized in aims 2 and 3 of this dissertation. While the primary
analyses will be discussed in Chapters 6-8, this chapter provided an overview of biometrical
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modeling as well as the results of preliminary analyses. There are a few limitations to note
specifically for our analyses of the BIQ.
Limitations: The Retrospective BIQ Preliminary Analyses
First, the fit statistics (χ2, RMSEA, CFI, TLI) of the final model were marginal and did
not meet standard minimum thresholds in the full sample (see Table 5.4). Such thresholds are
somewhat arbitrary, and fit statistics from other studies of the BIQ were similar except for the
study by Vreeke and colleagues (2012) (see Table 5.4). They utilized the more restricted BIQShort Form with a substantially larger sample, making it difficult to directly compare to the fit
statistics of the retrospective BIQ or previous BIQ studies. This limitation highlights the need for
scale assessment and improvement for BI measures. Second, because of its retrospective nature,
parent report of their now older child’s prior behavior is limited in reliability. In particular, statedependent recall could bias parents of high-anxiety children to report higher levels of early BI.
Third, there were limited potential external validators available in JAS that specifically tapped
into BI-related constructs. We restricted these to other parent report measures since these weakly
correlated with relevant child report measures, a notorious problem in child psychopathology
research. Nevertheless, using the available items it was possible to demonstrate both convergent
and divergent validity for all factors except for “Physical Challenges.” The retrospective BIQ has
shown limited correlation with the behavioral observation in another study (Hirshfeld-Becker et
al., 2016) and the original BIQ shows similar properties (Bishop et al., 2003). The issue of strong
construct validity for the entire retrospective BIQ remains an issue of the assessment. Fourth,
there was evidence of multicollinearity between factors in the bifactor model, meaning that the
“General” factor does not account for all of the variance in the subscales. This makes the
subscales necessary for the overall fit of the retrospective BIQ but reduces their independent
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interpretability and use. The most severe limitation, common to most measures of BI, is the
retrospective BIQ’s potential to validly assess a stable, reliable, construct of BI beyond early
childhood. As noted previously, a recent study in older children and adolescents found rather
modest correlation (r = 0.21) between the parent-report retrospective BIQ with BI defined by
observational laboratory protocols at ages 2-6 (Hirshfeld-Becker et al., 2016). Yet, other studies
of the non-retrospective BIQ report higher correlations with the behavioral observation
assessment (r = .46, Bishop et al., 2003; 74% agreement rate, Hudson & Dodd, 2012).
Points to Remember
There are points to note from this chapter that should be remembered while reading the
rest of this dissertation. First, the JAS sample used throughout this dissertation was limited to
mother and child report only for visit 1. Father reports of their children and all visit 2 analyses
(except for calculating reliability) were omitted. Second, the parent and child scores for the
SCARED were averaged together to reflect the fact that pre-adolescence is a time when parents
still know a great deal about their children but may not have total insight into their mental health
and related behaviors. Third, the retrospective version of the BIQ is a valid, reliable way to
measure early childhood BI. Finally, the PBI scales are best analyzed separately; no evidence for
a latent “parent” factor was found in the current sample.
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Chapter 6: Psychiatric Genetic Perspective on the Relationship Between Behavioral
Inhibition and Anxiety1
Introduction
First characterized by Kagan and colleagues, childhood behavioral inhibition (BI) is a
temperamental trait whereby children express shyness, restraint, or other negative affect in
response to novel people, objects, or environments (Garcia Coll, Kagan, & Reznick, 1984; Fox et
al., 2005; Kagan, Reznick, & Snidman, 1987). Roughly 20% of children initially scored as
having high BI continue to exhibit elements of inhibition as they age into adolescence (Kagan,
2012), and approximately 40% later develop social anxiety (Clauss & Blackford, 2012; Clauss,
Avery, & Blackford, 2015). While BI is a well-documented risk factor for later social anxiety
disorder in adolescents and adults (Clauss & Blackford, 2012; Chronis-Tuscano et al., 2009;
Hirshfeld-Becker et al., 2007; Hirshfeld-Becker et al., 2008; Essex, Klein, Slattery, Goldsmith, &
Kalin, 2010; Kagan, Reznick, & Snidman, 1987; Muris, van Braken, Arntz, & Schouten, 2011;
Schwartz, Snidman, & Kagan, 1999), it is also associated with other forms of anxiety-related
psychopathology such as specific phobia, panic disorder, separation anxiety, generalized anxiety,
and avoidant disorder earlier in childhood (Biederman et al., 2001; Dyson et al., 2011; Frenkel et
al., 2015; Muris, Merckelbach, Wessel, & van de Ven, 1999; Paulus, Backes, Sander, Weber, &
von Gontard, 2015). Development of any disorder, namely anxiety, is complex with many
possible branching points and outcomes, but a hypothetical example could be that a child with
elevated BI presents as more generally anxious during childhood. However, when they get to
middle school, a time of increased social pressure, social anxiety symptoms become more
prominent, and they are diagnosed with social anxiety disorder as an adolescent. Conversely, it is
possible for a child to exhibit elevated BI and continue on a linear progression to develop later
1

Modified version of the manuscript Bourdon, J. L., Savage, J. E., Verhulst, B., Carney, D. M., Brotman, M. A.,
Pine, D. S. … Hettema, J. M. (2019). The genetic and environmental relationship between childhood behavioral
inhibition and pre-adolescent anxiety. Twin Research Human Genetics, 1-8. doi:10.1017/thg.2018.73
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social anxiety. However, as they age further, they may learn to hide or better manage many of
their symptoms and not meet criteria for a diagnosis. Thus, the overall goal of the present study
is to clarify the etiological relationship between childhood BI and pre-adolescent anxiety
domains using novel genetic epidemiological approaches.
BI has been well studied from developmental and clinical perspectives over the last three
decades, but genetic epidemiological approaches have been underutilized. Past studies of
singletons have examined childhood and/or adolescent and adult ages (i.e., Chronis-Tuscano et
al., 2009; Frenkel et al., 2015; Schwartz et al., 1999), leaving pre-adolescence less well
understood from a developmental perspective. Prior twin studies report moderate heritability
through age 2 for BI (42-56%; Emde et al., 1992; Plomin et al., 1993; Robinson, Kagan,
Reznick, & Corley, 1992) and similar estimates for all childhood anxiety disorders (28-60%;
Lahey, Van Hulle, Singh, Wadman, & Rathouz, 2011; Scaini, Belotti, & Ogliari, 2014; Ogliari et
al., 2006; Ogliari et al., 2010). However, no twin studies have directly examined the sources of
shared genetic and environmental risk factors between BI and anxiety disorders in children.
Further, a twin design allows for the examination of possible causal pathways from BI to
strongly related anxiety domains even using a cross-sectional design. Pertinently, there is
ongoing debate as to whether BI is a distinct construct or simply an earlier version of social
anxiety (Clauss & Blackford, 2012).
Pre-adolescence is a key time to elucidate these shared genetic and environmental risks,
as symptoms of anxiety disorders, while common, remain largely still at pre-clinical levels in this
developmental period (Rapee, Schniering, & Hudson, 2009; Rapee & Spence, 2004).
Understanding this shared risks would complement prior work by further elaborating the etiology
of anxiety disorders from a trans-diagnostic, genetic perspective (i.e., Kagan, Snidman, Zentner,
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& Peterson, 1999; Rapee & Spence, 2004) and possibly inform future prevention/intervention
efforts. The current study specifically addresses two key knowledge gaps regarding the shared
etiologic pathways between childhood BI and related anxiety domains by dissecting their
developmental and phenotypic relationships at the genetic epidemiological level. The first aim of
this study is to clarify the exact relationship between BI and key anxiety domains. For example,
previously reported associations between BI and generalized anxiety, separation anxiety, or
panic symptoms (Biederman et al., 2001; Dyson et al., 2011; Frenkel et al., 2015; Muris et al.,
1999; Paulus et al., 2015) may be indirect effects of correlations between these symptoms and
social anxiety rather than the direct result of shared genetic and environmental effects. The
second aim is to disaggregate the overlapping sources of liability between the anxiety domains
for which BI shares the most genetic and environmental variance. Specifically, it will be tested
whether shared genetic and environmental factors are simply correlational, or if evidence for
causal pathways can be identified. This aligns with dissertation aim 2.1.
Materials and Methods
Participants
Participants were part of the Virginia Commonwealth University Juvenile Anxiety Study
(JAS; Carney et al., 2016). See chapter 5 for an overview of this study and its sample. As a
reminder, the final analytical sample included 352 families and 704 children (Mage = 11.22;
standard deviation [SDage] = 1.41; female = 53%; monozygotic [MZ] = 114 pairs; dizygotic [DZ]
= 238 pairs; 88% of full sample).
Measures
This study utilized two measures, a retrospective version of the Behavioral Inhibition
Questionnaire (BIQ; Bishop, Spence, & McDonald, 2003) and the Screen for Child Anxiety
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Related Emotional Disorders – Parent and Child Versions (SCARED) (Birmaher et al., 1997). A
series of preliminary analyses confirmed their validity, reliability, and appropriate usage in the
primary analyses as discussed in chapter 5.
Both parent and child responses to the SCARED were collected since both types of report
for any form of psychopathology are limited and potentially biased (De Los Reyes & Kazdin,
2005). As expected, parent-rated BI more strongly correlates with parent-rated than child-rated
recent anxiety (see Table 6.1), yet pre-adolescent children potentially offer additional insight into
their own symptomology. Information was combined across raters by including the average of
the parent and child SCARED sum scores for each subscale in analyses with parent-rated BI.
Analyses
An overview of biometrical modeling is provided in chapter 5.
Descriptive Statistics. The mean, standard deviation, and range were calculated for each
phenotype. Pearson correlations estimated the within-individual (i.e., phenotypic) associations
between anxiety clusters and BI. MZ and DZ twin correlations were calculated individually for
each phenotype as well as the cross-twin, cross-trait correlations between phenotypes (see Table
6.1). This information roughly predicts how the variance of the measures will decompose at the
univariate and multivariate levels (Neale & Cardon, 1992).
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Table 6.1. Pearson correlations between the BIQ and parent measures of child anxiety
and child measures of child anxiety (“C” indicates child report; “P” indicates parent
report).
Measure
1. BIQ
2. SCARED-C,
social anxiety
3. SCARED-C,
generalized anxiety
4. SCARED-C,
separation anxiety
5. SCARED-C,
panic
6. SCARED-P,
social anxiety
7. SCARED-P,
generalized anxiety
8. SCARED-P,
separation anxiety
9. SCARED-P,
panic

1

2

3

4

5

6

7

8

9

-.26**

--

.05

.40**

.04

.43** .41**

.04

.41** .49** .51**

.67** .29**

----

.03

.05

.00

--

.25**

.07

.20**

.09*

.08*

.48**

--

.22**

.05

.06

.26**

.08*

.39** .59**

.19**

.04

.03

.05

.10*

.43** .61** .61**

---

*p < .05; **p < .001

Covariates. Univariate linear regression was used to assess for the need to include sex
(male, female) as a covariate due to its known association with anxiety domains (Hettema et al.,
2005; Rapee, 2004).
Primary Analyses. For the first aim, biometrical SEM was used to fit a multivariate
Cholesky decomposition of BI and all anxiety clusters to assess which etiological latent genetic
and environmental factors are shared between phenotypes. The order of the clusters in the model
was based on the strength of the phenotypic associations between each cluster and BI. At the
multivariate level, each source of variance (A, C, E) was estimated as well as its contributions to
the covariance between phenotypes. A series of nested submodels tested whether the shared
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variance (covariance) paths could be eliminated from the model using likelihood ratio chi-square
tests and Akaike information criteria fit statistics.
As part of the second aim, a direction of causation model was utilized to further explicate
the relationship between BI and anxiety constructs with which it shared substantial variance (as
revealed from the multivariate biometrical model in the first aim). Traditionally in non-twin
samples, direction of causation models require longitudinal or experimental data to show
causality. In a cross-sectional, biometrical context, direction of causation models leverage known
differences between MZ and DZ twins’ shared genetics and environments. Specifically, these
models utilize cross-twin, cross-trait correlations across three unique sources of variance (A, C,
E, or dominance [D]) (Heath et al., 1993; Gillespie & Martin, 2005; Verhulst & Estabrook,
2012). To the extent that the sources of variance differ across the phenotypes (or that the
magnitudes of the same sources of variance differ substantially), inferences can be made about
whether a beta regression coefficient (as opposed to a correlation) best explains the relationship
between two phenotypes. This is tested via five scenarios that are nested within a full Cholesky
decomposition model (see Figure 6.1) (Verhulst & Estabrook, 2012): (a) phenotype 1 causes
phenotype 2, (b) phenotype 2 causes phenotype 1, (c) reciprocal causation between phenotypes,
(d) an external factor causes both (correlated liabilities), and (e) no association between the two
phenotypes. Additionally, the proportion of variance accounted for in the “outcome” phenotype
in each direction of causation model was estimated and compared to the proportion of variance
accounted for by the default correlated liability model (here, the bivariate Cholesky
decomposition). The direction of causation model is then compared to a correlated liability
model (i.e., a bivariate Cholesky decomposition with shared sources of variance) using
likelihood ratio test and Akaike information criteria fit statistics.
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Figure 6.1. Top: Full direction of causation model tested within a nested Cholesky
decomposition model. Bottom: Final model found in the present study.
Results
Correlations and Heritability Estimates
For all anxiety clusters, parent and child SCARED scores could be constrained to be
equal in their multiple indicator models (see chapter 5, Table 5.2). In other words, the average of
the parent and child SCARED sum scores provide a reasonable representation of these anxiety
domains for analyses with parent-rated BI and were used in all analyses.
Within-person correlations among BI and each anxiety domain were consistent with past
findings (see Table 6.2; Dyson et al., 2011; Muris et al., 1999; Paulus et al., 2015). Consistent
with prior reports, childhood BI had the strongest association with pre-adolescent social anxiety
symptoms (r = .57, p < .001) and smaller but significant correlations with generalized anxiety,
separation anxiety, and panic symptoms (r = .11 - .18, p < .05).
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Table 6.2. Within-person correlations between behavioral inhibition and anxiety
symptom clusters.
1.
2.
3.
4.
5.

Measure
Behavioral Inhibition
Social Anxiety
Generalized Anxiety
Separation Anxiety
Panic

1
-.57**
.18**
.15*
.11*

2

3

4

5

-.40**
.36**
.35**

-.47**
.52**

-.51**

--

*p < .05; **p < .001

All twin correlations for BI and each anxiety domain were significant except for the DZ
correlations for BI and social anxiety symptoms (see Table 6.3 and Figure 6.2 for these data and
other descriptive statistics on these measures).
Table 6.3. Descriptive and twin statistics for behavioral inhibition and anxiety symptom clusters.
Applicable
Mean (SD);
Median;
MZ
DZ
Measure
Report
Age Range
SE
Range
Correlation Correlation
Behavioral
95.24 (35.29);
92.00;
2-6
Parent
.84**
.05
Inhibition
1.37
30-199
4.06 (3.59);
4.00;
Parent
.70**
.03
.14
0-19
Social
5.00 (3.91);
6.00;
8-13
Child
.44**
.21*
Anxiety
.15
0-14
5.01 (2.75);
4.96;
Average
.64**
-.02
.11
0-14
3.97 (3.74);
3.00;
Parent
.63**
.13*
.14
0-19
Generalized
5.84 (3.63);
5.00;
8-13
Child
.43**
.26**
Anxiety
.14
0-16
4.91 (2.86);
4.50;
Average
.56**
.19*
.11
0-15.5
2.21 (2.81);
1.00;
Parent
.83**
.36**
.11
0-14
Separation
5.17 (3.38);
5.00;
8-13
Child
.44**
.38**
Anxiety
.13
0-16
3.70 (2.46);
3.00;
Average
.62**
.36**
.09
0-13.5
1.53 (2.70);
1.00;
Parent
.84**
.56**
.10
0-19
5.18 (3.91);
4.00;
Panic
9-13
Child
.41**
.25**
.15
0-24
3.35 (2.48);
3.00;
Average
.68**
.39**
.10
0-14
*p<.05; **p<.001; bold indicates model used in primary analyses
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Heritability
.76
.61
.42
.52
.57
.47
.49
.35
.45
.62
.84
.68

Figure 6.2. Histograms of key variables.
For some scales, the DZ correlations were less than half of the MZ correlations, indicating
possible influence of non-additive genetic factors such as genetic dominance or epistasis
(denoted as D). ADE models which estimate non-additive genetic influences were tested but did
not significantly improve model fit over ACE models for any of the phenotypes tested. This is
unsurprising, as the power to detect non-additive genetic variance factors is typically poor in
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practical twin sample sizes (Martin, Eaves, Kearsey, & Davies, 1978). The magnitudes of the
remaining correlations indicated the possibility of both genetic and common environmental
contributions to the variance of each phenotype. The cross-twin, cross-trait genetic correlations
followed the same patterns of weaker cross-twin DZ correlations across phenotypes (see Table
6.4).
Table 6.4. Cross-twin, cross-trait genetic correlations between BI and anxiety symptom
clusters.
Measure
MZ Twins
1. Behavioral Inhibition – Twin 1
2. Behavioral Inhibition – Twin 2
3. Social Anxiety – Twin 1
4. Social Anxiety – Twin 2
5. Generalized Anxiety – Twin 1
6. Generalized Anxiety – Twin 2
7. Separation Anxiety – Twin 1
8. Separation Anxiety – Twin 2
9. Panic – Twin 1
10. Panic – Twin 2
DZ Twins
1. Behavioral Inhibition – Twin 1
2. Behavioral Inhibition – Twin 2
3. Social Anxiety – Twin 1
4. Social Anxiety – Twin 2
5. Generalized Anxiety – Twin 1
6. Generalized Anxiety – Twin 2
7. Separation Anxiety – Twin 1
8. Separation Anxiety – Twin 2
9. Panic – Twin 1
10. Panic – Twin 2
*p < .05; **p < .001

1

2

3

4

5

6

7

8

9

10

-.81
.50
.44
.06
-.09
.10
-.04
-.07
.04

--.42
.60
.04
.10
.05
.04
-.13
.13

---.60
.34
.10
.39
.07
.24
.08

----.21
.42
.32
.37
.15
.36

-----.47
.51
.33
.46
.25

------.23
.49
.27
.49

-------.57
.46
.38

--------.38
.58

---------.60

-----------

-.02
.52
-.06
.14
.002
.15
.05
.14
-.01

---.15
.64
.001

----.02
.34

----.12

------

------

------

------

------

------

.26

.05

.40

.17

--

--

--

--

--

-.05
.20
.06
.18

.34
.10
.33
.19

.02
.31
.12
.31

.43
22
.47
.26

.13
.44
.13
.53

-.35
.46
.25

--.23
.49

---.34

-----

There was a significant effect of sex on BI (β = 5.791, p = .035), social anxiety (β = .634,
p = .003), generalized anxiety (β = .682, p = .002), separation anxiety (β = .565, p = .003), and
panic (β = .446, p = .019). Sex was included as a covariate in all biometrical analyses.
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Heritability estimates were calculated for each phenotype within the multivariate
Cholesky decomposition (see below) to assess consistency with past literature. The estimated
heritability of retrospective childhood BI was higher than that of concurrent BI in toddlers (see
Table 6.3; h2 = .76; confidence interval = .65 - .84;) (Emde et al., 1992; Plomin et al., 1993;
Robinson, et al., 1992). For the anxiety clusters, heritability estimates were slightly different than
previously reported (Lahey et al., 2011; Scaini et al., 2014; Ogliari et al., 2006; Ogliari et al.,
2010) except for social anxiety, which was consistent with past studies (h2 = .52). Specifically,
heritability was slightly lower for generalized anxiety (h2 = .49) and slightly higher for both
separation anxiety (h2 = .62) and panic (h2 = .68).
Relationship Between BI and All Anxiety Clusters
The phenotypic ordering in the multivariate model was based on decreasing magnitude of
correlations found between BI and each anxiety domain (Table 6.2): BI, social anxiety,
generalized anxiety, separation anxiety, and panic (see Tables 6.5-6.6 and Figure 6.3).
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Table 6.5. Variance and covariance components for the best-fitting multivariate model between BI and anxiety symptom clusters
(95% confidence intervals).
BI (Trait 1)
Social (Trait 2)
Generalized (Trait 3)
Separation (Trait 4)
Panic (Trait 5)
Additive Genetic (A) Components Shared Between BI and Anxiety Symptom Clusters
A11
A21
A22
A31
A33
A41
A44
A51
A55
.76
.20
.32
.43
.42
.01
.29
(.65 - .84) (.10 - .30) (.22 - .41)
(.29 - .55)
(.29 - .53)
(.001 - .04) (.18 - .40)
Unique Environment (E) Components Shared Between BI and Anxiety Symptom Clusters
E11
E21
E22
E31
E33
E41
E44
E51
E55
.24
.16
.32
.07
.40
.05
.29
.26
(.16 - .35) (.07 - .28) (.25 - .42) (.03 - .14) (.29 - .52) (.02 - .10)
(.22 - .39)
(.20 - .34)
Additive Genetic (A) Components Shared Between the Anxiety Symptom Clusters
A32
A42
A43
A52
A53
A54
.06
.06
.14
.10
.20
.08
(.01 - .16) (.01 - .15)
(.54 - .26)
(.03 - .20) (.09 - .33)
(.02 - .17)
Unique Environment (E) Components Shared Between the Anxiety Symptom Clusters
E32
E42
E43
E52
E53
E54
.04
.03
.01
.03
.03
.004
(.01 - .09) (.01 - .07) (<.001 - .04) (.01 - .07) (.01 - .08) (<.001 - .02)
Notes on variance component naming:
A11/E11 = Behavioral Inhibition symptoms
A22/E22 = Social anxiety symptoms; A21/E21 = Shared between BI and social anxiety symptoms
A33/E33 = Generalized anxiety symptoms; A31/E31 = Shared between BI and generalized anxiety symptoms
A44/E55 = Separation anxiety symptoms; A41/E41 = Shared between BI and separation anxiety symptoms
A55/E55 = Panic symptoms; A51/E51 = Shared between BI and panic symptoms
All other paths represent shared variance between the anxiety symptom clusters
Notes: Variance components above are equal to the squares of the standardized path estimates seen in Figure 2. Within each phenotype, these should add up to
1.00 but may not due to rounding error.
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Table 6.6. Model fit statistics for from multivariate analyses between BI and anxiety symptom
clusters.
Model
EP
-2LL
DF
AIC
Δ LL
Δ DF
p
Full ACE Parameters
Full ACE
55 17200.516 3109 10982.516
ACE drop all C *
40 17204.918 3124 10956.918
4.401
15
.996
ACE drop all A
40 17306.158 3124 11058.158 105.642
15 <.001
ACE drop all A and C
25 17498.420 3139 11220.420 297.904
30 <.001
Final Model from Above – Drop Parameters Shared with BI
Full AE
40 17204.918 3124 10956.918
AE drop all shared A
36 17240.292 3128 10984.292
35.374
4 <.001
AE drop all shared E
36 17244.994 3128 10988.994
40.076
4 <.001
AE drop all shared A and E
32 17474.040 3132 11210.040 269.122
8 <.001
AE drop E51 *
39 17205.620 3125 10955.620
.702
1
.402
AE drop A31 *
39 17206.437 3125 10956.437
1.519
1
.218
AE drop A41 *
39 17207.393 3125 10957.393
2.475
1
.116
AE drop A51
39 17209.877 3125 10959.877
4.960
1
.026
AE drop E41
39 17213.725 3125 10963.725
8.807
1
.003
AE drop E31
39 17215.306 3125 10965.306
10.388
1
.001
AE drop E21
39 17255.350 3125 11005.350
50.433
1 <.001
AE drop A21
39 17237.923 3125 10987.923
33.005
1 <.001
Full AE – Drop Non-Significant Parameters from Above
Full AE
40 17204.918 3124 10956.918
AE drop E51, A31, A41 **
37 17209.341 3127 10955.341
4.422
3
.219
* Indicates best-fitting model(s) from that series of nested sub-models; ** Indicates final best-fitting model overall
EP = Estimated Parameters; -2LL = twice the negative log likelihood; DF = degrees of freedom; AIC = Akaike
Information Criteria; p = p-value statistic; delta (triangle) = change in
Notes on path naming:
A21/E21 = Shared between BI and social anxiety symptoms
A31/E31 = Shared between BI and generalized anxiety symptoms
A41/E41 = Shared between BI and separation anxiety symptoms
A51/E51 = Shared between BI and panic symptoms

Consistent with past findings for each individual phenotype, only additive genetic (A) and
unique environment (E) significantly contributed to this multivariate relationship (Lahey et al.,
2011; Robinson et al., 1992; Scaini et al., 2014; Ogliari et al., 2006; Ogliari et al., 2010). At least
some proportion of genetic or environmental risk of each anxiety cluster was shared with BI (see
Figure 6.2). Specifically, social anxiety shared the most of its variance with BI (A = .20; E =
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.16), followed in smaller magnitudes by generalized anxiety (E = .07), separation (E = .05), and
panic (E = .01).
1
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Figure 6.3. Standardized path estimates from the final multivariate model depicting the shared
paths between BI and anxiety symptom clusters and unique paths only (shared inter-anxiety
paths not included for simplicity but can be found in Table 6.7).
There was also significant shared variance between the anxiety clusters (see Table 6.5)
although not as much as previously reported in this age group (Ogliari et al., 2010). Generalized
and separation anxiety shared the most genetic variance (A = .14) while social and generalized
anxiety shared the most environmental variance (E = .04). A Cholesky decomposition of the
anxiety measures alone revealed that, except for social anxiety, these lower between-domain
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covariance estimates are not due to residual covariance accounted for by including BI in the
model (see Table 6.7).
Table 6.7. Variance and covariance components for the best-fitting multivariate
model between anxiety symptom clusters.
Social
Generalized
Separation
Panic
Additive Genetic (A) Components
A11
A21
A22
A31
A32
A33
A51
A52
A53
A54
.49
.06
.44
.06
.15
.42
.09
.19
.10
.30
Unique Environment (E) Components
E33
E54
E11
E21
E22
E31
E32
E51
E52
E53
.52
.09
.41
.06
.01
.29
.03
.03 <.001
.27
Notes on variance component naming:
A11/E11 = Social anxiety symptoms
A22/E22 = Generalized anxiety symptoms
A33/E33 = Separation anxiety symptoms
A44/E55 = Panic symptoms
All other paths represent shared variance between the anxiety symptom clusters
Notes: Within each phenotype, these should add up to 1.00 but may not due to rounding error.

Relationship Between BI and Social Anxiety
Due to the modest but significant amounts of additive genetic and unique environmental
variance shared between BI and social anxiety but not with other anxiety clusters, the direction
of causation model was only tested between these two phenotypes. This model with social
anxiety symptoms regressed onto BI fit significantly better than the other direction of causation
models tested (BI regressed onto social anxiety, joint causation, no association), notably ruling
out these other three possibilities as explanations for the relationship between BI and social
anxiety. When compared to the correlated liabilities model, which represents an external
unmeasured factor causing both phenotypes, the model with BI causing social anxiety was not
significantly worse; it estimated a small but notable regression coefficient (β = .047; see Tables
6.8-6.9, Figure 6.1). Both models had comparable parameter estimates and fit indices, making it
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important to assess the amount of social anxiety’s variance accounted for by BI in each model to
further explain their relationship from a genetically-informed perspective.
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Table 6.8. Variance components and proportion of social anxiety’s variance accounted for by BI in the best-fitting correlated
liabilities and direction of causation models.
Correlated Liabilities Model with Cross Paths Between Phenotypes
Unique A
Unique E
R2 for A (A21)
R2 for E (E21)
Total R2
Behavioral Inhibition
.79
.21
.31
Social Anxiety
.32
.24
.13
.37

Behavioral Inhibition
Social Anxiety

Direction of Causation Model with Causal Beta Paths Between Phenotypes
R2 for A
R2 for E
Unique A
Unique E
β1 Causal Path
.85
.15
.047
.51
.49
.30
.08

Total R2
.38

Notes: Variance components above are equal to the squares of the standardized path estimates. Within each phenotype, these should add up to 1.00 but may
not due to rounding error
Notes on path naming:
A21/E21 = Shared between BI and social anxiety symptoms
β1 = Causal path from BI to social anxiety symptoms
R2 = Amount of social anxiety’s variance that is accounted for by BI
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Table 6.9. Model fit statistics for from the direction of causation and correlated liabilities
models between BI and social anxiety symptoms.
Model
EP
-2LL
DF
AIC
Δ LL
Δ DF
p
Model with Correlated Liabilities (Cross Paths) Between Phenotypes
Full AE with A21 and E21 *
10 8911.565 1245 6421.565
---AE drop A21
9 8944.554 1246 6452.554
32.989
1 <.001
AE drop E21
9 8947.257 1246 6455.257
35.691
1 <.001
AE drop A21 and E21 **
8 9172.122 1247 6678.122 260.557
2 <.001
Direction of Causation Model with Causal Beta Paths Between Phenotypes
10 8912.351 1245 6422.351
---Full AE with β1 and β2
9 9116.040 1246 6624.040 203.689
1 <.001
AE drop β1
9 8913.621 1246 6421.621
1.270
1
.260
AE drop β2 *
8 9172.122 1247 6678.122 259.771
2 <.001
AE drop β1 and β2 **
Comparing Final Models
Full AE with A21 and E21
10 8911.565 1245 6421.565
9 8913.621 1246 6421.621
2.055
1
.152
AE drop β2 *
* Indicates best-fitting model(s) from that series of nested sub-models; ** Indicates identical models

EP = Estimated Parameters; -2LL = twice the negative log likelihood; DF = degrees of freedom; AIC = Akaike
Information Criteria; p = p-value statistic; delta (triangle) = change in
Notes on path naming:
A21/E21 = Shared between BI and social anxiety symptoms
β1 = Causal path from BI to social anxiety symptoms
β2 = Causal path from social anxiety symptoms to BI

BI in both models accounted for a similar proportion of social anxiety’s variance.
Specifically, 37% of social anxiety’s variance (24% of the A and 13% of the E variance) was
accounted for by BI in the correlated liabilities model compared to 38% (30% of the A and 8%
of the E variance) in the direction of causation model. Taken together with their comparable fit
to these data, this implies that a direction of causation model with a single beta coefficient from
BI to social anxiety symptoms modestly informs their relationship beyond the correlated risk
structure.
Discussion
Using novel approaches that complement existing developmental research, the current
study examined the shared genetic and environmental influences between BI and anxiety
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symptomology. The first aim of the study sought to clarify the etiology between BI and related
anxiety domains, and the second examined potential causality between BI and the anxiety
domain(s) with most substantial genetic and environmental overlap with BI from the first aim.
Findings explicate prior reported phenotypic associations of BI with various anxiety symptoms
in childhood and its role as a particular risk factor for later social anxiety. It was found that
retrospectively-reported childhood BI shared both genetic and environmental variance with preadolescent social anxiety symptoms, but there was little-to-no genetic overlap between BI and
other domains of anxiety symptomatology. Tentative evidence was also found for causality
between BI and social anxiety.
These findings clarify that associations between childhood BI and pre-adolescent anxiety
symptoms other than social anxiety are primarily a function of shared environmental influences
and not simply indirect effects from the correlations between social anxiety and other anxiety
clusters. The residual variance of social anxiety increased when BI was taken out of the model,
but the genetic and environmental components for the rest of the anxiety clusters and their
interrelationships remained unchanged. This implies that associations found in the model that
included BI are fairly robust. If the relationship between BI and the other clusters was due to
correlations with social anxiety, then their variance components should have differed in the
model without BI. Given the generally more stable effects of genetic versus environmental
influences across development, this finding helps clarify the more robust, longitudinal
relationship seen between early BI and later social anxiety disorder compared with other anxiety
disorders.
Further, there is tentative evidence that the relationship between BI and social anxiety is
causal. A significant proportion of the variance of pre-adolescent social anxiety symptoms was

134

explained by childhood BI, specifically about a quarter of the additive genetic variance and a
tenth of the unique environmental variance. While it had been previously shown that about 40%
of children with BI later develop social anxiety (Clauss & Blackford, 2012; Clauss et al, 2015),
the current findings suggest a particularly strong, etiologically-relevant link. Our twin direction
of causation model provided a potential approach for distinguishing correlation and direct
causation between etiological sources of covariance between BI and social anxiety. The model
fits were not significantly worse, and variance estimates were on par with those of the correlated
model, implying that either is an appropriate way to represent the relationship between BI and
social anxiety disorder. The direction of causation model provides an etiologically informed twin
version of a linear regression, bridging the gap between genetically-informed and behavioralbased studies.
These findings contribute to two key threads in the BI and social anxiety literature. There
has been a long-standing debate regarding the developmental distinction between BI and social
anxiety disorder (Clauss & Blackford, 2012). The current study adds a genetically-informed
perspective to this discussion by demonstrating that both shared genetic and environmental
factors partially, yet substantially, underpin the relationship between BI and social anxiety. This
expands upon past longitudinal studies and expert reviews (Kagan et al., 1999; Fox et al., 2005;
Rapee & Spence, 2004). Importantly, these findings also suggest that there are etiologic
distinctions, supporting the hypothesis that these phenotypes are not two measures of the same
underlying construct.
In addition, these results add to the growing evidence that childhood BI is a putative
endophenotype for later social anxiety. Endophenotypes are “intermediate” phenotypes that lie in
the etiological pathway between genetic variation and a disorder (Cannon & Keller, 2006;
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Gottesman & Gould, 2003). BI has previously been shown to meet a subset of the basic
requirements as an endophenotype for social anxiety, including association with the disorder and
being itself heritable. The present study adds further support to these two criteria and provides
the first firm evidence for a third requisite criterion: co-segregation of the two phenotypes within
families (instantiated here as cross-phenotype correlations within twin pairs). Furthermore, these
results suggest that this familial coaggregation is primarily due to additive genetic factors. This is
the first study conducted on a substantially-sized, genetically-informative sample that includes
measures of both phenotypes since Kagan’s longitudinal studies of BI (Kagan et al., 1988).
There are additional potential strengths and insights provided by this study design. We
modified the BIQ to a retrospective parent report in an attempt to, at least partially, capture the
mother’s recollection of her child’s BI at an earlier age. That version was shown to be similarly
reliable and valid as prior versions of the BIQ (however, also see limitations below).
Additionally, treating the included phenotypes as quantitative traits provides unique advantages.
Statistical power to detect effects with this method is generally increased compared to binary
categories. The use of quantitative measures of psychopathology is consistent with recent efforts
by the National Institute of Mental Health to shift research towards dimensional constructs that
potentially cut across diagnostic boundaries (Cuthbert & Insel, 2013; Insel et al., 2010). Finally,
our finding suggests that retrospective parent report of BI assesses a strongly heritable form of
inhibited temperament in this age group. This adds genetic evidence to existing rationale for
measuring BI in early childhood and provides further support that parent report is a viable
approach to assessing the trait when direct laboratory assessment is unavailable (Bishop et al.,
2003; Smith et al., 2012).
Limitations
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The results of this study should be interpreted in the context of several limitations. First,
using a retrospective report of BI could limit the reliability and validity of the measured trait due
to recall biases such as parents of high-anxiety pre-adolescents reporting higher levels of early BI
(McPhail & Haines, 2010). However, there is little evidence that such potential bias in
retrospective reports outweighs their utility (Hardt & Rutter, 2004). This limitation, together with
moderate stability of BI over development (Fox et al., 2005), suggests that our assessment likely
provides a compromise between past and current inhibition severity. Second, use of the BIQ to
index BI only moderately aligns with BI obtained by behavioral observation methods. As already
mentioned, however, the BIQ is a reliable measure of inhibited temperament that has been used
most often in recent studies of BI (i.e., Bishop et al., 2003; Broreren & Muris, 2010; Clauss et
al., 2016; Edwards et al., 2010; Fu et al., 2015; Hudson & Dodd, 2012; Kennedy et al., 2009;
Kim et al., 2011; Morales et al., 2016; Taber-Thomas et al., 2016; Vreeke et al., 2012). Third,
findings may not be generalizable to a wider population since the sample is made up of entirely
Caucasian participants selected to limit genetic variance for the larger aims of the study (Carney
et al., 2016). Fourth, twin direction of causation models ideally should examine phenotypes with
different sources of variance (Heath et al., 1993; Gillespie & Martin, 2005; Verhulst &
Estrabrook, 2012). The sources of variance between BI and social anxiety symptoms were the
same (additive genetics and unique environment) but of sufficiently different magnitudes to
make the model appropriate for use in the current study. Fifth, it is not possible with the current
final direction of causation model to eliminate error from the causal parameter. It is possible that
the causal parameter includes measurement error from the BIQ. Sixth, the translational
implications are not known. Specifically, it is assumed that the final model chosen, the direction
of causation model, has more translational capacity. However, it is possible that the correlated
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liabilities model is easier for stakeholders to understand. Given that both models had nearly
identical fit, this is a point that needs to be explored in further detail in the future. Finally, the DZ
correlations for BI and social anxiety symptoms were low and not significantly different from
zero (see Table 6.2). This has also been reported in past studies in which BI was assessed via
behavioral observation (Plomin et al., 1993; Robinson et al., 1992; Smith et al., 2012),
suggesting this is likely inherent in various measures of BI. There are a few possible
explanations for this which we discuss below.
There are several possible explanations for the vastly different MZ and DZ correlations
for BI and social anxiety symptoms. The first is sibling contrast effects. These can be ruled out
because the means and variances for these phenotypes could be constrained to be equal within
twin pairs and across zygosity. The second is a violation of the equal environments assumption
(EEA). The EEA, upon which all twin studies are predicated (Neale & Cardon, 1992), states that
MZ and DZ twins are equally correlated for their exposure to environmental influences that are
of etiologic importance to the trait under study. Thus, while most prior investigations of the EEA
have supported its validity (Eaves, Foley, & Silberg, 2003), we cannot rule out the possibility of
some level of violation here for BI and social anxiety that is driven by parent report. This could
occur if parents of MZ twins inflate similarities of a trait and parents of DZ twins deflate
similarities, introducing a pseudo unequal environment across zygosity (Emde et al., 1992). In
the current study, this trend is seen for parent-report BI and social anxiety symptoms but not for
child self-report measures. Such effects have been noted in a previous study of BI (Smith et al.,
2012) and, thus, could present a limitation for any twin study of BI and, possibly, social anxiety.
Parent and child measures offer their own unique insights and limitations into underlying
psychopathology (Cole, Hoffman, Tram, & Maxwell, 2000), including BI (Muris, Meesters, &
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Spinder, 2003) yet are often minimally correlated (Birmaher et al., 1997; Muris et al., 2003), so
we obtained reports from both types of informants. After testing more complex multi-rater
models, we used the average of the parent and child SCARED scores to provide an optimal
compromise in the main analyses.
Conclusions
This chapter (and first part of aim 2) presents the first study to examine the relationship
between childhood BI and a broad array of pre-adolescent anxiety symptom clusters from a
genetic epidemiological perspective. Of the anxiety symptoms examined, only social anxiety
shared a significant proportion of genetic and environmental factors with childhood BI. It also
found tentative evidence for a potentially causal pathway that partially explains the relationship
between these two phenotypes, expanding extant knowledge about the progression of BI and
etiology of social anxiety. Current findings support and extend past research indicating that
childhood BI is most robustly a risk factor for later social anxiety despite associations with other
anxiety domains. They also suggest that childhood BI and later social anxiety disorder are related
but distinct phenotypes, with early BI functioning as a potential developmental endophenotype
for later social anxiety. Unfortunately, the full range of translational impact is unclear, namely
treatment implications are not known. Yet, such research adds etiological insight into anxiety
risk prediction that may be useful for clinicians to consider. Future studies in this line of research
could expand the clinical impact of this work by informing clinicians’ treatment decisions. For
example, the specific mechanisms of the relationship between BI and social anxiety need further
exploration, including the developmental progression to social anxiety disorder in adolescence.
Such knowledge can help to guide early intervention and prevention efforts aimed at social
anxiety outcomes in middle-to-late childhood.
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Chapter 7: The Role that Parental Bonding Plays in the Relationship Between Behavioral
Inhibition and Social Anxiety1
Introduction
Social anxiety disorder typically emerges during the pre-adolescent years (Rapee &
Spence, 2004), and by adolescence the lifetime prevalence in the U.S. is 9.1% (Merikangas et al.,
2010). Thorough examination of all risk factors, their pathways, and their relative effects is
necessary to inform intervention and prevention efforts (Degnan, Almas, Fox, 2010). Behavioral
inhibition (BI) is a well-documented, robust childhood risk factor for later development of social
anxiety (Clauss & Blackford, 2012; Chronis-Tuscano et al., 2009; Hirshfeld-Becker et al., 2007;
Hirshfeld-Becker et al., 2008; Essex, Klein, Slattery, Goldsmith, & Kalin, 2010; Kagan, Reznick,
& Snidman, 1987; Muris, van Braken, Arntz, & Schouten, 2011; Schwartz, Snidman, & Kagan,
1999). It persists in approximately 20% of children (Kagan, 2012), and roughly 40% of those
who have high BI in childhood later develop social anxiety disorder (Clauss & Blackford, 2012;
Clauss, Avery, & Blackford, 2015). The relationship between BI and social anxiety has been
thoroughly investigated at both the phenotypic (i.e., Fox et al., 2005) and genetic
epidemiological levels (see chapter 6). In fact, previous analyses that examined the relationship
between BI and social anxiety revealed a partially causal link between the two (chapter 6;
Bourdon et al., 2019).
It has long been thought that parental bonding plays a key role in the development from
BI to social anxiety. Examination of the relationship between these three phenotypes to date has
been based on behavioral data and uninformed by genetic insights. Specifically, parental bonding
is associated with both inhibited temperament and related behaviors (Bayer, Sanson, &
Hemphill, 2006; Chorpita et al., 1998; Coplan & Armer, 2007; Hastings et al., 2008; Rapee,
1

Modified version of the manuscript Bourdon, J. L., Gillespie, N. A., Roberson-Nay, R., & Hettema, J. M. (In
Review). The phenotypic and genotypic effects of parental bonding on the relationship between behavioral
inhibition and social anxiety. Journal of Abnormal Child Psychology.
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2004), social anxiety (Arrindell, Emmelkamp, Monsma, & Brilman, 1983; Greco & Morris,
2002), and the trajectory between the two (Fox et al., 2005; Rubin, Burgess, & Hastings, 2002;
Degnan et al., 2010). Specifically, parental bonding is believed to have a broadly reciprocal
relationship with childhood temperament (Kiff, Lengua, & Zalewski, 2011; Van Zalk & Kerr,
2011), implying a gene-environment interplay. For example, a child’s temperament is at least
partially due to genes they inherited from their parents (who also raise them). The same heritable
components of their personality when manifest may evoke certain responses from their parents,
further influencing parental bonding. This reciprocal relationship between temperament and
individual differences in parental bonding can in turn can affect expression/development of
temperamental outcomes such as BI and later social anxiety. Accordingly, several studies have
documented that mothers who are overly anxious tend to have children who are also inhibited
and/or anxious (Aktar, Majdandzic, de Vente, & Bogels, 2014; Degnan et al., 2010; Hudson &
Dodd, 2012; Rapee, 2004). Such anxiogenic genes and environmental exposures position
parenting bonding as an important influence in the development from BI to social anxiety (Fox et
al., 2005; Rubin et al., 2002; Degnan et al., 2010). Further, several prevention and intervention
that have been effective in reducing later social anxiety and other internalizing syndromes by
targeting childhood BI (Chronis-Tuscano et al., 2015; Hirshfeld-Becker et al., 2010; Kennedy,
Rapee, & Edwards, 2009; Rapee et al., 2010; Rapee, 2013) have either assessed (ChronisTuscano et al., 2015) or targeted (Kennedy et al., 2009) aspects of bonding.
Despite some variation in item content, measures of parental bonding typically include
overprotection (intrusion, encouragement of dependence on parent), coldness (lack of
involvement, rejection), and authoritarianism (power-assertive parenting, controlling) (Bayer et
al., 2006). Despite the studies showing its association with BI and social anxiety, only a few
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studies have investigated how parental bonding directly affects the relationship between the two
(Degnan et al., 2010). More broadly, parenting has been shown to moderate the relationship
between BI and internalizing problems. One study found that toddlers with BI who were exposed
to higher levels of permissive parenting had more internalizing symptoms (Williams et al.,
2009). More topically, increased maladaptive levels of maternal bonding behaviors (intrusion,
control, derision) strengthened the relationship between BI and social reticence (Rubin et al.,
2002), and increased maternal over-control lead to higher levels of social anxiety in adolescence
among children with elevated BI (Lewis-Morrarty et al., 2012). A limitation of these reports is
their inability to determine if the moderating effects of parental bonding are acting on the genetic
and/or environmental risks shared between measures of BI and anxiety.
There is a need to further elucidate the moderating role that parental bonding plays
between BI and social anxiety specifically (Degnan et al., 2010). To date, no study has
investigated the moderating effect of parental bonding in the context of a genetically informative
design. Given the strong, potentially causal etiological link between BI and social anxiety
(chapter 6; Bourdon et al., 2019) and role of parental bonding, the second part of aim 2 assessed
how parental bonding (overprotectiveness, coldness, and authoritarianism) affects this
relationship at both the phenotypic and genotypic levels. First, it was hypothesized that the
effects of BI on social anxiety will be greater at higher levels of overprotection, coldness, and /or
authoritarianism. Second, an exploratory aim examined how the incorporation of parental
bonding into a genetic model between BI and social anxiety affected the model fit and total
variance explained. These align with the current dissertation’s aims 2.2 and 2.3. Findings will
contribute to a genetically-informed risk factor model for pediatric social anxiety (see chapter 9)
that may eventually inform prevention and intervention efforts.
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Methods
Participants
Participants were part of the Virginia Commonwealth University Juvenile Anxiety Study
(JAS; Carney et al., 2016). See chapter 5 for an overview of this study and its sample. As a
reminder, the final analytical sample included 352 families and 704 children (Mage = 11.22;
standard deviation [SDage] = 1.41; female = 53%; monozygotic [MZ] = 114 pairs; dizygotic [DZ]
= 238 pairs; 88% of full sample).
Measures
This study utilized three measures, a retrospective version of the Behavioral Inhibition
Questionnaire (BIQ) (Bishop, Spence, & McDonald, 2003), the Screen for Child Anxiety
Related Emotional Disorders – Parent and Child Versions (SCARED) (Birmaher et al., 1997),
and the parental bonding instrument (PBI) (Parker, Tupling, & Brown, 1979; Parker, 1990). A
series of preliminary analyses confirmed their validity, reliability, and appropriate usage in the
primary analyses as discussed in chapter 5. As a reminder, the BIQ and PBI are parent reports
and the average of parent and child scores were used for the SCARED in these analyses.
Analyses
Descriptive Statistics and Correlations. Basic descriptive statistics (mean, range) for each
variable were calculated as well as the Pearson correlation among all key variables.
Covariates. Univariate linear regression was used to assess for the need to include sex
(male, female) as a covariate due to its known association with anxiety domains (Hettema et al.,
2005; Rapee, 2004).
Aim 1: Phenotypic Moderation. Per standard moderation analyses (Baron & Kenny,
1986), four linear regressions were tested for each measure of parental bonding
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(overprotectiveness, coldness, authoritarianism): (a) social anxiety regressed onto BI; (b) social
anxiety regressed onto parental bonding; (c) social anxiety regressed onto both BI and parental
bonding; and (d) social anxiety regressed onto the interaction between BI and parental bonding.
If the interaction term in this fourth series of regressions is significant, then there is evidence for
moderation. There can still be main effects but those do not negate the significant moderation
(Baron & Kenny, 1986). Holm’s family-wise error rate was used to correct p-values within each
scale to account for the number of regressions tested.
The treatment of twins as individuals in the current study means that there are dependent
relationships between twins within pairs. This can introduce bias, namely autocorrelation or the
phenomenon where the error terms of cases within a variable are dependent on each other (i.e.,
correlated). This violates ordinary least squares (OLS) estimator assumptions of independence
among the error terms of a variable used in a regression. This can often be allowed with OLS
estimators, as it only affects the standard errors and not the beta estimates. However, in this
study the cause of potential autocorrelation is known a priori and can be anticipated and
corrected. The Durbin-Watson test was used to assess autocorrelation due to the relatedness
between the subjects. If this test was significant for a given regression, then the Cochrane-Orcutt
method was applied to correct for the autocorrelation (R package orcutt; Spada, Quartagno,
Tamburini, & Robinson, 2017). This method iteratively estimates transformed standard errors
until convergence.
Aim 2: Genetic Effects. Biometrical genetic structural equation modeling was used to
decompose the variance in each phenotype into additive genetics (A), familial environment (C),
and unique environment (E) components (Neale & Cardon, 1992). As already stated in chapter 6,
previous analyses examining the relationship between BI and social anxiety revealed that a
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causal model provided the best fit to the data (Bourdon et al., 2019). Specifically, independent A
and E variance components were significant for BI (A = .85; E = .15) and social anxiety (A =
.51; E = .49) as was a single directional beta coefficient from BI to social anxiety (β = .047)
explicating the developmental relationship between them. The current analyses expanded upon
this work by assessing how parental bonding further informs this relationship. This was done in
two ways.
First, parental bonding was regressed out of both BI and social anxiety sum scores across
participants, and then the final direction of causation biometrical model was re-fit. Specifically,
linear regression was used to regress BI and social anxiety separately onto parental bonding. The
residuals from each regression were then calculated and used for the biometrical modeling refitting. This option allowed for the effect of parental bonding on BI and social anxiety to be
taken into account without being explicitly modeled as a covariate.
Second, parental bonding was explicitly added as a variable into the biometrical model as
an additional phenotype. Previous studies have noted various biometrical structures and differing
variance estimates for the PBI scales, but these studies vary in rater (self, parent) and population
(adult male, adult female) (Kendler, 1996; Gillespie et al., 2003; Otowa et al., 2013) and do not
overlap with the current sample or measure (parent report of pre-adolescent children of both
sexes). To ensure that the correct biometrical structure for PB was added into the model in step
2, preliminary univariate biometrical analyses were conducted to assess the basic ACE structure
of the PBI scales (see chapter 5).
In both steps, the amount of social anxiety’s variance accounted for by BI in each model
was calculated to serve as an indicator of best fit in addition to traditional fit indices (minus
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twice the log-likelihood [-2LL] and Akaike Information Criteria [AIC]) (Akaike, 1987; Neale &
Cardon, 1992).
Results
Descriptive Statistics, Correlations, and Covariates
The means and ranges for each variable can be found in Table 7.1 and Figure 7.1 (note
that histograms for BI and social anxiety are in chapter 6, Figure 6.2). The highest correlations
among the variables was between BI and social anxiety (r = .56; p < .001) (see Table 7.2).
Among the parental bonding behaviors, overprotectiveness was the only measure that had any
associations with BI (r = .08; p < .05) and social anxiety (r = .09; p < .05). Thus, all further
analyses were conducted between BI, social anxiety, and overprotectiveness. Sex was
significantly associated with BI (β = 5.791; p < .05) and social anxiety (β = .634; p < .05) and
was included in analyses due to its effect on the outcome variable (social anxiety). It was not
significantly associated with authoritarianism (β = .113, p > .05), coldness (β = -.173; p > .05),
or overprotectiveness (β = -.022; p > .05).
Table 7.1. Descriptive information for variables.
Applicable
Sample Range
Measure
Type
Mean (SD); SE
Median
Age Range
(Min-Max)
Behavioral Inhibition
Parent report
2-6
95.11 (35.30); 1.37
92.00
30 - 199
Mean of parent
Social Anxiety
Current
5.00 (2.75); .11
4.96
0 - 14
& child report
Authoritarianism
Parent report
Current
4.01 (2.18); .08
4.00
0 - 10
Coldness
Parent report
Current
19.47 (2.16); .08
20.00
9 - 21
Overprotectiveness
Parent report
Current
3.46 (2.52); .10
3.00
0 - 14
Notes: Sample range is not the total possible range. Coldness reflects warmth but is worded to be consistent
with the other scales.
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Figure 7.1. Histograms of parental bonding scale variables.

Table 7.2. Correlations between key variables.
Behavioral
Social
Inhibition
Anxiety
Behavioral Inhibition
-Social Anxiety
.56**
-Authoritarianism
.03
.01
Coldness
.07
.06
Overprotectiveness
.08*
.09*
*p <.05; **p<.001

Authoritarianism

Coldness

Protectiveness

-.15**
.30**

--.03

--

Aim 1: Phenotypic Moderation
After correcting for multiple tests, BI (βBI = .044; p < .001) independently and
significantly predicted social anxiety but overprotectiveness did not (βOP = .090; p > .05) (see
Table 7.3). Accordingly, model 3 revealed no effect of overprotectiveness on social anxiety
when combined with BI (βOP = .044; p > .05), whereas the effect of BI remained significant (βBI
= .043; p < .001). Finally, Model 4 confirmed that overprotectiveness does not significantly
interact with BI to predict anxiety (βBI*OP = -.001; p > .05).

147

Table 7.3. Moderation analysis of the influence of behavioral inhibition and
overprotectiveness on social anxiety disorder symptoms.
Estimate (95%
Standard
p-value
Confidence Interval)
Error
(Corrected)
Model 1: Behavioral Inhibition
Behavioral Inhibition
.044 (.039 - .049)
.002
<.001 (<.001)
Sex
.311 (-.037 - .660)
.178
.080 (.452)
Model 2: Protectiveness
Overprotectiveness
.090 (.005 - .175)
.043
.038 (.268)
Sex
.586 (.166 – 1.006)
.214
.006 (.052)
Model 3: Behavioral Inhibition and Overprotectiveness
Behavioral Inhibition
.043 (.039 - .048)
.002
<.001 (<.001)
Overprotectiveness
.044 (-.026 - .115)
.036
.221 (.452)
Sex
.316 (-.032 - .664)
.178
.076 (.452)
Model 4: Behavioral Inhibition * Overprotectiveness
Behavioral Inhibition
.048 (.040 - .056)
.004
<.001 (<.001)
Overprotectiveness
.179 (-.018 - .375)
.100
.075 (.452)
Behavioral Inhibition
-.001 (-.003 - .001)
.001
.152 (.452)
*Overprotectiveness
Sex
.293 (-.056 - .643)
.178
.101 (.452)

Durbin-Watson
Value
DW = 1.992,
p = 0.456
DW = 2.006,
p = .523
DW = 1.992,
p = .454

DW = 1.991,
p = .450

Note: All models violated the Durbin-Watson test for autocorrelation (p < .001) and were corrected.
Models presented in this table have all been corrected for autocorrelation and multiple testing. The
dependent variable in all analyses was social anxiety disorder symptoms.
* indicates moderation
Bolded estimates are significant at p < 0.01

Aim 2: Genetic Effects
Direction of Causation Model with Overprotectiveness Regressed Out. After regressing
the contribution of overprotectiveness to the variation in BI and social anxiety and refitting the
causal BI-to-social anxiety model, the model using this residualized data fit better (AIC =
6216.626) than the original model (AIC = 6480.200) that did not remove the contribution of
overprotectiveness. This modified model accounted for nearly the same amount of social
anxiety’s variance (37% compared to 38%) (see Chapter 6; Bourdon et al., 2019). There was no
significant effect on the genetic or environmental variance components of BI or social anxiety in
the residualized model. See Table 7.4 for the full twin modeling results.
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Direction of Causation with Overprotectiveness Added. Univariate biometrical modeling
for overprotectiveness revealed significant familial (C = .81) and unique (E = .19) environmental
components (see chapter 5). Thus, for the second model tested, overprotectiveness with these
two latent factors were added to the original BI-to-social anxiety direction of causation model.
The final fit of this model included a regression coefficient between BI and overprotectiveness
but not between overprotectiveness and social anxiety. This model fit was worse (AIC =
7810.449) than the original one (AIC = 6480.200). However, it accounted for more of SOC’s
variance (43% compared to 38%). Table 7.4 and Figure 7.2 display the results for this aim.
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Table 7.4. Model fit statistics and final parameter estimates for the direction of causation models between behavioral inhibition,
overprotectiveness, and social anxiety disorder symptoms.
Model

EP

1. Original model

7

2. Modified model

7

-2LL
DF
AIC
Δ LL Δ DF
p
ABI ASOC COP EBI EOP ESOC
Best-fitting direction of causation model between behavioral inhibition and social anxiety
8976.200 1248 6480.200
---- .85
.51
-- .15
-.49
New model with protectiveness regressed out
8628.539 1205 6218.539
---- .80
.49
-- .21
-.51
New model with protectiveness added

BI2SOC

BI2OP

OP2SOC

.047

--

--

.046

--

--

3. Original model +
CE for
overprotectiveness 12 11533.852 1861 7811.852
---- .85
.51 .81 .15 .19
.49
.047
.004
.031
+ BI2PB +
PB2SOC
3a. Drop BI2PB,
10 11539.538 1863 7813.539 5.685
2 .058
.85
.51 .82 .15 .18
.49
.047
--PB2SOC
3b. Drop BI2PB
11 11538.973 1862 7814.973 5.120
1 .024
.85
.51 .82 .15 .18
.49
.047
-.030
3c. Drop PB2SOC *
11 11534.449 1962 7810.449
.560
1 .440
.85
.51 .81 .15 .19
.49
.047
.004
-Notes: A = additive genetics; C = familial environment; E = unique environment; BI = behavioral inhibition; SOC = social anxiety disorder symptoms; OP
= overprotectiveness (parental bonding); BI2SOC = regression path from behavioral inhibition to social anxiety; BI2PB = regression path from behavioral
inhibition to protectiveness; PB2SOC = regression path from protectiveness to social anxiety; EP = estimated parameters; -2LL = negative twice the log
likelihood; DF = degrees of freedom; AIC = Akaike information criteria; p = p-value statistic.

Sex was treated as a covariate (definition variable on the means) in all analyses
* Indicates best-fitting model in that section
Bold indicates best overall fitting model
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Figure 7.2. Top: Modified direction of causation model between BI and social anxiety that takes
overprotectiveness into account (regressed out of both phenotypes - residualized model). Bottom:
Final model that includes overprotectiveness (OP) with BI and social anxiety.
Discussion
This was the first study to examine the effects of parental bonding on the relationship
between BI and social anxiety at both the phenotypic and genetic levels in a large sample of preadolescents. Among the three parental bonding dimensions, only overprotectiveness correlated
with BI and social anxiety. This was not surprising given that overprotection has consistently
correlated more strongly with measures of BI and social anxiety (Bayer et al., 2006; Rubin 2002;
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Rapee, Schniering, & Hudson, 2009). Nevertheless, other studies have found associations
between these phenotypes and authoritarianism (often referred to as “control”) and coldness (Fox
et al., 2005; Lewis-Morrarty et al., 2012; Rapee, 2004; Rapee et al., 2009). Moreover, there was
no statistical evidence that overprotectiveness moderates the causal pathway from BI to social
anxiety although it needed to be taken into account when examining the genetic etiological
pathway from BI to social anxiety.
The first hypothesis that parental bonding would moderate the effect of BI on social
anxiety was not supported. While two past studies have found a moderating effect of parenting
on the relationship between these two phenotypes, these studies did not use the same
standardized measure (the PBI; Parker et al., 1979) and thus had different conceptualizations of
bonding (Lewis-Morrartay et al., 2012; Rubin et al., 2002), which could account for the
discrepant findings. Also, these studies relied on much smaller sample sizes (Lewis-Morrartay et
al., 2012; Rubin et al., 2002). Nevertheless, some interesting trends should be noted related to
this first hypothesis. Of the three parental bonding dimensions, only overprotectiveness had
small phenotypic correlations with BI and social anxiety. Yet, the effect of overprotectiveness on
social anxiety was non-significant when analyzed independently and also when jointly analyzed
with BI and controlling for sex. BI consistently exerted significant, direct effects on social
anxiety. Contrary to previous non-genetically informed studies based on smaller samples, the
findings here imply that the influence of parental bonding is of far less importance than inhibited
temperament in the development of social anxiety. These phenotypic findings provide clarity to
the small literature on this topic.
The second exploratory aim sought to examine the genetic effects of parental bonding in
the relationship between BI and social anxiety. This was done in two different ways. The first
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way regressed overprotectiveness out of the two key phenotypes and re-fit the models from
chapter 6. This residualized model was a better fit to the data than the model that did not take
overprotectiveness into account, but the genetic and environmental variance estimates were
almost identical and BI accounted for about the same amount of social anxiety’s variance. The
second model added overprotectiveness as a third variable in the model and was not a better fit to
the data. Overall, these findings indicate that the evidence of a causal relationship from BI to
social anxiety was not confounded by parental bonding, although taking it into consideration
when examining this relationship may be best. The weak phenotypic correlations between
overprotectiveness and the other two traits is of little consequence when examining the
development of BI to social anxiety from a research or clinical perspective. There is not much of
an impact of taking overprotectiveness into consideration at the genetic level.
Comparison to Past Association Studies
The current findings provide evidence that the causal relationship from BI to social
anxiety was not confounded by parental bonding in addition to finding little correlation among
the three phenotypes. This is antithesis to the previously noted strong links between parental
bonding and BI (Bayer et al., 2006; Chorpita et al., 1998; Coplan & Armer, 2007; Hastings et al.,
2008; Rapee, 2004), social anxiety (Arrindell et al., 1983; Greco & Morris, 2002), and the
development between the two (Degnan et al., 2010; Fox et al., 2005; Lewis-Morrarty et al.,
2012; Rubin et al., 2002; Williams et al., 2009). These disparate finding can likely be somewhat
explained by differences in sample age, instruments used, and classification of the sample (i.e.,
high/low BI). First, in regard to age, most studies that previously found an association between
parental bonding and either BI, social anxiety, or both assessed young children that were younger
than the current sample (infancy through age 8 across the studies) (Bayer et al., 2006; Greco &
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Morris, 2002; Hastings et al., 2008; Rubin et al., 2002). While BI was retroactively assessed for
children aged 2-6 in the current sample, anxiety and parental bonding were assessed concurrently
with the children’s current ages of 8-13 years. This developmental shift from young childhood to
pre-adolescence might bring with it a decrease in the importance of parental bonding in the
development of social anxiety.
Second, there was much variation in how parental bonding and BI were assessed across
past studies. Only one study also used the PBI (Greco & Morris, 2002). The other studies had
some overlapping parental bonding constructs with the current study (i.e., overprotection,
coldness), but they were typically measured via behavioral observation instead of a paper-based
assessment (Bayer et al., 2006; Hastings et al., 2008; Lewis-Morrarty et al., 2012; Rubin et al.,
2002; Williams et al., 2009). BI was not assessed the same way in any of the past studies as with
the current one. Three studies conceptualized of BI in the same way but they used the behavioral
observation method to assess it (Lewis-Morrarty et al., 2012; Rubin et al., 2002; Williams et al.,
2009). The other studies measured temperamental inhibition, social wariness, or similar
behaviors via behavioral observation (Bayer et al., 2006; Hastings et al., 2008). Some studies
also did not use anxiety as an outcome measure but broader internalizing problems or social
reticence (Hastings et al., 2008; Rubin et al., 2002; Williams et al., 2009). Finally, a couple of
the studies separated children into categories based on their inhibition or anxiety scores (Greco &
Morris, 2002; Rubin et al., 2002) which the current study did not do due to the desire to assess
dimension constructs of mental health concerns and the fact that the JAS draws from a
community sample, not a case-control sample.
Comparison to Past Prevention/Intervention Studies

154

A few of these inconsistencies in study design and analysis are also present in studies
assessing prevention/intervention efforts for anxiety. The current findings imply that if BI
symptoms are present, prevention/intervention efforts should focus on BI rather than parental
bonding in this pre-adolescent age group. Some programs have successfully reduced
internalizing symptoms by targeting childhood BI or related behaviors (Chronis-Tuscano et al.,
2015; Hirshfeld-Becker et al., 2010) as well as both BI and parental bonding simultaneously
(Bayer et al., 2010; Kennedy et al., 2009; Rapee et al., 2010; Rapee, 2013). One of the studies
targeting only BI also found an effect of parental warmth (the opposite of coldness) in the
reduction of childhood anxiety among children with high BI, but they found no effect of negative
control (authoritarianism) and did not assess overprotection (Chronis-Tuscano et al., 2015). This
study did not specifically target parental bonding but simply assessed its role in the relationship
between BI and anxiety in children. Thus, the level of success of the prevention can still be
attributed to targeting BI.
The studies that targeted both BI and parental bonding were from the same series of
randomized control trials (Kennedy et al., 2009; Rapee et al., 2010; Rapee, 2013) or were a
review (Bayer et al., 2010). Here, overprotection was part of the prevention program for anxiety.
Children with high BI were selected into the trials during young childhood and in addition to
educating parents on the development from BI to anxiety, parents were taught about
overprotectiveness and ways to reduce it. Parents’ levels of overprotectiveness were not assessed
before or after the trials, though, so it is impossible to say which educational component of the
prevention program made it effective. It is possible that overprotectiveness education had little
effect and the main effects came from educating parents about the development of anxiety as a
whole.
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Limitations
A key limitation compared to some studies is the retrospective parental report of BI
instead of a longitudinal behavioral observation. Using a retrospective report of BI could limit
the reliability and validity of the measured trait due to recall biases such as parents of highanxiety pre-adolescents reporting higher levels of early BI (McPhail & Haines, 2010). However,
the BI measure used in this study has been used in neurophysiological, genetically-informed, and
prevention studies (Bourdon et al., 2019; Clauss et al., 2016; Edwards, Rapee, & Kennedy, 2010;
Fu et al., 2015; Kennedy et al., 2009). However, there is little evidence that such potential bias in
retrospective reports outweighs their utility (Hardt & Rutter, 2004). The current study also did
not explicitly test genetic correlations or model reciprocal relationships in the exploratory aim.
Future studies should consider explicitly assessing gene-environment interplay once those
methods are more robust (e.g., passive gene-environment correlation). As discussed, there are
also multiple discrepancies across reports in terms of sample ages, measurements, and varying
thresholds of classification (e.g., high vs low BI) that might explain the lack of findings noted in
past studies. Finally, this study did not re-fit all of the models run in chapter 6 with
overprotectiveness regressed out. There is little reason to believe that it would significantly
changing findings from those analyses given the improved but still similar fit estimates.
Conclusions
The current findings significantly expand past research on the development from BI to
social anxiety by examining the influence of parental bonding and serve as the second part to aim
2 of this dissertation (see chapter 6 for part 1 of aim 2). At the phenotypic level,
overprotectiveness was weakly correlated with these two variables and does not appear to
moderate the relationship between them. At the genetic level, accounting for the minor
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contribution of overprotectiveness in the causal model between BI and social anxiety
significantly improved fit to these data, but the parameter estimates and variance accounted for
in the model did not change. It is possible that such findings could influence translational
prevention/intervention efforts aimed at pre-adolescent social anxiety.
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Chapter 8: A Neurologically-Informed Insight into The Relationship Between Behavioral
Inhibition and Social Anxiety
Introduction
Thoroughly understanding the relationship between behavioral inhibition (BI) and social
anxiety is key to prevention and intervention efforts, as 43% of children with BI later develop
social anxiety (Clauss & Blackford, 2012; Clauss, Avery, & Blackford, 2015). While associated
factors surrounding the relationship at the phenotypic level have been well documented (i.e.,
developmental trajectories, risk predictions; Clauss & Blackford, 2012; Chronis-Tuscano et al.,
2009; Hirshfeld-Becker et al., 2007; Hirshfeld-Becker et al., 2008; Essex, Klein, Slattery,
Goldsmith, & Kalin, 2010; Kagan, Reznick, & Snidman, 1988; Muris, van Braken, Arntz, &
Schouten, 2011; Schwartz, Snidman, & Kagan, 1999), the specific mechanisms involved are not
thoroughly understood. Additional inquiry ought to include biological domains, namely genetic
and neurophysiological factors that play a role in this relationship. Results from chapter 6
indicated the importance of shared genetic and environmental variance between BI and social
anxiety as well as a causal path from BI to social anxiety (aim 2.1). These results encourage the
study of the biological measures that may intervene between BI and social anxiety, such as brain
function.
Inquiries into the neurophysiological level of this relationship remain unexplored.
Amygdala activation has long been thought to play a role in the development from BI to social
anxiety (Kagan & Snidman, 1991; Fox et al., 2005). Specifically, the amygdala has been
implicated in animal studies for behaviors related to BI in humans (Kagan & Snidman, 1991).
One circuit involving the amygdala relates to motor response in animals that are often seen in
infants and toddlers with BI (e.g., tense muscles). The second circuit involving the amygdala has
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been shown to be activated in animals who are in distress (e.g., crying), which also relates to
infant and toddler BI. Thus, amygdala sensitivity (i.e., an overactive amygdala) among those
with BI has long been an assumption in the field, as stated by Kagan himself, for these reasons as
well as the brain area’s association with fear (Kagan & Snidman, 1991; Fox et al., 2005). This
amygdala sensitivity sets the stage for an enhanced fear response to people, places, and objects
that are novel (Fox et al., 2005). Emotion reactivity is a key way to tap amygdala activation and
is itself a logical place to begin investigating the relationship between BI and social anxiety from
a neurophysiological perspective.
Neurophysiology of Social Anxiety and Behavioral Inhibition
Emotion Reactivity. Emotion reactivity is the human response to highly stimulating
emotions, namely fear and threat (Hariri et al., 2002). This reactivity likely stems from
evolutionary necessity and has been shown in response to emotionally-charged faces and
threatening or fearful scenes such as snakes and explosions (Hariri et al., 2002). A validated
method of assessing emotion reactivity is to directly activate the amygdala using face-specific
emotional responses (i.e., the emotional face activation task [EFAT]; Hariri et al., 2002; Phan et
al., 2008; Swartz et al., 2014).
Social Anxiety. Heightened emotion reactivity, as assessed via amygdala activation, has
long been implicated in anxiety broadly (Ressler & Mayberg, 2007) and is robustly associated
with social anxiety in adults (Birbaumer et al., 1998; Cooney et al., 2006; Evans et al., 2008;
Phan, Fitzgerald, Nathan, & Tancer, 2005; Stein et al., 2002; Stein et al., 2007). The association
between social anxiety and emotion reactivity via amygdala activation has been shown across
tasks, whether engaging participants’ attention directly in the task (i.e., asking for a response
during imaging data collection; Cooney et al., 2006; Phan et al., 2005; Stein et al., 2002; 2007;
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Swartz et al., 2014) or passively (i.e., passive view of images during task; Birbaumer et al., 1998;
Evans et al., 2008; Killgore & Yurgelun-Todd, 2005). Most evidence of the robust relationship
between emotional reactivity and social anxiety has been found in adult samples (Birbaumer et
al., 1998; Cooney et al., 2006; Evans et al., 2008; Phan et al., 2005; Stein et al., 2002; Stein et al.,
2007), although two studies have examined this in adolescents to mixed effects (Killgore &
Yurgelun-Todd, 2005; Swartz et al., 2014). While there is a lack of evidence associating emotion
reactivity and anxiety overall (Swartz et al., 2014), an association has been found between
heightened amygdala activation in response to the passive viewing of threatening faces and
social dimensions of anxiety (Killgore & Yurgelun-Todd, 2005). To date, evidence of this effect
is lacking for younger samples, raising the question of when this neurophysiological response to
emotions among those with social anxiety develops. The current study will seek to replicate past
findings (Killgore & Yurgelun-Todd, 2005) of an association between increasing social anxiety
symptoms and emotion reactivity in pre-adolescents using a direct measure of the amygdala, the
EFAT.
Behavioral Inhibition. Comparatively, associations between BI and emotion reactivity
have been mixed and are possibly task-dependent rather than due to consistent neurological
patterns across individuals with BI. Only a handful of studies examining the neurophysiological
correlates of BI have assessed amygdala activation. Methods have been split across studies
between passive viewing of faces (Schwartz et al., 2003), attentional tasks focused on threat (Fu,
Taber-Thomas, & Perez-Edgar, 2017; Jarcho et al., 2014; Perez-Edgar et al., 2007), and
anticipation tasks (Clauss et al., 2016) to assess amygdala activation. Only some of these studies
(Clauss et al., 2016; Perez-Edgar et al., 2007; Schwartz et al., 2003) probed the amygdala via
emotional reactivity and are thus the most relevant to the current study’s second aim of
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examining the correlation between levels of BI and emotion reactivity using a direct amygdala
activation task (the EFAT).
Specifically, heightened amygdala activation in individuals with a history of BI and those
with currently high levels of the trait across development have been found (Perez-Edgar et al.,
2007; Schwartz et al., 2003). In adults previously diagnosed as having high BI in toddlerhood,
such activation was evident when passively viewing novel versus familiar faces (Schwartz et al.,
2003). When attending to internal levels of threat while viewing faces, it has been noted that
adolescents previously identified as having high BI had heightened amygdala activation
regardless of the emotion of the face (Perez-Edgar, 2007). Finally, a similar trend was recently
noted for children with currently high levels of BI who were anticipating faces regardless of
emotion (Clauss et al, 2016).
It must be noted, however, that neurophysiological studies designed to elicit attentional
bias toward threat and not emotion reactivity have not found heightened amygdala response in
those with BI or a history of BI. Specifically, a dot probe task (Fu et al., 2017; Morales, TaberThomas, & Perez-Edgar, 2017) in adolescents and a unique attentional task in adults (Jarcho et
al., 2014) did not elicit amygdala activation, although other areas of the brain were engaged
during these tasks. Thus, paradigms that assess emotion reactivity and the amygdala directly, as
opposed to attentional tasks, may be key to understanding the role of neurological mechanisms
of BI and its relationship with social anxiety. The use of differing methods when examining BI
and amygdala activation in prior studies likely contributes to the variability of findings.
Social Anxiety and Behavioral Inhibition. Of studies that have found significantly
heightened amygdala activation in those with elevated BI (Clauss et al., 2016; Perez-Edgar et al.,
2007; Schwartz et al., 2003), findings were not emotion-specific. Coupled with the fact that a
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key component of BI is novelty more so than threat (Fox et al., 2005), there is reason to believe
that amygdala activation in those with BI would be more global to faces as a whole, as well as
possibly be more pronounced during the beginning of an imaging task (similar to findings from
individuals with social anxiety). Additionally, it has been established that emotion reactivity
among those with social anxiety is emotion-specific to threat, fear, or other negative valence
stimuli. Therefore, it follows that there are two possible mechanisms through which amygdala
activation developmentally changes in the progression of BI to social anxiety: (a) individuals
with a history of BI eventually become more selective toward threatening faces, or (b)
individuals with social anxiety who have a history of BI generally show broader emotional
responses but extant studies have not differentiated such individuals from those without a history
of BI. Accordingly, it is possible that emotion reactivity moderates the relationship between BI
and social anxiety. Due to the fact that both BI and social anxiety have been associated with
emotion reactivity, a mediation model is not being tested. This model would assume a causal
path from BI to emotion reactivity to social anxiety, which does not appear to be the case.
Instead, a moderation effect is most likely whereby the effect of BI on social anxiety changes
depending on the level of emotion reactivity.
Study Hypotheses
No study to date has used emotion reactivity as a way to examine the neurophysiological
relationship between childhood BI and later social anxiety, although many studies have
investigated reactivity in each construct separately. The purpose of the current study (aim 3 of
this dissertation) is to assess the neurophysiological mechanisms between childhood BI and preadolescent social anxiety with the following hypotheses. First, heightened emotion reactivity to
threatening faces will be correlated with increased symptoms of social anxiety in pre-
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adolescents, a replication of past findings. Second, heightened emotion reactivity to any face
(regardless of emotion) will be positively associated with early childhood symptoms of BI.
Third, emotion reactivity to threatening faces will moderate the relationship between BI and
social anxiety such that higher levels of reactivity to threatening faces will lead to a stronger
relationship. These align with the dissertation aims 3.1, 3.2, and 3.3, respectively, and will
inform the overall risk factor model for social anxiety disorder (see chapter 9).
Methods
Participants
Participants were part of the Virginia Commonwealth University Juvenile Anxiety Study
(JAS; Carney et al., 2016). See chapter 5 for an overview of this study and its sample. A subset
of participants from the JAS were invited back to be part of a pilot study investigating the
relationship between negative valence systems (NVS) and internalizing disorders at the
neurophysiological level using functional magnetic resonance imaging (fMRI). This subset of
participants comprises the current study (N = 41; Mage = 11; female = 59%). Note that
participants in this study are part of twin pairs but were treated as individuals for these analyses
due to the small number of pairs (monozygotic = 11 twins; dizygotic = 29 twins; singleton = 1
individual).
Behavioral Measures
Two behavioral measures were used in the current study: The Screen for Child Anxiety
Related Disorders – Parent and Child Versions (SCARED; Birmaher et al., 1997) and a
retrospective version of the Behavioral Inhibition Questionnaire (BIQ; Bishop, Spence, &
McDonald, 2003). The SCARED subscale of interest was the social anxiety scale. See chapter 5
for more details about both of these measures.

163

Differences Between Samples
There were no statistically significant demographic or behavioral differences between the
full JAS sample and the fMRI-specific sample recruited for the current study. Differences in age
(t = 1.717; df = 42.977; p = .093), sex (t = -.807; df = 43.716; p = .424), SCARED social anxiety
subscale score (t = .953; df = 42.445; p = .346), and BIQ score (t = .831; df = 45.428; p = .410)
were assessed using independent sample t-tests. While the participants included in the current
sample were also part of the larger JAS study, the samples were treated as independent due to
their size and the fact that measures were not assessed at different time points. The purpose was
to see if restricting the sample to 41 participants biased the behavioral measures, which it does
not appear to have done.
Neuroimaging Acquisition
All fMRI data was collected at the VCU Collaborative Advanced Research Imaging
facility using a 3.0T Philips Ingenia magnetic resonance image scanner with a 32-channel head
coil. Imaging protocol included Series 5 Face Match with the following parameter settings: flip
angle = 68 degrees; FOV = 25.6cm; slices = 38; slice thickness = 3mm; 256x256 matrix;
repetition time = 8.1ms; echo time = 3.7ms. Data underwent standard preprocessing which
included illuminating related voxels at voxelwise p < .001 false discovery rate (FDR) threshold
and then a p < .05 FDR threshold across all images. The regions of interest were voxels covering
the right and left amygdala.
Neuroimaging Measures
fMRI data was collected while participants completed the Emotional Face Assessment
Task (EFAT) (Hariri et al., 2002). The EFAT was programmed and presented to participants
using E-Prime Version 2.0. The EFAT uses faces from a standardized sample (Gur et al., 2002)
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and has been well-validated across multiple studies as a way to directly assess amygdala
activation via emotion reactivity (Hariri et al., 2002; Swartz et al., 2014; Phan et al., 2008). The
EFAT consisted of six 20 second trials within each block. Each full block was repeated three
times each over two runs. During each trial, participants were shown either four series of faces or
shapes. These objects were presented in a triangular manner. One object was in the top row and
two were in the second row (see Figure 8.1).

Figure 8.1. Example of two trials in the EFAT.
Participants were instructed to match the object at the top to one of the objects on the
bottom. For face conditions, participants were instructed to match based on the emotion of the
face in the top row. Matching faces were one of four emotions: angry, fearful, sad, or happy. The
non-matching face was always neutral. The identity of each face was never the same within a
trial. Shape trials were the same as face trials except participants matched based on shape, which
was either a circle, square, or triangle. Emotion and shape trials were counter-balanced across
participants and data was collapsed across runs. The accuracy and reaction time of each response
was recorded with a button box. The variables of interest to this study included blood oxygen
level dependent (BOLD) signals in the right or left amygdala to: (a) faces overall, (b) fear, and
(c) threat (see Table 8.1). These BOLD signals measure blood flow to active areas of the brain,
changing the ratio of oxygenated to deoxygenated blood that can be detected using magnetic
imaging.

165

Table 8.1. Overview of neuroimaging variables.
Variable
Subtraction
Left Hemisphere
Faces overall
Faces – Shapes
Fear
Fear – Happy
Threat
(Fear + Anger) – Happy
Right Hemisphere
Faces overall
Faces – Shapes
Fear
Fear – Happy
Threat
(Fear + Anger) – Happy

Amygdala Activation Representation
Overall emotion reactivity
Emotion reactivity specific to fear
Emotion reactivity specific to threat
Overall emotion reactivity
Emotion reactivity specific to fear
Emotion reactivity specific to threat

Statistical Analyses
Differences Across Time. After both neuroimaging runs were combined, significant
differences and equal variance were assessed between the 1st third, 2nd third, and 3rd third of
responses for each imaging variable (left/right faces overall, fear, threat) using an independent
samples t-test. This was done to assess potential sensitization to the task whereby the signal
would become weaker over time. If no differences were detected within a variable, then the data
across time could be combined in further analyses.
Basic Descriptives and Normality. The mean, standard deviation, and range were noted
for all variables of interest (BOLD left/right faces overall, fear, and threat; social anxiety; BI).
Subsequently, variables were assessed for normality using the Shapiro-Wilks test of normality.
Any variables with a non-normal distribution were log-transformed due to the small sample size
of this study. (Note that variables were not log-transformed for other dissertation aims that used
the same data because those sample sizes were larger, eliminating the need to transform because
the tests are more robust against skew in larger samples) (Field, Miles, & Field, 2012).
Covariates. Age and sex were tested as potential covariates of all key variables using
multiple linear regressions. Significant covariates were incorporated into later analyses as
appropriate.
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Main Analyses. It must be noted that the current study took a dimensional approach to
psychopathology, treating symptoms continuously instead of categorizing pre-adolescents as
having high vs. low BI and social anxiety vs. no anxiety. This is atypical of imaging studies and
thus, analytic approaches not usually found in such projects were used. To replicate past findings
that heightened emotion reactivity to threatening faces is correlated with increased symptoms of
social anxiety, Pearson correlation coefficient was estimated between the BOLD threat response
and the SCARED social anxiety sum score. Similarly, a Spearman correlation coefficient was
used to determine the degree to which heightened BOLD emotion reactivity to any face, using
the overall faces variable, was associated with symptoms of BI. Finally, a moderation
relationship was tested via three general linear regression models: social anxiety regressed onto
BI, social anxiety regressed onto overall face activation, and social anxiety regressed onto BI,
overall face activation, and the interaction of the two (Baron & Kenny, 1986).
Autocorrelation. The treatment of twins as individuals in the current study means that
there are dependent relationships between twins within pairs. This can introduce bias, namely
autocorrelation or the phenomenon where the error terms of cases within a variable are
dependent on each other (i.e., correlated). This violates ordinary least squares (OLS) estimator
assumptions of independence among the error terms of a variable used in a regression. This can
often be allowed with OLS estimators, as it only affects the standard errors and not the beta
estimates. However, in this study the cause of potential autocorrelation is known a priori and can
be anticipated and corrected. The Durbin-Watson test was used to test for autocorrelations in all
regression models and corrected with the Cochrane-Orcutt method (R package orcutt; Spada,
Quartagno, Tamburini, & Robinson, 2017). This method iteratively estimates transformed
standard errors until convergence.
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Results
All statistical analyses were performed in the R software package (version 1.0.136; R
Development Core Team, 2015). Pre-processing of fMRI data was done using analysis of
functional neuroimages (AFNI; https://afni.nimh.nih.gov/) and Freesurfer.
Descriptive Statistics
Differences Across Time. Testing for significant differences across each “third” of BOLD
signals both within and across hemispheres revealed few significant differences (see Table 8.2).
Holm’s Family-Wise Error Rate (FWER) method was used to correct for the fact that three tests
were run per variable. For faces overall, there were no significant differences across time in
either hemisphere, and data from all three time points was used in subsequent analyses. The
same was true for threat and fear in the left hemisphere but not the right hemisphere. For the
right activation from these latter two variables, significant differences were evident, and only the
first and second time points were collapsed and used in subsequent analyses.
Table 8.2. Results of testing for significant differences across time points within hemispheres.
Variable
Faces
overall

Fear

Threat

Left Amygdala
1st vs. 2nd
t = .793
df = 79.854
p = .430
p-c = 1.000
t = .514
df = 2.000
p = .880
p-c = 1.000
t = -.186
df = 79.659
p = .853
p-c = .853

2nd vs. 3rd
t = -.119
df = 78.858
p = .906
p-c = 1.000
t = .689
df = 79.564
p = .493
p-c = 1.000
t = 1.131
df = 79.999
p = .262
p-c = .785

Right Amygdala
3rd vs. 1st
t = .621
df = 77.949
p = .536
p-c = 1.000
t = .888
df = 79.889
p = .377
p-c = 1.000
t = .981
df = 79.632
p = .330
p-c = .785

1st vs. 2nd
t = .297
df = 77.764
p = .767
p-c = 1.000
t = -.608
df = 78.577
p = .545
p-c = .545
t = -.727
df = 79.558
p = .469
p-c = .469

2nd vs. 3rd
t = .537
df = 79.914
p = .593
p-c = 1.000
t = 2.928
df = 79.834
p = .004
p-c = .013
t = 3.086
df = 78.913
p = .003
p-c = .008

Notes: p-c indicates corrected p-value using Holm’s FWER method. Bold indicates significance.
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3rd vs. 1st
t = .870
df = 76.8
p = .387
p-c = 1.000
t = 2.517
df = 77.514
p = .014
p-c = .028
t = 2.505
df = 77.206
p = .015
p-c = .003

Basic Descriptives and Normality. The mean, standard deviation, standard error, and
range for all of the main variables (neuroimaging and behavioral) can be found in Table 8.3.
Table 8.3. Descriptive information for behavioral and neuroimaging variables.
Applicable
Measure
Type
Mean (SD); SE
Age Range
Behavioral Inhibition
Behavioral
2-6
90.54 (34.16); 5.34
Social Anxiety
Behavioral
9-13
4.51 (3.21); .51
Faces Overall – Left
Neuroimaging
Current
.13 (.10); .02
Faces Overall – Right Neuroimaging
Current
.17 (.12); .02
Fear – Left
Neuroimaging
Current
.02 (.23); .04
Fear – Right
Neuroimaging
Current
.04 (.22); .03
Threat – Left
Neuroimaging
Current
.02 (.19); .03
Threat – Right
Neuroimaging
Current
.02 (.19); .03

Range (MinMax)
30 - 186
0 - 13.5
-.44 - .41
-.11 - .39
-.40 - .50
-.40 - .69
-.44 - .41
-.33 - .55

Median
88.00
4.00
.14
.17
.10
.02
.07
.00

A significant Shapiro-Wilks test of normality indicates significant difference from a normal
distribution and hence non-normality. Only BI scores were not normally distributed (W = .934; p
< .05; see Table 8.4). To account for this, a Spearman test was used with correlations involving
BI, and the data was log-transformed for use in regression analyses only (not correlations).
Specifically, Spearman correlation coefficient is appropriate for skewed distributions, however,
OLS is sensitive to non-normality.
Table 8.4. Shapiro-Wilks test for normality.
Measure
Behavioral Inhibition
Behavioral Inhibition – log transformed
Social Anxiety
Faces Overall – Left Amygdala
Faces Overall – Right Amygdala
Fear – Left Amygdala
Fear – Right Amygdala
Threat – Left Amygdala
Threat – Right Amygdala

W

p

.934
.957
.953
.991
.984
.954
.972
.959
.981

.019
.126
.100
.982
.806
.096
.402
.144
.708

Note: Bold indicates significance.

Finally, BI and social anxiety were highly correlated (r = .58; p < .001), which aligns with past
literature.
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Covariates. Age and sex were tested as potential covariates on all main variables (see
Table 8.5). Neither was found to have a significant effect on the key variables of interest. BI was
sensitive to autocorrelation in this regression (DW = 1.512, p < .05) which was corrected using
the Cochrane-Orcutt method. Only corrected regressions are presented in the table below.
Table 8.5. Effect of covariates on main outcome variables.
Variable

β

Age
Sex

-.375
1.231

Age
Sex

.046
.117

Age
Sex

.004
.051

Age
Sex

.006
.033

Age
Sex

-.025
.076

Age
Sex

-.019
.012

Age
Sex

-.024
.039

Age
Sex

-.010
-.017

Standard Error

p

Social Anxiety
.337
.273
1.035
.242
Behavioral Inhibition
.047
.339
.129
.369
Faces Overall – Left
.011
.709
.033
.139
Faces Overall – Right
.013
.658
.040
.415
Fear – Left
.023
.291
.072
.299
Fear – Right
.024
.438
.075
.871
Threat – Left
.020
.240
.061
.533
Threat – Right
.021
.620
.063
.787

DurbinWatson
Score

p

1.852

.267

1.958

.417

1.962

.394

2.001

.442

1.067

.526

1.979

.414

2.393

.867

2.181

.666

Main Results – Behavior and Neurophysiology
Overall, results did not clarify the mixed extant literature as originally hoped (see Table
8.6). Hypothesis 1 sought to replicate past findings that heightened emotion reactivity to
threatening faces as measured by BOLD signal in the amygdala is correlated with increasing
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symptoms of social anxiety. There were no significant correlations between these variables for
either hemisphere. Subsequently, hypothesis 2 was designed to test the degree to which
heightened emotion reactivity to any face is associated with symptoms of BI. In the right
hemisphere, there was a significant association between BI and fear (r = -.33, p < .05), but this
went away after correcting for multiple tests.
Table 8.6. Correlations between social anxiety, BI and neuroimaging variables.
Behavioral
Measure
Social
Anxiety
Behavioral
Inhibition

Neuroimaging
Variable
Faces overall
Fear
Threat
Faces overall
Fear
Threat

Left Amygdala
r
-.11
-.05
-.05
-.04
-.29
-.22

p
.4869
.7623
.7730
.7864
.0629
.1616

Right Amygdala
p-c
1.00
1.00
1.00
.7864
.1887
.3232

r
-.03
-.02
.00
.07
-.33
-.29

p
.8741
.9129
.9780
.6500
.0324
.0672

p-c
1.00
1.00
1.00
.6500
.0972
.1344

Notes: p-c indicates corrected p-value using Holm’s FWER method. Bold indicates significance.

Even though hypothesis 3 should not have progressed based on results from aims 1 and 2,
analyses were conducted for completeness (see Table 8.7). First, univariate linear regression
analyses unsurprisingly revealed that BI significantly predicts social anxiety but that overall
emotion reactivity in either hemisphere does not. The moderated regression analysis was not
significant, with level of emotion reactivity not influencing the degree to which BI impacts social
anxiety. Both of the multivariate regressions were corrected for autocorrelation (initial DW for
left hemisphere = 1.352, p = .015; initial DW for right hemisphere = 1.350, p = .016).
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Table 8.7. Results of moderated regression analyses.
Variable
BI
Faces Overall – Left
Faces Overall – Right
BI
Faces overall
BI x Faces overall
BI
Faces overall
BI x Faces overall

β

SE

p

p-c

Univariate Regressions
6.105
1.020
<.001 <.001
-3.537
5.037
.487
.974
-.699
4.380
.874
.974
Multivariate Regression – Left Hemisphere
7.311
1.544
<.001 <.001
32.467
31.574
.311
1.00
-8.068
7.435
.285
1.00
Multivariate Regression – Right Hemisphere
7.139
1.598
<.001 <.001
21.983
27.610
.432
1.00
-5.072
6.233
.421
1.00

DW
Score

p

1.867
1.740
1.761

.342
.199
.223

1.903

.419

1.874

.399

Notes: BI is log transformed in all analyses. The multivariate regressions have been corrected for autocorrelation
using the Cochrane-Orcutt method. SE indicates standard error; DW indicates Durbin-Watson test score. p-c
indicates corrected p-value using Holm’s FWER method. Bold indicates significance

Discussion
Insight into the relationship between BI and social anxiety from a neurologicallyinformed perspective is weak, with no studies to date utilizing a sample which has included
measures on both phenotypes. The current study sought to replicate past findings showing the
effect of emotion reactivity on BI and social anxiety in a sample of pre-adolescents as well as
assess whether emotion reactivity moderates the relationship between BI and social anxiety.
Unfortunately, all findings were non-significant. The robust effects previously seen between
emotion reactivity and social anxiety at the adolescent and adult levels (Birbaumer et al., 1998;
Cooney et al., 2006; Evans et al., 2008; Killgore & Yurgelen-Todd, 2005; Phan et al., 2005;
Stein et al., 2002; Stein et al., 2007) were not replicated in this pre-adolescent sample. Likewise,
no correlation was found between emotion reactivity and BI, which had been demonstrated in the
past (Clauss et al., 2016; Perez-Edgar et al., 2007; Schwartz et al., 2003). These initial null
results limit statistical ability to further examine the relationship between BI and social anxiety at
the neurophysiological level.
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Difference with Past Association Studies
It must be stressed that this does not indicate that a relationship does not exist at this
biological level, but that a different study design is necessary to examine it. There are many
factors to consider. First, while the current sample size is quite large for an fMRI study and there
was power to detect significant main and moderation effects, the sample is from a community
sample of pre-adolescents. They were not selected via a case-control design, which is what most
fMRI studies do. Thus, an even larger sample size may be needed to reduce the signal-to-noise
ratio when using a community sample and dimensional constructs of mental health concerns.
This concern is further exacerbated by the selection bias that went into asking families to come
back for the fMRI part of the JAS. Children with mild temperaments who could sit still (among
other requirements - see Methods section) may have been less likely to display a high number of
BI and social anxiety-related physiology (even if they display behavioral symptoms). Second,
past studies that found associations between BI and/or social anxiety and emotion reactivity were
in childhood (Clauss et al., 2016), adolescent (Killgore & Yurgelun-Todd, 2005; Perez-Edgar,
2007; Schwartz et al., 2003) or adult samples (Birbaumer et al., 1998; Cooney et al., 2006; Evans
et al., 2008; Phan et al., 2005; Stein et al., 2002; Stein et al., 2007). It is possible that
developmentally, the neurophysiological trends associated with pre-adolescence may be
different. However, confounding this developmental consideration is again the fact that the
current sample is not case-control. Third, as stated earlier (see Introduction section), it is possible
that the association between BI and emotion reactivity is task dependent. While studies that have
found associations have used emotion reactivity in their tasks, no study has used the EFAT.
Future Directions
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Thus, in seeking to clarify the literature, the current study only raises more questions.
First, it is still unclear when the emotional reactivity response in those with social anxiety
becomes robust. One study has shown it in adolescents (Killgore & Yurgen-Todd, 2005). The
current study’s goal of expanding this work in a slightly younger sample highlights the need for
more neurophysiological studies across development. Second, findings emphasize the
differences in effects found in case-control versus community samples. While understanding
etiology and developmental relationships at the pre-disorder level is critical, this may not be
possible at the neurophysiological level without extremely large sample sizes. Finally, additional
results revealed a direct relationship between BI and social anxiety, which is supported by
multiple past studies. Findings also revealed a lack of influence of age or sex as covariates, the
latter of which is a bit surprising. Sex differences have not been widely noted for BI and have
been consistently noted for social anxiety in adolescents (Rapee, 2004) but not adults (Hettema
et al., 2005). It is possible that the age of the sample diminished sex differences that will become
apparent later.
Limitations and Strengths
The current study is not without need for improvement. First, examining
neurophysiological differences in a non-clinical, community sample likely affected our ability to
detect significant effects. Even though phenotypes present clinically on continuums and not
“yes/no” or “high/low” categories, such categorization may be necessary to examine these
research questions in the future. Second, the retrospective nature of assessing BI may be subject
to recall bias. Third, it would be best to examine the neurophysiological relationship between BI
and social anxiety developmentally over time, allowing for differences between those who
exhibit social anxiety symptoms and those who have no symptoms (but who all have a history of
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BI) to be better assessed. Finally, the sample included only Caucasian participants due to
limitations in other aspects of the larger JAS (see Carney et al., 2016 for a full explanation).
Nevertheless, this study is novel and with design changes, this critical research question
could be more fully investigated. The use of emotion reactivity to gauge BI and social anxiety in
a sample of pre-adolescents has not previously been done. Even though few insights occurred,
understanding this relationship is key to better prevention and intervention efforts in a
translational manner. For example, understanding the nature of the relationship between BI and
social anxiety at the endophenotypic level, and the role that neurophysiology plays, can inform
identification of risk in children and pre-adolescents. This information can also guide researchers
and clinicians when expanding risk models for social anxiety, as the purpose of such models is to
inform prevention and intervention efforts (Zvolensky, Schidt, Bernstein, & Keough, 2006).
Additionally, current risk factor models for social anxiety do not include detailed
neurophysiological insights (Degnan et al., 2010; Ollendick & Benoit, 2012; Rapee & Heimberg,
1997; Rapee & Spence, 2004). Future studies should take these findings into consideration when
designing neurophysiological experiments that assess the relationship between BI and social
anxiety.
Conclusions
The ultimate goal of research into mental health conditions is to improve patient
outcomes. An immediate goal of examining biological etiology of disorders is to someday
combine the genetics and neurophysiology into well-powered studies. The field of imaging
genetics is improving daily mostly by way of increasing sample sizes (Moore, Sawyers, Adkins,
& Docherty, 2017). The current study did not find strong neurophysiological links between
social anxiety and a strong risk factor for it, BI. Nevertheless, null findings can be clinically
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useful by providing insights into what type of information is not ready to be translated. Perhaps
the field of imaging genetics is not the way forward for research into the etiology of preadolescent social anxiety.
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Chapter 9: Final Risk Factor Model for Social Anxiety Disorder and Translational
Implications
Recap of Purpose and Findings
The purpose of this dissertation was to examine the translational capacity of psychiatric
genetic research in broad and specific ways. It was divided into three aims. Aim 1 assessed the
state of the science regarding the translation of the genetic information to the clinical care of
mental health disorders from an academic perspective. Aim 2 examined the genetic and
environmental risk factors of social anxiety disorder and developed a genetically-informed risk
factor model for the disorder. Aim 3 assessed the inclusion of neurophysiological data into the
risk factor model for pre-adolescent social anxiety disorder.
Aim 1 (chapter 3) was accomplished via a survey that was sent to academic stakeholders
in mental health-related fields. The survey queried participants across three areas: professional
translational practices, genetic knowledge and competence, and the translation of genetic
information related to mental health. Overall, participants had moderate levels of self-reported
translational practices and were familiar with translational science. They also reported moderate
levels of genetic knowledge but weaker levels of genetic competence. Accordingly, they did not
have strong positive attitudes toward the impact that translating genetic information could have
on mental health care except for disorders for which there is more biological knowledge or
understanding. This indicates a translation-genetic competence gap whereby genetic knowledge
reinforces linear ways of viewing translation that include solely the inclusion of molecular
genetic information. Genetic competence is needed to think outside the box and utilize nonmolecular genetic information in non-linear frameworks (e.g., dissemination & implementation
[D&I], prevention science).
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Aim 2 (chapters 6 and 7) focused the translational scope to pre-adolescent social anxiety,
as all translation still requires basic science information and must start somewhere. The
mechanisms of specific genetic and environmental risk factors for social anxiety were
disentangled and contributed to a detailed risk factor model that may have more translational
capacity. Specifically, it was found that there is a robust biometrical relationship between social
anxiety and behavioral inhibition (BI) that is potentially causal. When adding an additional risk
factor into this model, parental bonding (specifically overprotectiveness), it was found that
overprotectiveness did not have a direct effect on social anxiety nor a moderating effect on the
relationship between BI and social anxiety.
Aim 3 (chapter 8) attempted to examine the neurophysiological connection between BI
and social anxiety as a way to provide additional biological insight. Specifically, the relationship
between each phenotype and emotional reactivity (assessed via amygdala activation) as well as
the moderating effect of emotion reactivity were examined. No strong neurophysiological links
were found between BI and social anxiety. These null findings do provide clarification to past
literature and indicate that pre-adolescence may be too early in development to detect these
neurophysiological connections between the phenotypes. They also imply that genetic etiology is
more informative knowledge that can influence risk factor models and eventual prevention and
intervention efforts for social anxiety (see chapters 6 and 7).
Together the findings from aims 2 and 3 provide evidence that childhood BI is a putative
endophenotype for later social anxiety. Endophenotypes are “intermediate” phenotypes that lie in
the etiological pathway between genetic variation and a disorder (Cannon & Keller, 2006;
Gottesman & Gould, 2003). The results from aim 2 (chapter 6) add further support to this claim.
The five criteria of an endophenotypes are: (a) the endophenotypes is associated with illness in
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the population; (b) the endophenotypes is heritable; (c) the endophenotype is state-independent;
(d) the endophenotype and illness co-segregate in families; (e) the endophenotype is found in
non-affected family members at higher rates than the general population (optional criteria). BI
has previously been shown to meet the first three requirements across various studies. The
current study adds to these first three criteria and adds substantial evidence for the fourth
(instantiated here as cross-phenotype correlations within twin pairs which show that the coaggregation is primarily due to genetically-informative factors). No study to date has provided
evidence for the fifth criteria. The fifth criteria could be tested using a more expansive set of
questionnaires or behavioral measures. For example, parents of twins in the current study could
have been queried about their history of BI (although this is not the best measure of the trait) or
questionnaires could have been given to parents to fill out about their non-twin children’s history
of BI, social anxiety, and related constructs.
Risk Factor Model
A goal of this dissertation was to provide a new risk factor model for social anxiety that
could be easily expanded in the future after investigation of other risk factors and which also
included genetic and neurophysiological information. Such a risk factor model could have
translational implications for those preventing and treating pre-adolescent social anxiety,
although right now the true translational implications are unknown (see Translational
Implications - Social Anxiety Risk Factor Model below). Figure 9.1 presents the final risk factor
model for pre-adolescent social anxiety based upon the findings from this dissertation. As a
reminder, past risk factor models have been broad in their included factors (Degnan et al., 2010;
Ollendick & Benoit, 2012; Rapee & Heimberg, 1997; Rapee & Spence, 2004). The current
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dissertation took the opposite approach and is meant to complement these past models, not serve
as a competing model.

Figure 9.1. Final risk factor model for aim 2 of this dissertation.
Specifically, the model depicts the relationships found in this dissertation in a visually
engaging manner. The goal is to examine the development from BI, red, to social anxiety, purple.
All risk factors of importance are in varying degrees of blue shading on the right. Risk factors
that were not found to be important are in gray on the left. It is hoped that this risk factor model
may be expanded in the future. There are many other risk factors that impact both BI and social
anxiety that were not discussed in this dissertation. These include parental anxiety (Ollendick &
Benoit, 2012), parent information processing (Ollendick & Benoit, 2012), child information
processing (Ollendick & Benoit, 2012), attachment (Ollendick & Benoit, 2012), and peer
relations (Degnan et al., 2011). The structure of the current risk factor model would make it easy
to update given new etiological insights into the relationship between BI and social anxiety.
Translational Implications
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This dissertation examined translation first at a broad level by examining the translational
implications of psychiatric genetic research and second at a specific level by creating a social
anxiety risk factor model. To discuss the translational implications of this dissertation, it is
crucial to return to the foundational questions of the field of psychiatric genetics. The three key
questions of the field are: (a) do genes affect a trait, (b) how much do genes affect a trait, and (c)
where/what are the genes. As discussed in chapter 1, most psychiatric disorders are common and
the product of the environment plus hundreds or thousands of genes. Thus, additional questions
need to be posited which complement the core three. These are: (a) is this information
actionable, (b) if so, for whom is this information actionable, (c) how can this information be
used, and (d) what are the barriers to using this information. Such questions make the field of
psychiatric genetics, and genetic information in general, more approachable for all stakeholders
involved in translating such information to clinical care. The next two sections reflect upon and
discuss these questions in the context of the translational survey and social anxiety risk factor
model.
Translation of Non-Molecular Genetic Information into Mental Health Care
The findings from the survey in aim 1 (chapter 3) are immediately actionable
information, albeit in a small way. Steps should be taken to continue this research and ultimately
examine the translational capacity of non-molecular information in mental health care. This
would involve perspectives from all possible stakeholders over many stages of research
development. Stakeholders may include public heath specialists, health educators, psychologists,
psychiatrists, therapists, social workers, researchers, patients and their families, and
administrators. To avoid the barrier likely created by the survey of asking an overly broad
question, this line of work should limit its scope. This research should focus on a specific
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disorder moving forward to help facilitate involvement of stakeholders with key areas of
expertise.
For example, a broad idea of how this line of research could be carried out is as follows:
(a) Create a new instrument that specifically assesses the incorporation of non-molecular genetic
information into treatment and recovery efforts for alcohol use disorder (AUD) on a college
campus. This step will involve building partnerships with collegiate recovery groups, campus
health educators, and researchers. It will also require qualitative, inductive approaches such as
focus groups and interviews prior to the creation of a new survey instrument. (b) Based upon
findings from step 1 as well as known barriers to the incorporation of genetic information in
clinical care, a research agenda that involves many stakeholders will be created next. This may
involve experimentally testing the incorporation of non-molecular information into on-campus
treatment settings, creating workshops about the genetic epidemiology of AUD, deducing which
components of genetic information are most effective in which settings, testing which
stakeholder groups utilize the information the most, and so on. (c) Finally, application of these
findings to other common mental health disorders and different environments would be explored.
Thus, this information is actionable and for the key stakeholders mentioned above. How
the information can be used as outlined above is hypothetical and will change based on
collaboration and communication from future stakeholders per a socio-ecological-focused
translational perspective. The possibilities are endless. For example, patients could find great
meaning from learning basic psychiatric genetic information in a clinical setting, workshops may
help individuals with certain disorders or be used to train stakeholders, patients may want this
information to guide reproductive decisions, and there are also ethical implications that should be
explored. However, it might not be wise to incorporate genetic information into clinical care
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(Lebowitz & Ahn, 2017; Lebowitz & Applebauk, 2017) and any attempts to do so need to be
carefully researched. Future work in this area is contingent on addressing multiple barriers to this
process. A key main barrier, which was found in the survey, is the translation-genetic
competence gap. This ties heavily into the already cited education and engagement of
stakeholder gaps. There is a big need to overcome the assumptions made about genetic
information, namely that non-molecular information holds much promise. Again, this is likely
best accomplished through socio-ecological translational frameworks such as D&I and
prevention science where the emphasis will be on the prevention, intervention, treatment, and/or
recovery of a specific disorder.
Social Anxiety Risk Factor Model
Findings from aims 2 and 3 (chapters 6-8) provide less of an immediate, actionable
product. There is a need to step away from the traditional academic model of not only relying on
linear frameworks, but relying on traditional academic translational methods of discussing the
model with peers and publishing. A big hurdle in translating knowledge to practice is the gap
between academic publishing goals and policy-oriented interest of public / behavioral health
(Baldwin et al., 2017). There is a need to overcome this academic barrier; only then will this
model (or a version of it) be implemented into care. There is a need to emphasize factors and
stakeholders that are outside of this academic impact, such as community engagement, network
building, and practical application of evidence (Baldwin et al., 2017). It also needs to be
explored how well a risk factor like the current one aligns with current best practices.
Thus, D&I or prevention science frameworks will allow for this linear-appearing model
to be collaborative and socio-ecological. This can only happen by not simply publishing the risk
factor model and hoping that pediatric clinicians utilize the information. The use of focus groups,
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clinical stakeholders from academic and non-academic environments, patients, and families need
to be consulted. This can happen through focus groups, targeted surveys, and a more inductive
approach. To summarize, this information is potentially actionable for researchers, clinicians,
and/or patients if it can be used in a clinical setting and key barriers can be overcome.
Final Thoughts
After thinking about translational science broadly and in the context of psychiatric
genetics for many years, it is only appropriate to end this dissertation with a novel and inclusive
definition of the term. To me, translational science is a way of approaching science and practice
that, at minimum, integrates perspectives from researchers, clinicians, and patients. Specific
behaviors vary by framework, but broadly translational science involves constant
communication, cooperation, and partnership between all interested parties to further patient
outcomes. It is my sincere hope that all stakeholders embrace this definition, but especially those
in the field of psychiatric genetics. If even a fraction of the emphasis can be removed from
molecular genetic information and efforts and put toward non-molecular genetic information,
perspectives can shift. Through such a shift, true partnerships and dialogues can be formed that
will propel the field forward and usher in an era of genetically-informed mental health care.
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